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SUMMARY 
The lungs are protected against the toxic effects of 
inhaled dusts al'!d infectious agents by a variety of innate and 
adaptive responses. However the production of antibody against 
seemingly il'\(\oCUOUS organic dusts can occasionally be associated 
with hypersensitivity lung disease. The most commonly recognised 
of these pulmonary h~persensitivity, or allergic, states are 
acute extrinsic asthma and extrinsic allergic alveolitis. Acute 
asthma is an obstructive respiratory disease due to an 
anaphylactic reaction in the central airways and the symptoms 
occur classically within 30 minutes of antigen inhalation. The 
role of IgE antibody to the inhaled antigen in the pathogenesis of 
the disease is well established. Alveolitis, on the other hand, 
is a respiratory disease with a restrictive ventilatory defect 
associated with additional systemic symptoms of fever and malaise, 
which becomes apparent 4 - 8 hours after antigen exposure. The 
patients often have serum IgG antibody to the inhaled antigen but 
the role of this antibody in the pathogenesis of the disease is 
unresolved. This report examines some humoral immune parameters 
and their involvement in the pathogenesis of extrinsic allergic 
alveolitis. The patients under investigation were individuals 
who were regularly exposed to organic dusts during the husbandry 
of pigeons. This exposure can cause one syndrome of alveoli tis 
namely pigeon breeders disease. This disease is a very useful 
working model of alveoli tis since the population at risk can be 
easily identified and the relevant antigens purified. 
The main antigens were the avian equivalent of secreted 
IgA, and fragments of this molecule, readily found in saline 
soluble extracts of pigeon droppings and of the fine powder 
coating feathers. This protein has partial immunological 
identity with the main pigeon serum gammaglobulin antigen, and the 
common antigenic determinants were on the immunoglobulin light 
chains. 
The serum IgG antibody response against these antigens 
was quantified by radio-immunoassay in a population of pigeon 
breeders. The antibody levels in non-exposed individuals were 
very low; always less than 4 ug/ml, and by comparison, the levels 
.xv • 
could be measured at approximately 500 ug/ml in the most florid 
responders among the pigeon breeders. Very few of the subjects 
had these high titres, however, and the distribution of antibody 
levels in a population of pig~on breeders demonstrated that 
increasing numbers of subjects had lower IgG levels with about 
half of them having insignificant levels, despite extensive avian 
exposure. The population could therefore be separa ted 
arbitrarily into an antibody non-responder or tolerant, group, and 
high and low responder groups. Some constitutional and 
environmental factors which might have had a bearing on this 
responsi veness weri e>camlned. 
Cigarette smoking appeared to have a profound inhibitory 
effect on the ability to mount an antibody response to the inhaled 
antigens and this effect was reversible since some ex-smokers had 
raised antibody levels. The extent of the antigen exposure also 
affected the antibody response. The'monthly serum antibody level 
was seen to fluctuate in parallel with the amount of time 
individuals spent with their birds due to seasonal requirements of 
husbandry. However, in population studies there was an 
association between increased avian exposure in decades and 
decreased antibody levels, which was unrelated to the age of the 
individuals. This suggests that either a tolerogenic or 
desensitisation mechanism exists or that there is some 
self-regulation of exposure in the symptomatic population; for 
example as individuals with high antibody levels develop disease, 
they will moderate their exposure in an attempt to remain 
asymptomatic thus reducing antibody levels. Thus the high 
antibody responders may be under-represented in the groups with 
progressive exposure. 
The constitutional factors of age, HLA and P1 phenotypes, 
and the atopic status have no bearing on the antibody 
responsiveness and disease. 
The subjects with the most vigorous antibody response in 
the IgG class also had the most florid responses in the IgA and 
IgM classes. Furthermore when antibody activity was me~sured in 
the IgG subclasses, it was found in all four in proportion to the 
total IgG activity. There was therefore a spectrum of 
responsiveness to the inhaled antigens, and the subjects with 
xvi. 
alveoli tis tended to be in1he high-responder group. The high-
responder group included almost all the subjects with raised total 
immunoglobulin of the three major classes and most of the subjects 
with raised acute phase proteins, moreover this group also had a 
high incidence of serum immune complexes and reduced mean levels. 
of complement components, suggesting that in these subjects there 
was an active inflammatory response allied to the active antibody 
response against the antigens to which these individuals are 
constantly exposed. 
A close association between antibody and disease was 
observed, with the incidence of alveoli tis rising from 3.7% in the 
antibody negative group to 50% in the subjects with greater than 
50 ug/ml, and virtually everyone with IgG antibody greater than 
150 ug/ml had alveoli tis. Furthermore in population studies 
investigating the symptoms associated with alveolitis, the 
antibody levels increased with an increasingly complete 
description of the classical symptom of the disease. In order to 
correlate antibody with the disease process of alveolitis, serial 
measurements of serum immunological parameters were made in 
subjects at different phases of the disease. During the acute 
phase of disease in individuals following inhalation challenge 
wi th antigen there was an association between symptoms, 
physiological changes and the formation of immune complexes with 
evidence of complement activation and production of C3d. 
Conversely, in subjects convalescing after an acute episode of 
alveoli tis there was a very rapid fall in circulating immune 
complex level, the specific IgG titre falling with a half-life 
similar to the normal IgG turnover and there was a slow return to 
normal levels for the total immunoglobulins and C4 levels. 
Skin testing these pigeon breeders with common allergens, 
specific avian antigen and tuberculin has demonstrated that the 
atopic status had no bearing on the disease incidence of 
alveolitis. There was, however, a high incidence of immediate 
weal and flare reactions following intracutaneous injection of 
pigeon serum antigens and the weal diameter correlated with the 
titre of specific IgG and not with to~al IgE. This suggested 
that a possible anaphylactic activity was associated with this 
antibody, and future considerations of disease mechanism must take 
xvii. 
this into consideration, perhaps as an initial trigger for the 
subsequent immune-complex mediated disease. There was an 
association between cutaneous anergy to tuberculin and active 
disease, and there were also no delayed 48 - 72 hour reactions 
against the avian antigens, despite the probable presence of 
sensi tised lymphocytes· in these subjects. This suggests that 
cellular immune mechanisms were also involved in the disease. 
CHAPTER 1. 
INTRODUCTION 
1. PULMONARY IMMUNOLOGY. 
The large gas-exchanging area of the lung is protected 
against inhaled bacteria and the toxic effects of airbourne dusts 
by combinations of various mechanisms of host defence. These 
include the innate properties of the lung such as reflex coughing 
or bronchoconstriction and also the anatomical structure of the 
airways which cause inhaled particles to impact onto the walls of 
the airways which are lined with ciliated epithelium down to the 
level of the terminal bronchioles. These cilia constantly waft a 
layer of mucus; the "mucociliary blanket", with the impacted 
dust up into the back of the throat. Inhaled particles which 
penetrate to the peripheral airways (respiratory bronchioles and 
alveolar spaces) are met by the phagocytic alveolar macrophages, 
and a range of soluble proteins which deter the settlement of 
micro-organisms, these include the iron scavengi~g properties of 
lactoferrin, "natural" antibody and complement components. 
The lung is not just a passive framework protected by 
serum derived antibody and cells, but is increasingly understood 
to function autonomously as an immunoresponsive organ. The 
production of local antibody and the beneficial effects of local 
rather than systemic vaccination was first studied by Fazekas de 
St. Groth (1950) using influenza infections in ferrets as a model 
of respiratory disease. The comparative effects of pulmonary 
immunisation and parenteral immunisation on local and serum 
antibody and cellular immune responses was outlined in a series of 
papers by Waldman and colleagues (1971, 1972,1973) in both humans 
and experimental animals. This work demonstrated the predominance 
of pulmonary antibody and cellular responses following local 
rather than systemic immunisation, and the relatively poor local 
immune responsiveness to parenteral immunisation. The benefits 
of respiratory vaccination for health care programmes and for the 
economy form the basis of recent reports (Developments in 
Biological Standardisation, 1975; Chanock, 1981). 
2 
The respiratory system can be arbitrarily divided into 
upper and lower (central or peripheral) airways, at the 
broncho-alveolar junction; between the terminal and respiratory 
bronchioles. This arbi~rary division corresponds operationally 
to distinct immunolog~cal structure and function. The general 
physiological features of the central airways consist of· 
vascularity mediated by the bronchial artery, a rich nerve supply 
of chiefly cholinergic fibres, atropine sensitivity and an 
immunological responsiveness mainly mediated by IgA and IgE, and 
low molecular weight mediators. Peripheral airways are 
characterised by a vascular supply from the system of the 
pulmonary artery, a poor nerve supply and a mainly cell mediated 
or IgG and IgM immune responsiveness. 
This immune responsiveness is mediated by the extensive 
fixed lymphoid tissue present throughout the lung. This tissue 
has been described classically by Arnold in 1880, but has been 
recently redefined by Bienenstock, Johnson and Perey (1913) and is 
now known by the acronym BALT (bronchus-associated lymphoid 
tissue). This includes the regional lymph nodes (the mediastinal 
and hilar nodes) which drain the lymph of the respiratory system, 
the lymphoid nodules strategically sited at branchings of the 
large and medium-sized bronchi, and the lymphoid aggregates sited 
in the submucosa and in the lamina propria particularly in the 
lower respiratory tract. 
The organisation of this tissue is progressively simpler 
from the proximal airways to the peripheral air spaces. The 
lymph nodes are complex structures similar to others of the human 
reticulo-endothelial system. The lymphoid nodules contain 
follicles but lack capsules, and they extend from subepi thelium 
through submucosa to the peribronchial connective tissue. The 
nodules are covered on their air side by a single layer of 
flattened, nonciliated epithelium which is infiltrated by 
lymphocytes; and called lymphoepithelium (Chamberlain, 
Nopajaroonsri & Simon, 1913). Ultrastructural analysis demon-
strated an abundance of lymphatic channels and blood vessels 
within the follicles and provided morphological evidence for both 
transvascular and transepithelial migration of lymphocytes. 
Therefore a potential pathway exists for the interchange of 
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lymphoid cells among vascular, interstitial and intra-alveolar 
compartments. 
The morphological similarities between these nodules and 
similar structures in the gut have been drawn by Bienenstock et al 
(1973) and he sugges~ed a common mucos.al immune system. The 
lymphoid aggregates are compact accumulations of lymphocytes and 
mononuclear phagocytes, they are very prominent in the respiratory 
broncioles and are separated from the lumen also by 
'lymphoepi thelium' • These lymphoid structures are in direct 
contact with the blood vessels and close to the respiratory 
membrane, and are called von Hayek's lymphoepithelial organs (von 
Hayek, 1960). Lymphatic capillaries originate within these 
aggregates as blind pouches close to the respiratory membrane and 
the smallest branches of blood vessels. The alveolar clearance 
afforded by the lymphatic system is of vital importance and is the 
subject of an extensive review (Lauweryns & Baert, 1977). 
When an antigen is inhaled or experimentally instilled 
via the trachea it is taken up by these areas of lymphoepithelium 
(Racz et al, 1977) and processed in the local lymph nodes. This 
route was first demonstrated using dye uptake (Correll & Langst~n, 
1958). The kinetics of the subsequent antibody and cell mediated 
immune resp~nses in experimental animals is reported widely in the 
literature; one typical report is by Brownstein et al (1980). 
These workers instilled sheep erythrocytes into one lobe of a 
canine lung. They found histological evidence of an immune 
response within 2 days in the ipsilateral tracheobronchial lymph 
nodes, and on day 5 in immunized lung lobes. Pulmonary lymphoid 
infiltrates appeared initially around pulmonary venules and veins. 
There was expansion of the infiltrates into alveolar spaces, where 
mixed mononuclear aggregates were formed in association with 
alveolar macrophages 7 days after immunization. A similar but 
attenuated and delayed response occurred within contralateral 
control lung lobes, although mononuclear aggregates· were not 
found. Activated lymphocytes in lavage samples increased prior 
to histological evidence of pulmonary lymphoid infiltrates. The 
authors suggested that after intrapulmonary immunization the lung 
recruits circulating immunocytes produced in ipsilateral 
lung-associated lymph nodes as a source of specific antibody-
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forming cells in bronchoalveolar air spaces. This is in 
agreement with experimental lymphocyte recirculation in mice where 
there is pulmonary recruitment of lymphocytes after 48 hours 
(Emeson & Veith, 1979). Cell transfer experiments using 
radiolabelled thoracic duct cells from rats have demonstrated an 
enhances traffic of recently divided "effector" cells, 
predominantly B-cells, into the lung (Beacham & Daniele, 1982). 
Moreover, antigen specific recruitment of circulating T-cells into 
the lung has been shown in guinea-pigs following intratracheal 
administration of influenza virus (Lipscomb et aI, 1982), and 
recruitment of specific T-cells with cytotoxic effector cell 
activity into the lungs of mice has been observed following 
immunization with alloantigenic P915 cells (Llu, Ishizaka and 
Plant, 1982). Earlier work has shown that pulmonary 
T-Iymphocytes exhibit memory, since a lymphokine response can 
occur 2-3 days sooner following a booster (Gado, Johnson and 
Waldman, 1974; Clancy et aI, 1978). Such information is 
unfortunately not available for humans. However, by using 
fibreoptic bronchoscopy it has become possible to lavage the human 
peripheral lung and obtain a profile of the local cells and 
proteins (Reynolds & Newball, 1974; Daniele et aI, 1975). The 
T-B lymphocyte ratio in lung lavage is the same as in peripheral 
blood, but there is a larger number of null cells; up to 30%. 
The percentages of these cells are altered by smoking, where the 
total number and percentage of alveolar macrophagesis increased, 
and in various pulmonary diseases such as sarcoidosis (Crystal et 
aI, 1981), and also by extrinsic allergic alveoli tis and 
cryptogenic fibrosing alveoli tis (Reynolds et aI, 1977) where 
increases in local T-cells and neutrophils are thought to account 
for and perpetuate disease. 
The predominant local humoral antibody response involves 
secretory antibody, and the work in this field was pioneered by 
Tomasi and Grey (1972). The respiratory secretions contain IgG, 
IgA, IgM and IgE and the relative amounts of these differ markedly 
from serum. Secretory IgA is the predominant immunoglobulin in 
the upper respiratory fluids (saliva, nasopharyngeal· and 
tracheobronchial secretions) whereas IgG is predominant in the 
serum. Lavage fluid from the lower respiratory tract contains 
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intermediate levels of IgG and IgA (Reynolds & Newball, 1914 ; 
Kal treider & Chan, 1916) • In general, IgA, IgM and IgE are 
present in secretions in amounts greater than can be explained on 
the basis of transudation from serum; this, therefore suggests 
either some local synthesis or selective active transport. There 
. 
has been some transudation of radiolabelled IgG from serum 
measured in the airways therefore the local and systemic antibody 
levels cannot be strictly separated, however, local synthesis of 
all the immunoglobulins has been shown by immunofluorescence by 
Martinez-Tello, Braun & Blanc (1968), Tada & Ishizaka (1910) and 
Tomasi & Grey (1912). IgA producing cells have been demonstrated 
in the lamina propria and submucosa of the entire respiratory 
tract. This locally synthesized IgA is secreted from plasma 
cells as a dimer linked by a J-chain. This IgA dimer combines 
covalently to secretory component in epithelial cells and is 
transported across the cells in endocytic vesicles to the lumen 
(Goodman et aI, 1981), 90% of IgA in bronchial secretions is in 
this form. 
The BALT cells do not stain for cytoplasmic 
immunoglobulin but consist of predominantly B-cells and null 
cells, and BALT is thought to be a repository for precursors of 
antibody producing cells of IgA, IgG and IgE classes (Bienenstock, 
Clancy & ·Perey, 1916) • BALT cells can repopulate the lamina 
propria of both lung and gut mucosa with IgA producing cells 
following lethal irradiation of recipient animals (Rudzik et aI, 
1915). This suggests a route of recirculation following antigen 
stimulation, maturation then local antibody production of specific 
IgA. It also suggests that there may be a common mucosal 
immunity (Bienenstock & Befus, 1980). This is supported by a 
reported link between pulmonary and urinary tract IgA production 
against E. coli 06 in the bladder (Mat tsby, Hanson & Kaijser, 
1919). 
Local pulmonary antibody production is controlled 
primarily by T-cells, but other non-specific controlling factors 
include the effects of alyeolar macrophages and pulmonary 
surfactant. Macrophages have a central role in the immune 
response (Rosenthal, 1980) and a similarly important role is 
emerging for the alveolar macrophage (Brain et aI, 1918; Hocking 
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& Golde, 1919). These macrophages can modulate the antibody 
response depending on the macrophage:lymphocyte ratio. When this 
ratio is the same as in normal lung there is an in vi tro 
im~unosuppressive effect on peripheral blood lymphocyte 
stimulation (McCoomb~ et aI, 1982), and when the macrophage 
numbers are reduced the effect is stimulatory (Kaltreider, 1982). 
Pulmonary surfactant material isolated from lung lavage 
fluid contains a potent non-cytotoxic suppressor of lymphocyte 
proliferation (Ansfield et aI, 1919) but the nature of the active 
substance is still unknown even after considerable biochemical 
analysis. It is possible that this effect is caused by a soluble 
factor derived from alveolar macrophages (Yeager, Barsoum & Kagan, 
1980). 
The importance of the immune system in protecting the 
lung is best emphasised by the high incidence of pulmonary 
infections in situations where a patient is immunodeficient or 
immunocompromised either as an unwanted side effect of cancer 
chemotherapy or deliberately in an attempt to induce a host to 
accept transplants, or just non-specifically following surgery 
(Williams, Krick & Remington, 1916). In this latter case, there 
was an incidence of post-operative bronchopulmonary infections in 
38% of one series of patients (Lazlo et aI, 1913). 
Immunodeficiency can be a severe life threatening 
disorder of infants, however, recently there is increasing 
recognition of defects both mild and severe in almost every 
component of the immune system in both children and adults. 
Antibody deficiencies are related to frequent bacterial infections, 
commonly Staphylococcus aureus and Streptococcus pneumoniae. By 
far the commone~t immunoglobulin defect seen in one study of 43 
young people with severe recurrent respiratory infections was a 
gross or partial selective IgA deficiency (Turner-Warwick, 1915). 
Of interest in this respect was the association between transient 
IgA deficiency in children and development ·of atopy caused by 
ineffective clearance of allergens (Taylor et aI, 1913), however 
rather than being cause ~ and effect, these may both be a 
consequence of a more fundamental immunological defect. A 
selecti ve IgA deficiency can occur in I in 100 normal heal thy 
subjects and the difference between these and IgA deficient 
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subjects who develop recurrent infections was found to be due to a 
co-existing IgG2 deficiency in 7 out of 43 patients (Oxelius et 
aI, 1981). Selective deficiencies in IgG subclasses were found 
in patients who had normal IgG lev~ls and had recurrent pulmonary 
infections (Schur et aI, 1970). Four other patients who had 
frequent pneumonia and bronchiectasis had completely normal 
immunoglobulin profiles except for a virtual absence of IgG4 (Beck 
& Heiner, 1981). T-cell deficiencies, however, are associated 
primarily with opportunistic infections caused by viruses and 
fungi; Candida albicans, Aspergillus fumigatus and Pneumocystis 
carinii. Defects in neutrophil function along with serum 
complement 
infections. 
deficiencies also predispose to repeated lung 
Alper et al (1972) described a congenLtal complement 
deficiency of C3 in a patient with recurrent pyogenic infections, 
and the importance of an intact complement system for the 
cleara~ce of Gram positive organisms was demonstrated 
experimentally by Gross, Rehm & Pierce (1978). This complement C3 
requirement for efficient killing of S.aureus 502A, but not E.coli 
ON2, by normal human neutrophils was confirmed by Repine et al 
(1979J. A defect in cellular chemotaxis was reported to 
predispose to recurrent infections (Witemeyer & Van Epps, 1976) 
and this type of defect was considered to be part of a common 
membrane disturbance which was correlated with defective 
opsonization and recurrent pneumonias in paediatric patients 
(Murphy & Van Epps, 1979). The effects of immunodeficiency on 
pulmonary infections are reviewed more extensively by 
Turner-Warwick (1978) and Williams, Krick & Remington (1976). 
2. HYPERSENSITIVITY LUNG DISEASES. 
Despite the obvious benefits of these immune responses in 
maintaining the integrity of the lung and the sterility of the 
peripheral airways, they can also be involved in hypersensitivity 
reactions resulting in local tissue damage. It is difficult to 
draw a concise list of the various immunologically mediated lung 
diseases because virtually all lung diseases have some degree of 
immunological involvement. However, conditions which would not 
strictly comply would include for example recurrent pulmonary 
infections which commonly occur in immunodeficient or 
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immunocompromised patients, adult respiratory distress syndrome, 
silicosis and some forms of primary lung cancer which may involve 
altered immune surveillance. The lung is also a common site for 
tissue damage in the collagen vascular diseases and although they 
undoubtedly involve .immune.hyper-reactivity the pulmonary disease 
is only one part of a multi-organ system, therefore this disease 
could be classified on the periphery of the hypersensitivity lung 
diseases. There are also difficulties classifying diseases which 
are undoubtedly hypersensitivities, for example the same antigen; 
Aspergillus can cause at least three pat terns of disease, i. e. 
asthma, alveoli tis or both. The diseases sarcoidosis and 
cryptogenic fibrosing alveolitis are also difficult to classify 
because there is no clear aetiological agent and the pathogenesis 
involves a complex interaction of both cellular and humoral 
hypersensitivity. However, the flow chart (Table 1) includes a 
simplified version of current views of the involvement of the 
immune system in the main hypersensitivity lung disorders. 
a) The major classes of hypersensitivity lung disease. 
Immediate hypersensitivity (Type 1): 
This involves the release of mediators from reagin-sensitized mast 
cells, causing increased vascular permeability, oedema and smooth 
muscle contraction. The major reagin in man is IgE and the 
classical immediate hypersensitivity disease is extrinsic asthma 
where antigens recognised by the IgE can trigger an acute episode. 
More recently a similar anaphylactic acti vi ty for IgG has been 
described, however, this activity has not been conclusively 
designated to any of the four subclasses, although IgG4 has 
received considerable attention. Several other non-immunological 
factors contribute to the disease such as bronchial 
hyper-reactivity, infection, irritants, exercise, emotion and 
aspirin. These factors predominate in some adult asthma where no 
immunological senstivity can be detected. 
Cytotoxic, antibody-mediated disease (Type 2): 
The clearest example of this is Goodpasture's syndrome 
(glomerulonephritis and pulmonary haemorrhage). This disease is 
produced by auto-antibOdy which reacts with glomerular and 
cO 
en 
Type 1 (lmmedia.te lIypen;eruiilivily) 
Antigen Cell-bound ___ Mast cells releu.se Anaphylaxis 
Rcagenic Chemical Smooth muscle contraction and bronchospasm 
An tibody Mediators }'l ucus stimulation 
(lgE, IgG) (Histamine, SRS., and Influx of eosinophils (chemotactic stimuli) 
leukotrienes ) 
Type 2 (Cytotoxic) 
Autoantibody __________ _ Cell-bound __ Cell-lysis 
Type 3 (Arthllii) 
(?Faulty T-.suppressor 
cell function) 
Antigen (1 Antibody-mediated cytotoxicity) 
Antigen _ Antibody Activation __ Chemotactic 
Complex I Alveola.r Factors 
(ll-Lymphocytes) :\lacropha.gc:; (C5a and of 
macropha.ge origin) 
Complement Proteolytic enzyrnl's . Altered ~TOXiC O~ radicaLs Fibroblas ts 
, Type 4 (Delayed hyperseruitivity) 
Antigen _. :\lononuclcar _____ _ 
Cell activation 
T-lymphocytcs 
T..;helper, T suppres:;or 
Cell imbalance 
Colla.genase Collagen synthesis 
~~;~OPhiLs} Alveoli!is __ Inten:;titia.l _~ __ Fibrosis 
LymPhOC%E i/mmation 
Lymphokinc __ :\Iacrophage Epithelioid cell 
Secretiorui Activation and Differentiation 
:\lIF altered mobility Granuloma 
B cell stimulation 
(T-helper) 
TABLE 1. Some pathways of involvement of the immune ~ystem in the disease processes 
of the four major classes of hypersensitivity reaction. 
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alveolar basement membrane (Dixon, 1968). 
Immune complex, Type 3 and cellular, Type 4 hypersen-
sitivity: 
In practice there are no examples of either of these 
disease profiles in isolation. There is, however, a spectrum of 
. 
presentation with relatively more evidence for immune complex 
damage at one end, and cell mediated tissue damage at the other. 
Cryptogenic fibrosing alveoli tis (idiopathic pulmonary fibrosis) 
is one example where there is a consistent finding of a granular 
pattern of IgG and C3 shown by immunofluorescence in patients with 
predominantly cellular changes associated with high titres of 
auto-antibody (Turner-Warwick, Haslam & Weeks, 1971), but not in 
patients with predominantly fibrosis. IgG in the airway 
secretions and in blood, often in the form of immune-complexes 
. 
seems to be clearly associated with the inflammatory cell reaction 
in lung tissue, and circulating titres of immune complexes 
correlate well with the degree of cellularity of histological 
lesions (Dreisen et aI, 1978). The postulated sequence of events 
commences with immune complex formation with as yet an 
unidentified ant~gen, these complexes activate the pulmonary 
macrophages to release chemotactic factors which can cause an 
influx of inflammatory cells, which set in motion a cycle of 
tissue injury resulting in pulmonary fibrosis. This is supported 
in part by the ~linical improvement seen in patients at the 
cellular, immune-complex stage of disease, on treatment with 
corticosteroids. There is also a possibility of Type 4, cellular 
hypersensitivity involvement since isolated peripheral blood 
lymphocytes from cryptogenic fibrosing alveoli tis patients can 
produce a lymphokine; macrophage migration inhibition factor, and 
undergo blastogenesis on exposure to collagen (Kravis et aI, 
1976). 
Isolated immune complex reactivity also appears to be the 
primary disease mechanism in patients with rheumatoid lung 
disease. The lung diseases associated with rheumatoid arthritis 
include pleural disease, vasculitis, nodules, Caplan's syndrome 
and pulmonary fibrosis. The association of rheumatoid lung 
disease with high-titre rheumatoid factor is suggestive of 
immunopathogenesis. This is supported by measurement of high 
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concentrations of immune complexes and decreased concentrations of 
complement in the pleural fluid of patients with rheumatoid 
pleuritis, and the presence of pulmonary vasculitis with deposits 
. of immunoglobulin and IgM rheumatoid factor in pulmonary vascular 
and alveolar walls. It seems likely that immune-complex 
mechanisms are important also in non-infectious pulmonary 
manifestations of other collagen vascular diseases (Hunninghake & 
Fauci, 1979). 
The classical example of Type 4 hypersensitivity is cell 
mediated immunity to tuberculin, where all the pulmonary 
histological finding can be accounted for by sensitised 
lymphocytes. Another disease is chronic beryllium disease in 
which sensitisation by inhaling beryllium dust results in 
primarily cell mediated mechanisms. 
One systemic granulomatous disease which affects the 
lungs and in which the causative agents is unknown is sarcoidosis. 
The response is primarily a T-cell mediated inflammatory reaction 
wi th mononuclear pulmonary infil tra te and granuloma. forma tion. 
The local pulmonary cells collected by lung lavage contain a very 
high percentage of T-helper cells, and thes~ are thought to 
stimulate the local production of IgM as well as the high local 
and circulating total immunoglobulins. Patients have a decreased 
Circulating T-helper cell population and this may account for the 
associated cutaneous energy (Crystal et aI, 1981). There is also 
a high incidence of serum immune complexes in these patients but 
their significance is unknown. 
One lung disease syndrome in which there is compelling 
evidence for both Type 3 and Type 4 hypersensitivies is extrinsic 
allergic alveolitis, which therefore occupies a central position 
in the spectrum of hypersensitivity lung diseases. The greater 
clarification of the immunopathogenesis of this disease should 
help in understanding the mechanisms of normal and 
hypersensitivity responses of the lung. 
3. EXTRINSIC ALLERGIC ALVEOLITIS. 
Extrinsic allergic alveoli tis is a pulmonary hypersen-
si ti vi ty disease caused by inhaling organic dusts from a wide 
variety of sources: fungal, bacterial and animal proteins. The 
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symptoms of this disease in the acute phase include shortness of 
breath with no wheezing, general malaise with aching discomfort in 
the joints and muscles. There is an associated pyrexia with 
rigors and sweating and an irritating unproductive cough. These 
. symptoms occur 4 to 8 hours after exposure to the offending dust 
. 
and are similar to an active viral infection often being described 
as "flu-like" by affected subjects, however, these symptoms 
usually resolve within 24 hours. The insidious, chronic form of 
the disease, however, is characterised by a slow progressive 
increase in shortness of breath and reduction in exercise 
tolerance, with a chronic cough. 
The disease affects the distal, gas exchanging parts of 
the lung, and for this reason it was called "Extrinsic Allergic 
ALveolitis" by Pepys (1967). However, since the disease can 
also affect the terminal bronchioles it has been termed "Extrinsic 
Allergic Pneumonia" (Nicholson, 1972), "Extrinsic Allergic 
Bronchiolo-Alveolitis" (Scadding, 1970 Seal, 1975) and in the 
American literature, "Hypersensitivity Pneumonitis" (Reed, 1972). 
The disease, therefore, is associated with a decrease in lung 
function with a reduction in carbon monoxide diffusing capacity 
(Dinda, Chatterjee & Riding, 1969; Schlueter, Fink & Sosman, 
1969) • Wi th this restrictive defect, there is a loss of lung 
volume (decreased vital capacity) and an increase in compliance 
(loss of lung elasticity). In the chronic stages of the disease 
there can also be increasing airways obstruction (Allen, Williams 
& Woolcock, 1976). Radiological investigation of the disease 
commonly demonstrated abnormalities described as honeycombing 
throughout the lung parenchyma, or "ground-glass" appearance 
(Molina, 1976), and auscultation demonstrated the presence of fine 
crepitations throughout the lung fields, most prominent at the 
bases. The clinical and pulmonary function aspects of the 
disease are discussed further in appendices A and C, and Chapter 
5. The clinical aspects are very similar for all syndromes of 
alveoli tis despite the causative agent. 
The number of dusts which are known to cause extrinsic 
allergic alveoli tis form an ever lengthening list which is 
increasing with greater general awareness of the disease (see 
Table 2). The majority are organic dusts, animal derived 
TABLE 2. The major disease syndromes of 
Extrinsic Allergic Alveolitis 
loLa. 
SYNDROME ANTIGEN 
Farmer's Lung Micropolyspora faeni 
Bagassosis Thermoactinomycete vulgaris 
Thermoactinomycete sacchari 
Suberosis Penicillium Frequentans _. 
Mushroom Worker's Lung Th~rmoactinomycete sp. 
Agarieus hortensis spores 
Humidifier Fever Micropolyspora faeni 
Naegleria grubii 
Malt Workers Lung Aspergillus clavatus 
Maple Bark Strippers 
Lung Cryptostroma corticale 
Wood pulp workers Lung Alternaria sp. 
Woodworkers Lung Ramin extract 
Redwood extract 
Cheese Washers Lung Penicillium casei 
Enzymes Papain 
Bacillus subtilis 
Snuff Taker's Lung Bovine or Porcine pituitary 
extract 
Rat Handlers Lung 
Fish Meal Workers 
Lung 
Prawn Workers Lung 
Wheat Weevil Lung 
Fungal 
Byssinosis 
New Guinea Lung 
Sequoiosis 
Coffee workers Lung 
Furriers Lung 
Paprika splitter's 
Lung 
Sisal workers Lung 
Smallpox handlers 
Lung 
Seaweed processors 
Lung 
Rat serum proteins 
Fish meal extract 
Prawn meat extract 
Sitophilus granarius 
Streptomyces albus 
Merulius lacrymans 
Aspergillus 
Cryptococcus 
Leucocyanidin 
Thatch extract 
Graphium spp. Aureubasiduim 
pullulans 
Coffee bean dust 
Animal hair 
Mucor stolanifer 
Sisal dust 
Smallpox scabs 
Alginate 
REFERENCE 
Pepys et aI, 1963 
Salvaggio et aI, 1969 
Lacey, 1971 
Pimental & Avila, 1973 
Sakula, 1967 
Stewart & Pickering, 
1974 
Fink et aI, 1971 
Edwards et aI, 1974 
Riddle et aI, 1968 
Emanuel et aI, 1966 
Schlueter et aI, 1972 
Howie et aI, 1976 
Cohen et aI, 1967 
de Weck et aI, 1969 
.Novey et aI, 1980 
Pepys et aI, 1969 
Pepys et aI, 1966 
Carroll et aI, 1975 
Avila, 1971 
Gaddie et aI, 1980 
Lunn & Hughes, 1967 
Kagen et aI, 1981 
O'Brien et aI, 1978 
Katz et aI, 1973 
Miyagawa et aI, 1978 
Taylor et aI, 1971 
Blackburn et aI, 1966 
Cohen et aI, 1967 
Van Toorn, 1970 
Pimental, 1970 
Hunter, 1969 
Pepys et aI, 1964 
Morris-Evans et aI, 
1963 
Henderson et aI, 1984 
Animal handlers Lung Laboratory animals Slavin, 1978 
Meriones unguiculatus (gerbil) 
Weavers cough Tamarind seed powder Tuffnel et a~ 1957 
TABLE 2 CONTINUED: 
Bird breeders Lung Duck - goose 
Parakeet 
Pigeon 
Budgerigar 
Chicken 
Turkey 
Lovebirds 
Dove 
Cockatail 
llb. 
Plessner, 1959 
Pearsall et aI, 1960 
Reed et aI, 1965 
Hargreave et aI, 1966 
Korn et aI, 1968 
Boyer at aI, 1974 
Fink, 1974 
Cunningham et aI, 1976 
Harries et aI, 1980 
TABLE 3. Reported prevalences of alveoli tis caused by avian exposure. 
NUMBER SYMPTOMATIC REFERENCE 
---------------------------------------------------------------------------
43 
30 
21 
11 
11 
o 
o 
o 
o 
o 
Reed et aI, 1965 
Hargreave et aI, 1966 
Maloney et aI, 1967 
Stiehm et aI, 1967 
Eyckmans et aI, 1968 
---------------------------------------------------------------------------
80 
14 
54 
41 
51 
o 
1 (7%) 
3 (5.5%) 
o 
o 
Fink et aI, 1968 
.Siegal et aI, 1969 
Jongerius, 1969 
Zaman et aI, 1971 
Verbeke et aI, 1971 
---------------------------------------------------------------------------
146 
200 
150 
53 
11 (8%) 
o 
1.4 per 1,000 
6% 
11 (21%) 
Elgefors et aI, 1971 
Fink et aI, 1972 
Maesen et aI, 1972 
Caldwell et aI, 1973 
Christensen et aI, 1975 
---------------------------------------------------------------------------
117 
38 
64 
1 per 4-5,000 
0.5 - 7.5% 
1 (2.6%) 
14 (22%) 
Molina, 1976 
Hendrick et aI, 1978 
ibid 
Boyd, 1975 
---------------------------------------------------------------------------
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proteins and fungal products, and the potential for production of 
disease following inhalation of this type of material was 
recognised by Pepys (1969). Due to the widespread occurrence of 
_ the thermophilic Actinomycetes, the spores of these organisms are 
most frequently the causative agent of alveoli tis in a variety of 
settings, and the popularity of different bird species has 
similarly resulted in widespread exposure to avian antigens 
(Hendrick, Faux & Marshall, 1978). Consequently, Farmer's Lung 
and Bird Breeder's Lung are the two most studied of the disease 
syndromes of extrinsic allergic alveoli tis and are therefore 
useful models for studying the immunopathogenicity of the disease 
processes which could equally apply to the more individual 
syndromes listed on Table 2. For further information in the 
historical, epidemiological, clinical and experimental aspects of 
al veoli tis the reader is directed towards the following reviews 
(Nicholson, 1972; Molina, 1976; Roberts & Moore, 1977; Boyd, 
1978; Turner-Warwick, 1978; Salvaggio & Karr, 1979). 
Similar inflammatory reactions have been described 
following inhalation of grain dust (Broder & McAvoy, 1981) and 
endotoxin rich sewage dust (Mattsby & Rylander, 1978) however 
these were thought to be due to the toxic nature of the dusts 
ra ther than a hypersensi ti vi ty reaction. Similarly, the toxic 
effects of prolonged high dose oxygen (Fox et aI, 1981), 
irradiation, beryllium and drugs, particularly chemotherapy 
(Sostman et aI, 1976) can result in lung inflammation and 
fibrosis. However, on closer examination some degree of 
immunological hypersensi ti vi ty has also been. seen following drug 
administration (McCormick et al, 1980). The specific and 
non-specific agents causing lung fibrosis have been reviewed 
elsewhere (Kissler, 1983). 
a) Extrinsic allergic alveoli tis caused by avian 
exposure. 
The first description of alveoli tis caused by exposure to 
pigeons was reported in 1965 by Reed and colleagues and brought to 
light similar disease patterns in subjects exposed to other avian 
species, listed on Table 2. This first clinical report however 
was not the first recognition of the problem because the pigeon 
breeders (fanciers) themsel ves had long known about the 
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intolerance to their birds which was different from orni thosis 
(Lamers & Maesen, 1976; Lynch, P.P. personal communication), and 
the typical disease pattern was previously described in subjects 
exposed to avian antigens (Fawcitt, '1936; Feldman & Sabin, 1948; 
Emmons, 1955; Plessner, 1959; Pearsall et aI, 1960). Long 
. 
before these reports however, there was a typical description of 
the disease in the "gaveurs de pigeons"; the people who force fed 
pigeons in Paris which necessitated daily contact with thousands 
of birds (Renon, 1897). Nevertheless, Reed et al (1965) gave the 
first full clinical and serological report and proved the 
association of the disease with pigeons by provoking the symptoms 
in one subject after contact with his pigeon in a controlled 
environment. The disease was subsequently reported worldwide 
(Boyd, 1975; Molina, 1976). 
4. IMMUNOPATHOGENESIS OF ALVEOLITIS. 
The pathogenesis of extrinsic allergic alveoli tis is 
thought to be a complex hypersensitivity rection against inhaled 
antigens with involvement of both humoral and cellular responses. 
This is based on the finding of antigen specific antibody and 
lymphocytes in the circulation of affected patients. Skin testing 
these individuals with the appropriate antigens often results in a 
dual immediate (15 min. maximum) and late (4-8 hours) reaction. 
This late skin reaction has the histological characteristics of an 
Arthus reaction and the close temporal relationship between this 
skin reaction and the late (4-8 hours) pulmonary reaction has 
suggested that a similar inflammatory process may prevail. 
However, conventional histology of lung biopsy suggested a 
predominantly cellular reaction. The evidence for the 
involvement of antibody as well as sensitized cells is discussed 
below, and parallel studies in animal models are discussed in 
Appendix D. 
a) Antibody. 
The association of serum antibody with extrinsic allergic 
alveoli tis was first described by Pepys et al (1961), when the 
serum of a farmer with disease was shown to precipitate with an 
extract of thermophilic Actinomycetes grown from mouldy hay. 
\ 
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Serum precipitins against avian antigens were first described by 
Pearsall et a1 (1960), in a budgerigar keeper with an unexplained 
febrile illness, and the significance of serum precipitins against 
pigeon serum was discussed by Reed et a1 (1965) in the first fu~l 
description.of an interstitial lung disease caused by exposure to 
pigeons. 
The ,serum antibody is predominantly IgG, and mi11igram/m1 
quanti ties have been reported (Fink et a1, 1969; Boren et a1, 
1977) and antibody activity in the other main classes has also 
been measured (Faux, Wells & Pepys, 1971; Patterson et a1, 1976). 
The IgG antibody when combined with avian antigens can activate 
complement (Caldwell et a1, 1973) and the role of antibody in 
disease is discussed fully in Chapter 3. 
Coincidental antibody findings include a profile of 
raised antibody to viruses and bacteria, thought to be an 
anamnestic response (Boyd et a1, 1967; Bach et a1, 1971; Marx et 
a1, 1977; Miyagawa et a1, 1978). There was a high incidence of 
rheumatoid factor reported in pigeon breeders disease (Banazak & 
Thiede, 1974) and in farmers lung (Parrat, 1976) although 
Turner-Warwick & Haslam (1971} found a distribution of 
autoantibody in alveoli tis patients sera similar to a normal 
population. 
b) Skin testing. 
The sera from sensitized pigeon breeders can mediate 
passive cutaneous anaphylaxis in guinea-pigs following skin 
testing with pigeon serum antigens (Fink et a1, 1967), and on 
passi ve transfer intraderma11y, could also sensitize human skin 
for a Prausnitz-Kustner reaction, this being mediated by a 
short-term sensitizing antibody, which was heat stable and 
resistant to mercaptoethano1 (Warren et a1, 1977). However, 
positive immediate' skin prick test reactions against avian 
antigens have been reported infrequently among bird breeders, and 
only usually in association with asthma (Fauz et a1, 1971). 
Following intracutaneous injection of these antigens there are 
many reports of late, 4-8 hours, skin reactions with a variable 
incidence of preceding early reactions (Hargreave & Pepys, 1972; 
McSharry et a1, 1983). This late reaction consisted of an 
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oedematous non-irritating swelling which showed histologically in 
2 cases, an eosinophilic vasculitis (Jean et aI, 1970). Sahn & 
Richerson (1972) also described oedema with a mainly perivascular 
infiltration of polymorphonuclear _ leucocytes and a few 
eosinophils, and Caldwell et al (1973) described Berivascular 
inflamma tion with polymorphonuclear leucocytes and eosinophils, 
with no histological appearances suggestive of cell mediated 
hypersensitivity. Immunofluorescence demonstrated IgG, IgM, C3 
and C4 in the capillary walls (Jean et aI, 1970; Caldwell et aI, 
1973) and Pepys et al (1968) demonstrated the, presence of IgG 
antibody and complement at first outside, and later inside 
phagocytic cells. 
This type of skin reaction was first described by Maurice 
Arthus (1903) and the term "Arthus type" reaction has been widely 
used to describe local immune complex mediated tissue injury, and 
this mechanism was suggested to mediate the lung damage associated 
with alveolitis. 
c) Lung biopsy. 
There have been numerous histological reports from lung 
biopsies of individual cases of bird breeders disease (Eyckmans et 
aI, 1968; Hensley et aI, 1969; Palma-Carlos et aI, 1971; Fasske 
et aI, 1974; Hogan, 1978; Barrios et aI, 1979) whereas 
histological studies have been performed on greater numbers of 
farmers lung patients and several series have been reported (Seal 
et aI, 1968; Reyes et aI, 1976; Sutinen et aI, 1983). 
The most consistent histological features are an 
interstitial and alveolar inflammation, which may also involve the 
bronchioles (Nicholson, 1972; Reyes et aI, 1976). There was a 
marked infiltrate of mononuclear cells, predominantly lymphocytes, 
often arranged in follicles with variable numbers of plasma cells. 
There are only rarely reports of neutrophils and eosinophils in 
the interstitium. The presence of interstitial foam cell 
aggregates, occasionally also in the alveolar spaces, is suggested 
to represent a distinctive. lesion for pigeon breeders disease 
(Hensley et aI, 1969; Hogan, 1978) and a role for activated 
bronchopulmonary macrophages in the pathogenesis of alveoli tis has 
been suggested (Stankus, Cashner & Salvaggio, 1978). More 
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advanced cases of pigeon breeders disease are characterised by 
increasing fibrosis with thickening of the alveolar septa, along 
with capillary and alveolar basement membranes and bronchiolitis 
obliterans .(Shannon et aI, 1969; Hensley et aI, 1969; Heywood,. 
1971 ; Fasske et aI, 1974). A similar picture is true also for 
. 
farmers' lung (Barrowcliff & Arlblaster, 1968; Tukianen et aI, 
1980). 
Immunofluorescence studies on lung biopsies from patients 
with alveolitis have not conclusively demonstrated the presence of 
immune complexes. Wenzel, Emanuel & Gray (1971), demonstrated 
immunoglobulins located in plasma cells throughout the diseased 
lung and C3 fixed in large amounts to macrophage but not in 
reI a tion to capillary walls, and Turner-Warwick et al ( 1971 ) , 
examining biopsies from 8 cases of bird breeders lung failed to 
demonstrate immunoglobulin or complement deposited around the 
capillary walls· although some immunofluorescence was demonstrated 
in 2 cases in germinal centres and in surrounding plasma cells. 
In these two reports it is probable that the workers only 
demonstrated local immunoglobulin and complement synthesis 
(Col ten, 1976) • Furthermore, Emanuel et al (1964) could not 
demonstrate antigen, antibody or complement in lung biopsies from 
farmers with alveolitis, however 2 biopsies were shown to have IgG 
and complement deposited along the alveolar capillaries (Meijer et 
aI, 1971) and only one out of 10 biopsies in a further study of 
bird breeders lung had demonstrable deposits of immunoglobulin and 
complement (Barrios et aI, 1979). However, in animal models of 
disease, antigen antibody an,d complement can be readily detectable 
in lung tissue (Hensley et aI, 1974) but these deposits can be 
detected only if the lesions are studied before extensive 
phagocytic infiltration (Cochrane & Koffler, 1973). 
It is highly probable that the immunofluorescence studies 
mentioned above in human cases were performed either as 
investigations of chronic cases (as suggested by the histological 
findings) or long after the last antigen exposure. The normal 
phagocytic acti vi ty would have removed the immunoreactants and 
therefore negative immunofluorescence findings do not rule out the 
possibility that immune complexes are involved in the pathogenesis 
of alveoli tis. Some supporting evidence for the association 
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between immune complexes and disease is provided by Boyd (1975) 
and Akoun et al (1975) who both described renal deposition of 
immune-complex like material suggesting this to be overspill from 
antigens absorbed via the respiratory tract, through the 
bloodstream and filtere? out in the k~dney. A further unusual 
pulmonary-renal syndrome was described by Dunn et al (1981) who 
reported mesangiopa thic glomerulonephritis in alveoli tis. Other 
diseases reported in conjunction with alveoli tis include 
impotentia coeundi (Lamers & Maesen, 1976), allergic cerebral 
manifestations (Misur & Takac, 1978), pericarditis (Reybet-Degat, 
1979), sarcoidosis (Cohen et aI, 1976), jejunal villous a trophy 
(Berrill et aI, 1975), and extrinsic asthma (Karl', Kohler & 
Salvaggio, 1978). 
d) Cellular immunity. 
The occasional' finding of pigeon breeders disease in 
subjects with no specific serum antibody (Allen et aI, 1975; 
Sennekamp et aI, 1978; Canet et aI, 1980) and the predominantly 
mononuclear infiltrate and granulomatous inflammatory response 
observed on histology, have suggested a role for cell-medi_ated 
hypersensitivity in the pathogenesis of alveolitis, despite the 
paucity o~ reports on delayed skin tests (Heywood, 1971; Warren, 
1972; EI Hefny et aI, 1980). The first reports on cell 
sensitivity to pigeon derived antigens in one subject with pigeon 
breeders disease (Jean et aI, 1970; Bach et aI, 1971) 
demonstrated peripheral blood lymphocyte stimulation with pigeon 
derived antigens. Thereafter, avian antigen specific 
blastogenesis and lymphokine production from circulating 
lymphocytes of patients with pigeon breeders disease have been 
reported (Caldwell et aI, 1973; Moore et aI, 1974; Hansen & 
Penny, 1974; Fink et aI, 1975; Allen et aI, 1975; Schatz et aI, 
1976). It was initially thought that this lymphocyte sensitivity 
was a feature only of subjects with alveoli tis but Allen et al 
(1975) demonstrated production of macrophage migration inhibition 
by cells from 2 symptomatic as well as 2 asymptomatic pigeon 
breeders, all without precipi tins. Furthermore, Schatz et al 
(1976) demonstrated lymphocyte blastogenesis using pigeon serum 
antigen in lymphocyte cultures using cells from pigeon breeders 
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with and without alveolitis, and also in one subject 'with no 
exposure to pigeons. In this latter subject, the lymphocyte 
sensitivity increased following experimental intracutaneous 
injecton of pigeon serum antigens. These workers observed the 
lymphocyte stimulation index at intervals after cessation of 
exposure in one patient with alveoli tis and found a significant 
decline in antigen induced blastogenesis coincidental with 
clinical recovery. Sennekamp et al (1978) also reported a 
decline in lymphocyte transformation following cessation of avian 
contact in a precipitin-negative case of pigeon breeders disease. 
A further fluctuation in cell sensitivity was shown by Lazary et 
al (1975), in alveoli tis in cattle where a fluctuation in 
blastogenesis on exposure to Micropolyspora faeni antigen occurred 
in vitro, which correlated with the seasonal rate of antigen 
exposure. The interpretation of studies of cell mediated 
immunity among patients with alveoli tis has ·been made more 
difficult because there was no information on the patients' 
current drug therapy in the literature reports, and the effects of 
steroids have been shown to cause depressed blastogenesis while 
the phytohaemagglutinin response was unaltered (Toogood et aI, 
1980). This is an area which therefore requires further detailed 
re-examination. 
e) Local pulmonary immunity. 
The technique of bronchial lavage using the fibreoptic 
bronchoscope has greatly increased the knowledge of local events 
during pulmonary disease, and using this procedure Warren & Tse 
(1974) first obtained evidence for local antibody production in 
extrinsic allergic alveoli tis where precipitins to chicken feather 
extract were found in proportionally greater amounts in bronchial 
washings than in the serum of one affected subject. Local 
antibody production in symptomatic pigeon breeders has been 
confirmed (Voisin et aI, 1981) and this activity has been assigned 
to both IgA and IgG antibody classes (Patterson et aI, 1979). In 
extrinsic allergic alveolitis, total lavage protein and 
immunoglobulins have been demonstrated in higher ti tres than in 
normal subjects (Reynolds et aI, 1977; Voisin et aI, 1981) with 
the importance of local production of IgM and a high IgG to 
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albumin ratio being stressed by Weinberger et al (1978), and 
increased local production of IgG subclass 4 was suggested to play 
a role in the pathogenesis of the disease by Calvanico et al 
- (1980). The altered lipid profile of surfactant o_btained from 
lavage fluid has bee? suggested to influence the mechanical 
abnormali ties in the disease (Jouanel et aI, 1981). Lung· 
histology and bronchial lavage demonstrates an increase in total 
cell numbers, predominantly of mononuclear cells characterized as 
T lymphoyctes (Reynolds et aI, 1977; Weinberger et aI, 1978; 
Godard et aI, 1981), which is particularly marked during the acute 
phase (Molina et aI, 1979). These local T lymphocytes have been 
shown to respond specifically to pigeon antigens by lymphokine 
production (Schuyler, Thigpen & Salvaggio, 1978) and cellular 
proliferation (Moore et aI, 1980). 
The respiratory tract is the route of antigen entry and 
the lung is the primary target organ. Sequential quantitative 
measurement of humoral and cellular immune parameters at the 
pulmonary level therefore is likely to increase our understanding 
of the disease mechanism in extrinsic allergic alveoli tis and of 
the general capability for antigen processing by the lung in this 
condition. 
f) Prevalence. 
A true reflection of the prevalence of avian induced 
alveoli tis is difficult to achieve because the appropriate' 
epidemiological studies have not yet been done. 
The main literature information regarding the prevalence 
of alveoli tis among subjects exposed to pigeons is listed on table 
3 and the range is from zero to 21%. There will be many reasons 
for the discrepancies including:-
(a) the population selection; some studies encouraged 
the co-operation of subjects with symptoms whereas 
others, e.g. Molina (1976) based their figures on a 
small number of local subje~ts who had restricted 
avian exposure in well ventilated lofts, with a 
consequently low incidence of disease. 
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(b) the unwillingness of symptomatic subjects to 
co-operate in a study which may suggest that they 
have to give up their hobby in which they may have a 
major social and financial investment. 
( c) the cri t~ria on which a decision of alveoli tis is 
based. For example although none of 200 subjects 
investigated by Fink et al (1972) were considered to 
have disease, some may have had chronic alveolitis 
since cough and breathlessness were common, and some 
had compatible radiographic and pulmonary function 
abnormalities. 
The question of assessment of the "disease has proved to 
be very difficult, and a wide experience of treating this disease 
is of primary importance. Various presentations are discussed by 
Boyd et al (1982) and it is possible that some subjects with 
either subacute or chronic forms of disease were overlooked in the 
earlier studies listed on table 3. However, even a conservative 
estimate of prevalence would generate a large number of cases 
since the numbers of subjects exposed to pigeon in various 
countries is: UK - 180,000; Belgium - 250,000; US - 75,000; 
Sweden - 1,000; France - 40,000 (Molina, 1976). The incidence in 
Britain of people keeping pigeons is quoted as 0.3%, and 
budgerigars 12% (Hendrick et aI, 1978). The population at risk 
is, therefore, considerable. Consequently, ~ clinicians and 
general practitioners should be made aware of these figures. 
g) Genetic markers of alveolitis. 
The genetic control of the immune response in humans and 
the genetic susceptibility to immunological disease has been 
reviewed recently by some major workers (Bodmer & Bodmer, 1978; 
Zinkernagel, 1979; Benacerraf, 1981). The empirical clinical 
findings of variable associations between the incidence of 
specific diseases and certain HLA antigens has provided evidence 
for basic immune defects associated with disease and has been used 
as a probe to examine the immunology of diseases, for example 
these HLA haplotypes have been used as disease markers. 
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With respect to extrinsic allergic alveolitis, the 
relative contribution of various constitutive factors, including 
genotype, and environmental factors, on the antibody response and 
on. disease remains unknown. Attempts at HLA typing pigeon 
breeders with alveoli tis have shown no association with HL-A in 30 
patients (Boyd & Dick: personal communication), and no significant 
associa tion wi th HLA-A, Band C in 51 symptoma tic and 102 
asymptomatic pigeon breeders nor HLA-DR in 32 and 29 respectively 
although HLA-DR3 was higher in patients (Rodey et aI, 1979). 
Furthermore there was no correlation between pigeon breeders 
disease and immunoglobulin allotypes in 9 symptomatic and 14 
asymptomatic subjects (Moore et aI, 1975). Muers et al (1982) 
studied 23 patients with budgerigar fanciers disease and 154 
controls, and although HLA-B8-DR3 was increased in the patient 
group the difference did not reach significance. 
There was some early interest in a reported link between 
pigeon breeders disease, coeliac disease and HLA-B8 (Berrill et 
aI, 1975; Rittner et aI, 1975). However this was resolved by 
Faux et al (1978) who demonstrated different avian antigens 
associated with each condition; dietary ovalbumin with coeliac 
disease and inhaled avian ganma-globu1in antigens with al veoli tis. 
There have been some reports however linking a particular 
genotype with alveoli tis. Flaherty et al (1975) described an 
increase in HL-A8 in 20 farmer's lung patients, i.e. 40%, compared 
with 8% in controls. Some subtle genetic links with bird 
breeders disease were described by Allen et al (1975) in 2 
families with 7 individuals affected. Three with disease in one 
family were all HL-A2, W15, and in the other family 2 children 
with severe disease were HL-A2, W10 and 2 with mild disease were 
HL-A1, 8. Furthermore, on further examination of 28 patients, 
there was a reduction of HL-A3, 7, i.e. 3.7% compared with 40% in 
a normal population, and these authors associated this with 
hyporesponsiveness. Diaz de la Vega et al (1980) report an 
association of HLA-BW40 with members of a family with disease, and 
Morell et al (1981) again report a familial incidence of 
alveoli tis this time in 2 brothers who are HLA-BW15. A recent 
report (Rittner et aI, 1983) supports an association between 
disease and HLA-DR3 when comparing 52 symptomatic and 64 
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asymptomatic pigeon breeders, and Berrill & van Rood (1977) 
suggested a link with HLA-DW6. 
In relation to other respiratory disorders the hereditary 
component of ast~a was recognised long before the awareness of 
the. genetic principles (Cooke & Vander .Veer, 1916). However, 
even· wi th the current awareness, the genetic predisposition to 
asthma cannot be designated to anyone HLA haplotype in the 
general population (Turton et aI, 1979), and although within 
families some HLA haplotypes related to asthma were reported to 
prevail, unfortunately these were different between families. 
These observations are in keeping with the complexity of asthma 
where various contributory factors, e.g. IgE production, bronchial 
hyper-reactivity, etc, are all under separate genetic control. 
There has been one report linking HLA-B8 with cryptogenic 
fibrosing alveoli tis (Turton et aI, 1978). This study of 167 
patients demonstrated a significantly raised incidence of B8 in 
women, and in patients with an onset of disease at less than 50 
years of age. There was no association with HLA-A or C. A 
further study of 33 white patients with the same disease could 
find no association with HLA-A or B antigens (Fulmer et aI, 1978). 
There has been no HLA association with the other major 
interstitial inflammatory disease with no known cause; 
sarcoidosis. Nevertheless, HLA-B8 is reported to be associated 
with spontaneous resolution of disease (Smith et aI, 1981). 
Goodpastures syndrome has been added to this list by Rees et al 
(1978) who reported an 88% incidence of HLA-DRW2 in a series of 17 
patients compared with 32% in a normal control population, and in 
pulmonary tuberculosis there was a reported increase in HLA-DR2 in 
124 patients with a concurrent decrease of DRW-6 (Singe et aI, 
1983). 
5. SCOPE OF PRESENT THESIS. 
It has been reported at an early stage in the study of 
alveoli tis that the presence of serum precipitating antibody did 
not ful~y correlate with disease. The next logical investigative 
step was for studies on cellular sensitivity to be performed but 
this proved to be no better in delineating the symptomatic 
subject. This thesis attempts to reappraise the role of humoral 
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immuni ty in the hypersensi ti vi ty response associated with acute 
extrinsic allergic alveoli tis among pigeon breeders. 
Firstly, the relevant antigens were described, and these 
were selected for use in sensitive assays in order to quantify the 
serum antibody respon~e among various populations of pigeon 
breeders. There was a full appraisal of the incidence and 
severi ty of symptoms in these subjects, and the antibody levels 
and disease were clearly demonstrated to be very closely related. 
Various constitutional factors such as age and atopic status along 
wi th various environmental factors such as smoking and various 
indices of antigen exposure were studied for their effects on the 
antibody response and disease. 
Other serological parameters were measured and it 
appeared that there was an abnormal inflammatory profile in those 
subjects who were sensitised to the inhaled antigens. These 
parameters were followed serially in individuals during different 
phases of disease, and the changes observed suggested that these 
dynamic events were closely related. 
Finally, the various laboratory investigations of 
serology, skin testing and inhalation provocation testing were 
assessed for their bearing on the disease process and for their 
diagnostic value to the clinician in the management of the 
disease. 
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CHAPTER 2 
THE ANTIGENS 
1. INTRODUCTION. 
The sources of antigens which can cause alveoli tis are 
widespread and form an ever increasing list which was discussed in 
the last chapter (Table 2). However, despite this range of 
antigens the clinical presentation. of affected subjects is 
similar. This suggests that although the initial antigen 
recogni tion is highly specific, the subsequent hypersensi ti vi ty 
reactions are common for all affected subjects. For this simple 
reason it could be argued that there can be no "disease-specific 
antigen" as such, although there are some immunologically specific 
and non-specific factors common to all these antigens. 
a) Non-specific factors 
The antigens are generally derived from the dusts or 
aerosols of organic material, or from organisms growing on organic 
waste (Pepys, 1969). The airborne particles which can cause 
alveoli tis are of the order of one micron in diameter (Austwich, 
1966) which is the correct aerodynamic size to reach and settle in 
the alveoli (Brain & Val berg , 1979), and it is at the alveolar 
level that the disease process is most evident (Hensley et aI, 
1969; Seal et aI, 1975). 
There will inevitably be some non-specific irritant 
material in crude organic dust, an extreme case is with grain dust 
(Broder & McAvoy, 1981) where respiratory symptoms are common in 
most heavily exposed subjects and soluble extracts from grain dust 
can react non-specifically with all sera. The presence of 
irritant material in Micropolyspora faeni extracts has hampered 
the use of these extracts in the investigation of farmers lung by 
skin testing and inhalation provocation testing (Williams, 1963). 
Bacterial teichoic acid as well as "C-substance like" material 
have been identified in various dust extracts and these have 
~aused false-positi~e precipitin reactions with sera of patients 
under investigation for alveoli tis (Faux et aI, 1970). This is 
now routinely avoided by the incorporation of citrate buffer in 
the gel (Longbottom & Pepys, 1964). 
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It would seem that a vigorous immunological stimulus is 
required to establish experimental alveoli tis in animal models 
(discussed in Appendix D). As well as the experimental antigen, 
there is also a need for an adjuvant (Richerson et aI, 1918), 
mi togen (Hollingdale et. aI, 1918) or non-specific inflammatory 
agent such as carrageenan or BeG (Peterson et aI, 1911) in order 
to initiate disease. For alveoli tis in man, a similar intrinsic 
immunological adjuvant activity in the antigens causing the 
disease has been postulated by Pepys (1918) and both mitogenic and 
adjuvant acti vi ty of spores of Micropolyspora faeni have been 
described (Bice et aI, 1911; Smith, Snyder & Burrell, 1980). 
Some glycoprotein precipi tinogens have been isola ted from 
Aspergillus clavatus which have non-specific alveoli tis-inducing 
activity in mice, and these have been suggested to potentiate the 
disease process of alveoli tis in maltworkers exposed to A.clavatus 
(Blyth, 1918). In these cases'there is the added potential of 
inhaled spores to grow in the l,ung. This has been recently 
confirmed by Anderson and Greatorex (1983) who demonstrated airway 
colonisation with M. faeni in 32 of 46 farmers lung patients who 
-had positive cultures from sputum. This would explain the 
aggressive features of the lung histology of farmers lung patients 
which show widespread granuloma formation and activated pulmonary 
macrophages (Seal et aI, 1915), whereas there is much less 
evidence for a foreign body reaction in the lungs of pigeon 
breeders who are exposed to primarily soluble antigens. 
The antigens associated with extrinsic allergic 
alveoli tis have been reported to directly activate complement when 
added to normal human serum (Marx, Boren & Moore, 1911). These 
antigens include soluble extracts from Micropolyspora faeni and 
Thermoactinomyces vulgaris (Edwards, 1916), antigens from bacteria 
and fungi associated with EAA (Marx & Flaherty, 1916; Huis in't 
Veld & Berrens, 1916) and avian antigens (Berrens, Guikers & Van 
Dijk, 1914; Moore & Fink, 1915; Marx, Boren & Moore, 1911; 
Boren, Moore & Abramoff, 1911; Berrens, 1918). Activation is via 
the alternative pathway although there is some evidence to suggest 
that the antigens can act directly at the level of C4 of the 
classical pathway (Marx, 1918). This worker described one 
further unusual feature in that these antigens did not activate 
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guinea-pig complement despite their efficiency in activating human 
complement. The mechanism of these acti vi ties awaits 
clarification by their proponents. The proteolytic enzymes from 
bacteria and fungi and_the hydrolytic enzymes from avian droppings 
were initially implicated in the activation. sequence (Berrens & 
. . 
Guikers, 1972) but this has now been discounted (Marx, 1978). 
b) SpecifiC factors 
All alveoli tis-inducing dusts have a soluble component 
which is immunogenic in subjcts exposed to that dust, and against 
which most subjects with alveoli tis can have high titres of serum 
antibody. It is this specific nature of the antigens which 
relates most closely with the disease incidence of alveolitis, 
although the non-specific activities undoubtedly have some 
importance in initiating and determining the extent of this 
specific response. 
Wi thin the soluble component of the dusts causing the 
major syndromes of alveoli tis there have been numerous antigenic 
determinants described. In farmers lung, antigen extracts from 
Micropolyspora faeni containing up to 46 antigens have been 
resolved by crossed-immuno-electrophoresis and up to 36 of these 
reacted with farmers lung patients' sera (Treuhaft et aI, 1979). 
In Aspergillus fumigatus extracts, 52 antigens have been similarly 
described with up to 17 of these reacting with sera from 
aspergillosis patients (Kim & Chaparas, 1978; Kim & Chaparas, 
1979). Some antigens in the M. faeni extract were considered to 
be "disease-specific" because they would precipitate only with 
sera from patients with alveoli tis and not with asymptomatic 
farmers who were exposed to the mouldy hay on which the M.faeni 
grew (Treuhaft et aI, 1979) • Some of these disease-specific 
antigens have been suggested to include one polysaccharide and one 
protein with chymotrypsin activity (Gari et aI, 1983). This 
aspect of alveoli tis is of considerable interest and was indicated 
as a useful area of future development by a recent international 
symposium (NIAID workshop, 1978). 
c) Antigens associated with pigeon breeders disease. 
Various antigens have been extracted from pigeon 
droppings, feathers, serum, egg yolk and white, crop fluid and gut 
wall (Barboriak et aI, 1965; Edwards et aI, 1970; Sennekamp et 
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aI, 1976). Early studies which sought to characterise the 
various antigens demonstrated, by cross absorption, that the major 
antigens occurred in pigeon droppings (Barboriak et aI, 1965). 
Subsequently pigeon droppings were considered the only "complete" 
source of antigens concerned with the disease (Edwards ·et aI, 
1970). 
In a series of papers Berrens and coworkers (1972 a-d) 
firstly described a crude pigeon droppings extract (PDE) as being 
a very heterogeneous mixture of soluble proteins, glycoproteins 
and polysaccharides which could precipitate in agar gel double 
diffusion with normal human sera. The aselective antigens could 
be separated from the specific antigens by gel filtration on 
Sephadex G-150; the first peak eluted was designated the "A 
antigens" and contained the aselective antigens. The second peak 
contained a mixture of glycoproteins designated the "B antigens", 
of which the major antigen having gamma-mobility on immuno-
electrophoresis (IEP), was more specific for detecting antibody 
among pigeon breeders by precipitin formation. These authors 
went on to describe complement consumption by these antigens as a 
simple laboratory test for the disease. 
A further group using immunoelectrophoresis of crude PDE 
separated four distinct components designated PDE 1-4 (Fredricks & 
Tebo, 1977). Two additional minor constituents PDE A and B were 
subsequently uncovered ·by partial purification and concentration 
(Fredricks & Tebo, 1980). Antigen PDE1, an acidic glycoprotein 
of molecular weight 200,000 was identified as pigeon IgA; it is 
quantitatively the major antigen of PDE, constituting 24% of the 
dry weight of PDE. Antigen PDE B, a basic glycoprotein (MWt = 
51,000) was identified by papain digestion of PDE 1 to be the 
basic Fab fragments of IgA (Fredricks & Tebo, 1980). PDE A 
corresponded to the acidic Fab fragments, and PDE 2 to the Fc 
fragments of pigeon IgA. The exact nature of antigens PDE 3 and 
4 has not been elucidated; however, present evidence suggests 
that PDE 3 is a highly heterogeneous acidic proteoglycan 
(McCormick et aI, 1982). The pigeon IgA antigen had already been 
described as XPGG, which was an antigen in pigeon droppings which 
cross-reacted with the main serum gamma-globulin antigen (Edwards 
et al, 1969). A Dutch group working on the same antigens also 
28 
described pigeon IgA (Goudswaard, Noordzij, & Stam, 1978; De 
Ridder, Goudswaard & Berrens, 1979), and suggested that this may 
be an important antigen in pigeon breeders disease. 
Pigeon serum was demonstarted to be a major antigen ,by 
serologica~ and, inhalation provocation tests in the first 
description of alveoli tis caused by pigeon exposure (Reed, Sosman 
& Barbee, 1965). Since then it has become the most readily used 
antigen source for investigating this condition. Avian serum, 
when separated electrophoretically, contained many antigenic 
proteins detected by the sera of sensitised pigeon fanciers (Faux, 
Wells & Pepys, 1971), and column chromatography of pigeon serum on 
Sephadex G200 generated many protein fractions of different 
molecular sizes, and these all had complement-depleting activity 
when incubated with the sera of pigeon fanciers (Berrens, 1978). 
The sera of many avian species have some proteins with 
antigenic identity (Faux, Wells & Pepys, 1971; Sennekamp et aI, 
1981) which could explain the positive precipitin reactions to 
pigeon serum in subjects with exposure to other avian species, or 
in patients with coeliac disease caused by ingesting hens' egg 
proteins (Faux, Hendrick & Anan<.1, 1978). There were, however, 
specific serum antigens associated with each avian specie.co 
belonging to the gamma-globulin fraction (Fink, Tebo & Barboriak, 
1969a; Faux, Wells & Pepys, 1971). Therefore pigeon serum 
gamma-globulin was considered to be the specific antigen 
associated with pigeon breeders disease, and this antigen was 
further demonstrated to be highly immunogenic in man, moreso than 
serum albumin (Fink, Tebo & Barboriak, 1969b). 
This chapter investigated some major sources of antigen 
deri ved from the pigeon in order to assess which was the mos t 
immunogenic among pigeon breeders, and furthrmore to clarify any 
association between a particular antigen and disease. 
2. EXPERIMENTAL. 
a) Pigeon serum 
Pigeon blood was obtained by cardiac puncture of ether 
anaes thetised birds. The blood was left to clot at room 
o temperature for 2 hours, then overnight at 4 C to allow the clot 
to retract. After centrifugation the serum was aspirated and 
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stored at -20 C until used. The serum was used neat as an 
antigen in Ouchterlony double diffusion (see Appendix B), and 
using this system 20 of 97 pigeon fanciers had serum precipitating 
antibody. This incidence of precipitins, 20.6%, was similar to 
that found using pigeon s~rum as antigen in 20q pigeon fanciers, 
where 20% had precipitins (Fink et aI, 1972). 
To investigate the various serum fractions for antigenic 
activity the pigeon serum was separate by molecular sieving on 
Sephadex G200 and ACA-22 (figures 1 and 2). All the protein 
peaks had antigenic activity except the last peak from each 
separation which was made up of low molecular weight proteins 
«1,000 daltons). 
The strongest precipitin band was formed against the peak 
containing the main gamma-globulin antigen; pigeon IgG. The 
antigenic nature of the pigeon IgG molecule was investigated 
further. The column-purified IgG was reduced and acetylated 
according to Hudson & Hay (1980) and passed through Sephadex G-75 
to separate the heavy (H) and light (L) chains (Figure 3). These 
two fractions were used as antigens in double-diffusion, and 
pigeon fanciers sera precipitated predominantly with the L chain 
fragment. 
The alb~in fraction of pigeon serum was separated from 
the globulin using 50% saturated ammonium sulphate (Hebert, 1974) 
and by passing the dialysed supernatant through Sephadex G200. 
This purified pigeon albumin, and the purified pigeon 
gamma-globulin (above) were used as antigens in an ELISA system 
(Appendix B) for the measurement of serum IgG antibody in 58 
pigeon fanciers, and 48 control subjects with no avian exposure. 
These results were plotted in Figure 4, where the mean IgG values 
against all the antigens were seen to be significantly greater in 
the symptomatic than the asymptomatic pigeon fanciers, and both 
these groups had significantly higher levels than the controls. 
b) Pigeon droppings extract. 
In order to investigate this particularly difficult 
antigen source in th~ laboratory, approximately 5gm of freshly 
voided pigeon droppings were extracted with 20ml of saline for 24 
hr. The greenish supsension was centrifuged at 3,000 rpm for 30 
min and the clear green supernatant was aspirated. An equal 
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volume of saturated ammonium sulphate was added dropwise and the 
globulin content precipitated. This was harvested by 
centrifugation, dissolved in 2ml saline, dialysed against saline 
and passed through Sephadex G200 (Figure 5). The first fraction 
collec~ed in the exclusion vO,lume contained pigeon IgA (Berrens & 
Maesen, 1972). This precipitated effectively with immune sera 
from pigeon fanciers and was used as an antigen for ELISA 
quantification of IgG antibody in 56 pigeon breeders and 48 
controls (Figure 6). This antigen was highly selective for 
detecting antibody in pigeon breeders sera and the mean level in 
the symptomatic group was significantly higher than the 
asymptomatic group, and both of these were significantly higher 
than controls. 
c) Feather dust (bloom) extract 
Precipitins to feather extracts have been demonstrated in 
the sera of pigeon breeders (Sosman, Barboriak & Reed, 1965) and 
the clinical relevance of these antigens was demonstrated by 
positive late reactions following inhalation challenge tests on 
susceptible subjects with aqueous extracts from feathers (Reed et 
aI, 1965; Muller et aI, 1976J Warren, 1977). However, because 
feathers were more commonly associated with immediate 
hypersensitivity reactions (Barr & Sherman, 1961; Halpin & 
Prince, 1963), and because pigeon droppings were thought to be the 
most complete antigen source, this antigenic material has since 
received very little detailed investigation. However, Boyd 
(1978) reaffirmed the clinical importance of this source of 
antigen following discussions with pigeon breeders who admitted 
having symptoms more often during the moult, when the birds cast 
their feathers which resulted in clouds of feather dust. 
Symptoms were also prominent during pigeon shows when birds are in 
prime condition, one index of this being the amount of bloom on 
the feathers, and where excreta is minimal. 
This section describes firstly the biochemical separation 
of bloom extract proteins and secondly the antigenic nature of 
. these proteins: 
i) Simple biochemistry of the proteins in the soluble bloom 
extract: 
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A soluble extract from the pigeon bloom was epared by 
swabbing the chest and wings of several birds with a sterile swab 
and then extracting several swabs wi th 400ml saline. The 
resulting white suspension was centrifuged for 30 min at 3000 rpm 
and the clear aqueous layer was aspirated, concentrated by 
pressure dialysis to 10ml and dialysed against saline. The 
extract contained 2.5mg/ml protein as measured by the Lowrie 
method, and 0.4mg/ml carbohydrate as measured by the 
phenol-sulphuric acid method. There was no detectable 
cholesterol or triglyceride. A dilute sample of the extract had 
an absorption spectrum profile in the U.V. range, similar to other 
allergen preparations (Berrens et aI, 1972), having a peak at 
280nm with .a shoulder at 260nm. There was no absorption in the 
visible range. 
Allergens derived from a large number of animal species 
have been found to have some similarity in their electrical charge 
properties (Ohman, 1978). They. migrated towards the anode on 
electrophoresis and had isoelectric points less than 7. 
lmmuno-electrophoresis (lEP) of the bloom extract at pH 8.6, 
developed using the serum of a highly sensitized pigeo~ fancier, 
suggested that the main allergenic components of the bloom extract 
were also acidic in nature. This was confirmed by polyacrylamide 
gel isoelectric focusing which resolved proteins with isoelectric 
points at 5.5, 4.9 and several between 4.7 and 4.2. A commercial 
skin test preparation of pigeon feather extract (Bencard) was 
focused in parallel, and proteins were also resolved between 4.7 
and 4.2. 
When the bloom was dispersed in saline, the bulk of the 
white waxy powder aggregated and formed an upper, highly 
hydrophobic layer. A sample of this was aspirated and examined 
directly by scanning electron microscopy, SEM. Aggregated 
microgranular material consisting of unit particles of diameter 
between 0.3 and 1.0 microns was observed. These particles could 
be clearly seen by SEM on a small breast feather (Figure 7). 
ii). Antigenic nature of the soluble bloom extract: 
The soluble bloom extract contained antigens which would 
precipitate with sera from pigeon fanciers but not with sera from 
subjects with no avian exposure. Precipitins were demonstrated 
FIGURE 7a. Scanning electron micrograph showing detail of 
the fronds of a small breast feather of a pigeon. 
These are coated with the bloom particles. 
The size bar is 100 urn. 
FIGURE 7b. S.E.M. showing detail 
feather in Figure 7a. 
are clearly seen, and 
diameter. 
The size bar is 10 urn. 
of one of the barbs on the 
The indivudal bloom particles 
they approximate to 1 urn. in 
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by double diffusion in agar in 59 of 97 pigeon fanciers' sera, 
with up to 5 clear bands resolved, whereas precipitins to pigeon 
serum were found in only 37. The five major antigenic components 
were confirmed by two dimensional IEP which demonstrated up to 
five arcs. 
The antigenic components of the extract, taking advantage 
of their acidic nature, were examined by counter-current IEP 
against the sera of 54 active pigeon fanciers. After 2 hours at 
10 volts/cm and overnight incubation, 36 sera had between one and 
six clear bands. 
The extent of each individual's response to the bloom 
extract as measured semi-quantitatively by the number of 
precipitin bands was seen to correlate very closely with the 
extent of the antibody response to pigeon serum gamma-glo~ulin 
antigen measured quantitatively by radioimmunoassay (figure 8). 
d) Comparison of the antigens from various extracts 
The correlation shown on Figure 8, between the extent of 
the antibody response to the bloom extract antigen as measured 
semi-quantitatively by the number of precipitin arcs resolved and 
the serum IgG antibody against the purified pigeon gamma-globulin 
antigen measured by radioimmunoassay, was highly significant for 
the 54 individual subjects (r=0.81, t =9.9, p<0.001). The immuno-
genicity of the other purified antigens was similarly compared by 
measuring the serum IgG antibody to each antigen by ELISA (see 
Appendix B) in a further 102 pigeon breeders and correlating the 
extent of the antibody response to each antigen. The antigens 
compared were the purified pigeon serum gammaglobulin, serum 
albumin, faecal (secreted) IgA, the pigeon erythrocyte and the 
_/ 
crude soluble bloom extract. It was found that each individual's 
response to all these antigens was significantly correlated (Table 
4; Figure 9). 
All subjects with antibody to one antigen tended to have 
antibody to all antigens, and furthermore the extent of the 
antibody response to one antigen was similar to the extent of the 
response to all the antigens. There was also a clearly 
non-responsive group who did not respond to any of the antigens 
serologically. 
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Comparison of the quantitative titre of serum 
antibody against pigeon serum gamma-globulin antigen 
(ug/ml IgG mean + standard deviation) and the extent 
of the serum antibody response against pigeon bloom 
extract antigens (number of precipitin bands resolved) 
in 97 pigeon breeders. 
32b. 
180 
-~ 
~ 
~ 
"'C 
0 
.Q 100 --.. 
C 
tt1 
C) 
C) 
..... 
o 
Avian rbc agglutination titre 
FIGURE 9: 
Comparison of the quantitative titre of serum 
antibody against pigeon serum gamma-globulin antigen 
(ug/ml IgG, mean + standard deviation} and the titre 
of serum agglutination of pigeon erythrocytes in 100 
pigeon breeders_ 
ANTIGENS COMPARED 
gamma-globulin and sIgA 
sIgA and serum albumin 
gamma-globulin and serum albumin 
sIgA and bloom extract 
gamma-globulin and bloom extract 
serum albumin and bloom extract 
32c. 
CORRELATION 
COEFFICIENT 
0.94 
0.91 
0.86 
0.86 
0.83 
0.76 
TABLE 4. Comparison of the extent of the serum IgG antibody 
response in each of 102 pigeon breeders against 
various avian antigens:- pigeon serum gamma-globulin 
and albumin, droppings secreted IgA (sIgA) and soluble 
feather dust (bloom) extract. 
ANTIGEN SYMPTOMATIC ASYMPTOMATIC t P 
Serum gamma-globulin 0.656 0.322 2.76 0.01 
Serum albumin 1.017 0.528 2.36 0.05 
Droppings sIgA 0.381 0.208 2.72 0.01 
Bloom extract 0.283 o. 193 2.3 0.025 
TABLE 5. Differences between the mean serum IgG antibody titres, 
as measured by optical density, of symptomatic and 
asymptomatic pigeon breeders using various pigeon 
derived antigens in an ELISA system. 
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The same antigens were tested to see which would best 
discriminate between pigeon breeders with and without alveolitis. 
The results of the comparisons between 29 symptomatic and 29 
asymptomatic subjects are listed on Table 5 (also illustrated on 
Figures 4 and 6). ,In all ?ases the symptomatic group had a 
significantly higher mean antibody level than the asymptomatic 
group, but there was no clear separation of these groups based on 
their serum antibody response to any of these antigens. 
In view of the very close association of antibody titres 
to each of the pigeon-derived antigenic materials discussed above, 
the possibility of a common antigen was considered. Double 
diffusion analysis using one high titre serum, and various 
combinations of antigens demonstrated multiple bands against 
pigeon serum, pigeon dropping extract and pigeon bloom extract. 
There were reactions of identity between each antigen source 
occurring between the major antigens as judged by the precipitin 
lines. There were also individual minor antigens which were 
specific for each antigenic source. The common antigenic 
material in each extract was investigated further, and it appeared 
to be due to the content of avian immu~oglobulin, with the 
light-chain being common to all. 
3. DISCUSSION. 
Soluble antigenic extracts from pigeon serum, droppings 
and feathers are known to be clinically important in that they can 
provoke an acute episode of alveoli tis when inhaled by a 
sensitised subject (Hargreave & Pepys, 1972; Muller et aI, 1976; 
Warren et aI, 1977). Equally in these patients, serum 
precipitating antibody to these extracts was prevalent. The 
extent of each individual's immune response to these antigens was 
determined by various genetic and constitutional factors 
(discussed in Chapter 3) however the rela ti ve responsiveness to 
each antigen was the same. This meant that the individual with 
the highest antibody titre to one antigen usually had the highest 
ti tres to all the antigens, and the subjects with low antibody 
levels to one antigen had similar relative titres against the 
other antigens. The relative responsiveness in one individual 
against the range of these inhaled pigeon-derived antigens was 
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therefore a reflection of the availability of these antigens and 
the immunogenicity of the antigens. For example, pigeon serum 
albumin appeared to be less immunogenic than pigeon serum globulin 
in accordance with the observations of Fink et. al ( 1969), and 
also, whereas albumins cou~d be detected in small amounts in 
pigeon droppings (Edwards et aI, 1969), the gamma-globulin 
constituted up to 24% of the soluble extract from droppings. 
This perhaps explained why the pigeon equivalent of IgA seemed to 
be the most antigenic of the purified proteins. Pigeon IgA was 
also identified in extracts from the bloom, therefore it was 
likely that some immunological identity existed between the major 
sources of antigen, including pigeon serum which tended not to be 
a feature of the loft environment. This identity was 
predominantly due to immunoglobulin light-chain determinants which 
were common to the serum IgG and the excreted IgA. It has been 
suggested that the pigeon erythrocyte has light-chain on the 
surface (Diment & Pepys, 1977) and this would explain the close 
correl~ion between the red cell agglutination titre and the 
anti-globulin titre of the patients' sera. Selective inhibition 
of the red-cell agglutination by adding aliquots of light chain 
and the various other purified antigens would help to identify the 
main red cell antigens. It is of interest at this point that 
there is a seemingly fortuitous identity between the antigens on 
the pigeon erythrocyte and the antigens associated with the human 
P1 blood group (Munro et aI, 1980). The antigenic structure of 
P1 is: alpha galactose(1-4)beta galactose (1-4) beta 
N-acetylglucosamine ( 1-3) beta galactose ( 1-4) glucose ceramide. 
It might be appropriate now to look for similar structures on the 
avian erythrocyte, and this may be an opportunity to study some of 
the antigens associated with this disease at the molecular level. 
There have been intermittent reports on disease-specific 
antigens associated with alveolitis (Barboriak et al 1968; 
Peeters, Brombacher & Maesen, 1971; McCormick et aI, 1982). This 
last group of workers claimed to have isolated a specific antigen 
which would only be precipi ta ted by ~he sera from subj ects with 
alveolitis (Calvanico, N. 1983, personal communication) however it 
is known that the disease process of alveoli tis is very dynamic 
an~ can be acute, sub-clinical or chronic, therefore, the role of 
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this putative disease-specific antigen in these various disease 
presenta tions is eagerly awai ted. It is noteworthy that the 
proposed disease-specific antigens are generally minor antigenic 
components, and it is possible that the observation of their 
"disease-specificity" is based. on the fact. that the subjects with 
disease have in general a more florid antibody response, including 
minor antigens, whereas asymptomatic, antibody-posi ti ve subjects 
will have more moderate antibody responses which would mean that 
the antibody titre of these minor antigens would be below the 
detection limit of the precipitin techniques used by the above 
workers. More sensitive quantitative techniques such as 
radioimmunoassay or ELISA (appendix B) would resolve this issue. 
An alternative source of antigen to pigeon droppings has 
been investigated, namely pigeon bloom. This material was 
abundant and is readily airborne in constrast to droppings which 
were hygroscopic and bulky. A soluble extract of bloom contained 
pigeon IgA and up to five other major antigens, and the protein 
bands which focussed at pI 4.7 to 4.1 were remarkably similar to 
the protein band of PDE 1 (pigeon IgA) which focussed at pI 4.6 
(McCormick et aI, 1982). The number of these bands which 
focussed between pI 4.7 and 4.2 was consistent with the charge 
heterogeneity. characteristic of polyclonal immunoglobulin. 
One further feature of bloom was its particulate nature. 
By microsocpy the particles ·were on average one micron in 
diameter, which was in accordance with the estimate of Stettenheim 
(1972). This ornithologist describes the bloom as being composed 
of granules of keratin approximately one micron in diameter. 
Keratin is a highly hydrophobic protein, very resistant to enzyme 
degradation and may act therefore as an inflammatory or adjuvant 
stimulus when inhaled into the lung. This resistance to 
proteolysis could also cause granuloma formation in the lung. 
The granules are coated with the main soluble antigens associated 
with the disease and they are of the correct aerodynamic size to 
penetrate and sediment in the alveoli, therefore, they may act as 
a vehicle carrying the antigens to the alveoli where the disease 
process is most evident. 
For this thesis the antigen source used for all 
serological testing and for skin testing and inhalation 
36 
provocation testing was pigeon serum. This antigen source was 
the most readily available and its use was described widely in the 
literature. Furthermore, when sterilised by heating at 560 C for 
30 min and Seitz filtering, it was considered_safe and proved to 
be non-toxic and non-irritant for skin testing and inhalation 
challenges. 
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CHAPTER 3 
THE ANTIBODY RESPONSE 
1. THE SERUM ISG ANTIBODY RESPONSE TO INHALED AVIAN ANTIGENS. 
Since serum antibody against inhaled antigens was first 
observed in cases of extrinsic allergic alveoli tis among farmers 
(Pepys, Riddell, Citron & Clayton, 1961), the association of 
specific serum precipi tins with each disease syndrome of 
alveoli tis has been consistently reported (Molina, 1976; 
Turner-Warwick, 1978; Belin, 1981). The incidence of these 
precipitins in the general population is very low (Elgefors, Belin 
& Lanson, 1971; Dodge &. Barbee, 1977; doPico et aI, 1976) 
whereas in populations of subjects with regular avian exposure the 
reported incidence of precipitating antibody has ranged from 11% 
(Boyer et aI, 1974), 16% (Reed, Sosman & Barbee, 1965), 20% 
(Barboriak, Fink, Sosman & Dhalival, 1973), 27% (Elman, Tebo & 
Fink, 1968), to 60% (Elgefors, Belin & Lanson, 1971). These high 
incidences of serum precipi tins have been used as evidence to 
suggest that this antibody was only a reflection of avian exposure 
rather than avian induced alveoli tis (Fink et aI, 1972), and this 
has brought the diagnostic significance of these precipitins into 
question (Salvaggio, 1972; Burrell, Law & Olenchock, 1978; 
Burrell & Rylander, 1982). However, a closer association between 
antibody and disease was suggested by Radermecker (1971) who found 
precipitins in 27% of healthy pigeon fanciers and in 75% of pigeon 
fanciers with respiratory disease, and Molina (1976) found a 
significantly higher incidence of precipitins in farmers with 
alveoli tis than in their asymptomatic counterparts. 
Using a sensitive quantitative radioimmunoassay technique 
in an attempt to improve upon the resolution of precipitins, Boyd 
(1978) confirmed that there was a difference in the mean IgG 
antibody levels against a defined pigeon-derived antigen between 
the sera ~f pigeon fanciers with and without alveolitis. 
Subjects with disease had a significantly higher antibody titre 
than the asymptomatic subjects but there was an overlap of values, 
with some asymptomatic subjects having high antibody titres, and a 
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small number of subjects describing typical symptoms without 
demonstrable antibody. 
A systematic evaluation of the humoral immune response 
against inhaled antigens was therefore required. Firstly, 
methods with· adequate sensit~vity for 'accurately measuring the 
serum antibody response were evaluated (see Appendix B). The 
most reliable system was a radioimmunoassay based on the method of 
Neilson, Parratt, Boyd & White, 1974. Using this the antibody 
levels were measured in a large population of pigeon breeders in 
order to assess the normal distribution of responsiveness against 
a purified pigeon gamma-globulin antigen. The effects of various 
parameters including age, avian exposure and smoking habit on this 
antibody response were also studied in order to provide a 
background against which the quantitative antibody levels could be 
compared with the clinical presentation and incidence of 
alveolitis, and with different symptom patterns 'of 
hypersensi ti vi ty in individuals atone point in time and, more 
importantly in a prospective manner. 
2. FACTORS AFFECTING THE ANTIBODY RESPONSE. 
a) Cigarette smoking 
Smoking has been reported to impair pulmonary immune 
mechanisms (Holt & Keast, 1977) and has been associated with an 
increased susceptibility to various lung diseases (Haynes, 
Krstulovic & Loomis, 1966). However, during epidemiological 
investigations of extrinsic allergic alveoli tis among farmers 
(Morgan et aI, 1975; Gruchow et aI, 1981) and among pigeon 
fanciers (Boyd, 1977; Warren, 1977), the reported incidence of 
the disease was found to be lower in cigarette smokers. 
In the survey of 102 pigeon fanciers (see appendix A) 
there were 23 smokers, 65 non-smokers and 14 ex-smokers. The IgG 
antibody levels against inhaled avian antigens in these subjects 
is plotted on Figure 10. The mean antibody level in the smokers 
is 2.9 ug/ml (standard deviation = 4.0) and this is significantly 
lower than the non-smokers' mean titre of 31.7 ug/ml (s.d. = 
39.2). The mean antibody level in the ex-smokers was 25.6 ug/ml 
(s.d. = 37.4) therefore this antibody responsiveness appeared to 
be restored in subjects who· stopped smoking, and the apparent 
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Serum IgG antibody levels against pigeon gamma-
globulin antigen in 102 subjects according to 
smoking history. 
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inhibitory effect of smoking on the antibody response to inhaled 
antigens seemed to be reversible. 
The smoking habit of the subjects in the earlier survey 
of 277 subjects (see appendix A) was divided into those who smoked 
at least 5 pack years or not (1 pack year = 20 cig. per day for 1 
year, or an equivalently shorter time with proportionally more 
cigarettes per day). The data from both surveys are summarised 
on Table 6. In this table the percentage of smokers who mounted 
an antibody response is clearly much lower than the non-smokers. 
Furthermore, the smokers who did mount an antibody response have a 
much reduced mean titre. This was highly significantly lower 
than the titre of non-smokers (T = 2.75, P < 0.01). 
Smoking would appear to have a profound inhibitory effect 
on the ability to mount an antibody response to these inhaled 
antigens. It was important therefore to establish the incidence 
of smokers according to age and years of avian exposure before 
drawing any conclusions about the effects of these parameters on 
the antibody response; which is to be discussed in the two 
following sUb-sections. Table 7 shows the distribution of 
smokers among 379 pigeon breeders divided into decades of age and 
avian exposure. There were no major differences in the 
percentage incidences of smokers with each decade group except for 
a lower incidence of smokers older than 71 years and similarly for 
subjects having kept pigeons for longer than 51 years. This was 
presumably due to the lower age survival of smokers. 
b) Age 
The ability to mount a serum antibody response to inhaled 
avian antigens as a function of age was investigated in 379 pigeon 
fanciers (Table 8). The mean age was 44.9 years and the 
population appeared to be normally distributed. The proportion 
of antibody positive subjects within each age-decade group was 
very similar between the ages of 21 and 70 years. This comprised 
the majority, 90.5%, of the study group. The youngest age group 
- younger than 20 years, had a lower incidence of antibody-
positive subjects, whereas the oldest group - older than 71 years, 
had a higher incidence. The mean antibody titre was also highest 
in this age group and this was in accordance with the lower 
numbers of smokers in the group (Table 7). The mean antibody 
Number 
Antibody positive 
Antibody level 
(mean plus s.d.) 
Smokers 
145 
27 (18.6%) 
17.1 (20.4%) 
-. t= 2.75 P < 0.01 
Non-Smokers 
220 
111 (50.5%) 
43.7 (49.1)· 
TABLE 6. The number of antibody positive subjects 
(IgG > 4 ug/ml) and their mean IgG antibody 
level (ug/ml) against pigeon gamma-
globulin antigen in 365 pigeon breeders 
according to smoking history. 
39a. 
Years Number Smokers 
Age 
1-20 19 7 36 
21-30 lJO 18 lJ5 
31-40 84 33 39 
41-50 89 36 lJO 
51-60 83 30 36 
61-70 47 20 42 
71-80 17 4 23 
Avian 
EXEosure 
1-10 102 lJ6 lJ5 
11-20 97 37 38 
21-30 85 31 36 
31-lJO 30 11 37 
lJ1-50 lJ2 1lJ 33 
51-60 23 6 26 
TABLE 7: The percentage of smokers within each 
decade increment of age and avian 
exposure for 379 pigeon fanciers. 
39b. 
· U 
0"1 
CV) 
AGE (Years) 
0-20 21-30 31-40 41-50 51-60 61-70 71-80 
Number 19 40 84 89 83 47 17 
Mean IgG Level 14.7 19.0 9.7 17.2 12.4 12.3 34.2 
Antibody Positive 
Number 4 14 27 30 37 16 9 
Percent 21 35 31 34 45 34 65 
Mean IgG level 62.3 50.6 26.0 47.1 25.3 32.3 62.8 
TABLE 8. Effect of increasing age in decades on the serum IgG antibody response (ug/ml) 
against avian antigen in 379 pigeon breeders. 
40 
levels in the other groups did not markedly fluctuate, and there 
was no correlation between antibody level and age (r=0.03, t=0.32, 
p=not significant). Moreover, when the antibody titre of the 
antibody-posi ti ve subjects only was compared with age theTe was 
again ~o correlation (r=-0.07, t=.0.69, p=not significant). It 
would appear, therefore, that the individual subject's age had no 
bearing on the ability to mount an antibody response to inhaled 
avian antigens, nor the extent of this response. 
c) Avian exposure 
The extent of avian exposure would be expected to affect 
the antibody response to avian antigens. An 'exposure index' was 
proposed by Fink and colleagues (1972) to include the length of 
time spent with birds and the number of birds; they suggested 
that there was a higher incidence of precipitins in the subjects 
with a greater exposure index. This relationship was examined in 
this section using quantitative antibody measurement techniques ·to 
assess the effects on the IgG antibody levels of various 
parameters of exposure, including number of birds and exposure 
time in hours per day and also in numbers of years. 
i) Number of birds 
The number of subjects who mounted a significant immune 
response to inhaled avian antigens was shown to increase with 
exposure to an increasing number of birds (table 9). Increments 
of 25 birds were chosen arbitrarily to give a reasonable scale of 
the numbers of birds normally handled. Between these increments 
there were minor fluctuations of mean serum IgG antibody levels 
but no trends emerged. There was however a clear trend of an 
increasing incidence of antibody responders having contact with an 
increasing number of birds. However, there was an indication 
that the extent of the antibody response of these antibody-
positive subjects was reduced with increasing avian contact. 
ii) Years of avian exposure 
The mean number of years of avian exposure for the group 
was 22 years and the distribution and range are listed on Table 
10. There was a gradual decrease in the mean antibody level of 
the subjects in each exposure decade, but this was not significant 
(r=-0.03, T=-0.28, p=ns). There was a gradual increase in the 
number of subjects who were antibody positive at each increasing 
40a. 
AVIAN EXPOSURE (Number of birds) 
25 50 75 100 >100 
Number 54 202 70 37 16 
Mean IgG level 6.0 18.6 11.6 13.5 13.0 
Antibody Positive 
Number 10 70 26 18 8 
Percent 18.5 28.6 35.8 48.6 50 
Mean IgG level 23.6 49.9 27.8 25.6 24.0 
TABLE 9. The serum IgG antibody response (ug/ml) to avian 
antigens in 379 pigeon breeders as a function of 
the number of birds kept. 
· .Q 
0 
~ AVIAN EXPOSURE (Years) 
1 - 10 11 - 20 21 - 30 31 - 40 41 - 50 
Number 102 97 85 30 42 
Mean IgG Level 17.2 l5~3 15.2 13.6 16.3 
Antibody Positive 
Number 27 31 34 15 20 
Percent 26 32 110 50 118 
Mean IgG level 59.6 113.6 34.9 25.1 32.1 
TABLE 10. Effect of increasing decades of avian exposure on the·serum IgG antibody 
response (ug/ml) to avian antigens in 379 pigeon breeders. 
51 - 60 
23 
5.8 
8 
35 
13.0 
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exposure decade, until the oldest group. Despite this there was 
a significantly decreasing mean antibody level when the IgG titres 
of the antibody positive subjects were plotted against years of 
exposure (r=-0.22, t=-2.3, p(0.025). This is plotted on Figure 
1~. It would appear, therefore, that increasing avian contact in 
terms of years exposure is associated with reduced antibody 
titres. 
iii) Hours of daily avian contact 
The information regarding the number of hours per day in 
contact with pigeons was tabulated for 102 subjects on Table 11. 
The average time spent was 3.9 hours/day. With increasing daily 
hours of exposure, there was a significant decrease in both the 
number of subjects who were antibody responders (r=-0.93, t=-5.78, 
p(0.005) and the mean antibody level (r=-0.88, t=-4.14, p(0.01). 
It would appear therefore that increasing daily avian contact, 
like the other parameters of' increasing avian exposure; is 
associated with reduced antibody titres. 
3. THE ASSOCIATION OF ANTIBODY WITH DISEASE. 
a) The profile of antibody levels in a population of pigeon 
breeders: 
The serum IgG antibody to pigeon gamma-globulin was 
measured in 507 pigeon breeders (see Appendix A), and the number 
of individuals occurring within 10 ug/ml IgG antibody increments 
are plotted in histogram form on Figure 12. The upper limit of 
normal had been previously established at 4 ug/ml of antibody, 
and 257 of the pigeon breeders, 51%, had levels above this limit. 
The mean antibody level for the whole group was 19.9 ug/ml and ' 
38.2 ug/ml for the 257 antibody positive subjects. The highest 
individual values of specific antibody were measured up to 
approximately 500 ug/ml. 
b) The incidence of alveoli tis relating to the antibody levels 
in a population of pigeon breeders: 
One hundred and ten subjects (22%) fulfilled the criteria 
for avian related extrinsic allergic alveoli tis (see Appendix A), 
and the percentage of these subjects within each of the above 
antibody-increment groups is illustrated on Figure 13. The 
incidence of disease was seen to increase from 3.7% in the 
4la. 
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FIGURE 11: 
The decrease of serum IgG antibody levels (mean + S.D.) 
of 135 antibody-positive pigeon breeders according to 
increasing decades of avian exposure. 
. 
.Q 
..... 
~ 
AVIAN EXPOSURE (Hours per day) 
1 2 3 4 5 6 7 
Number 6 25 19 8 25 11 7 
Mean IgG level 19.0 27.7 14.1 11.0 5.6 3.3 3.1 
Antibod~ Positive 
Number 4 16 9 3 7 2 . ·2 
Percent 66.6 64 47 37.5 28 18.2 28.6 
Mean IgG level 27.5 42.2 27.5 25.9 14.9 9.2 5.7 
TABLE 11. Daily avian exposure and the mean IgG antibody response (ug/ml) against avian antigens in 
102 pigeon breeders. 
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FIGURE 12: 
Histogram of the distribution of serum levels of IgG 
antibody to avian antigens in a population of 507 
pigeon breeders. 
41d. 
Distribution of symptomatic subjects 
% 100_ 
50 
I .1. 
-/I 
o 10 20 30 40 50 150 250 > 
JgG Antibody 
FIGURE 13: 
The incidence of extrinsic allergic alveolitis within 
groups of pigeon breeders with increasing increments 
of serum antibody levels (ug/ml). 
antibody-negative group to 18% with antibody greater than 30 
ug/ml, and virtually all subjects with antibody levels greater 
than 150 ug/ml had pigeon breeders disease. 
The_association between antibody and pigeon breeders 
disease was statistically significant (chi-squared = 51.1, 
P<0.001). The largest subgroup of the 501 subjects, 46%, had 
neither antibody nor disease, and the majority of the 110 
Subjects with PBD, 83%, had significant antibody levels. 
However, there was antibody without symptoms in 33% of the 
Subjects and a small percentage, 3.1%, claimed symptoms without 
antibody (Table 12). 
c) Correlation of symptoms of EAA with antibody levels: 
42 
In the group of 102 pigeon fanciers who were interviewed 
extensively for the occurrence of pulmonary and systemic 
hypersensitivity symptoms related t~ avian exposure (see Appendix 
A, Table 39), 53 denied any late symptoms whatsoever and 49 
admitted to a range of between one and all eight symptoms 
investigated. 
The extent of the antibody response to avian antigens in 
the asymptomatic group and the groups describing increasingly 
broader symptoms is outlined in Figure 14. This shows that a 
progressively complete symptomatic picture of classical 
alveolitis symptoms'in a population is closely associated with 
higher antibody levels. 
The same group of subjects also responded to questions 
relating to immediate hypersensitivity symptoms, and a similar 
Comparison of IgG antibody level showed no correlation with the 
extent of immediate symptoms following avian contact. Each 
group had a mean IgG antibody value similar to that of the whole 
study group population (group mean=23.2 ug/ml, sd=35.0). 
102 subjects were divided into symptomatic groupings 
according to the clinical criteria outlined in Appendix A. Four 
groups were categorised as having - A: alveolitis, B: no 
symptoms, C: indeterminate symptoms and D: asthmatic symptoms 
caused by avian exposure. The IgG.antibody levels of the 
Subjects in each subgroup are illustrated in Figure 15, ,and 
summarised along with the values of control groups on Table 13. 
The alveolitis group had a significantly higher mean antibody 
Less than 4 ug/ml 
Greater than 4 ug/ml 
Chi-squared = 120.1 
p < 0.001 
Negative 
296 (58.4%) 
101 (19.9%) 
Alveolitis 
42a. 
Positive 
19 ( 3.7%) 
91 (17.9%) 
TABLE 12. Correlation between the presence of IgG antibody (greater 
than 4 ug/ml) and extrinsic allergic alveoli tis in 507 pigeon 
fanciers. 
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FIGURE 14: 
The mean (Plus s.d.) IgG antibody level against avian antigens 
in 102 pigeon breeders according to a progressively more 
complete symptomatic picture of alveoli tis (late symptoms) or 
asthma (immediate symptoms). 
42c. 
GROUPS NUMBER MEAN S.D. POSITIVE 
Subjects 
Alveolitis 32 41.4 43.3 22 
Asymptomatic 28 14.0 25.5 8 
Indeterminate 34 13.2 22.2 10 
Asthma 8 7.2 11.2 2 
Controls 
Normals 58 3.7 2. 1 0 
Myeloma 32 4.37' 2.47 0 
S.L.E. 12 4.2 2.7 0 
Asthma 40 4.1 2.1 0 
TABLE 13. The mean and standard deviation of serum IgG 
. antibody levels (ug/ml) against pigeon 
gamma-globulin antigen in 102 pigeon breeders 
subdivided into symptomatic groupings, in 58 
normal subjects with no avian exposure and in 
83 pathological sera from patients with myeloma, 
systemic lupus erythematosus and asthma. 
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42d. 
The serum IgG antibody levels against pigeon 
gamma-globulin antigen in four groups of 
pigeon breeders: A, with alveoli tis; B, with 
no symptoms; C, with indeterminate symptoms; 
and D, with asthmatic symptoms. 
The mean bar is indicated by, the hatched line 
in each group, and the dotted line is the upper 
limit of normal. 
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titre than the other subgroups. Sera from healthy control 
subjects with no avian exposure had insignificant levels of 
antibody, and control pathological sera from patients with 
myeloma, systemic lupus erythematosis, S.L.E.,and asthma also 
had insignificant levels. Thus the presence of high levels of 
serum immunoglobulin in the myeloma sera and the high levels of 
immune complexes in S.L.E. sera did not affect the measurement of 
specific antibody. There was also no specific IgG antibody to 
avian antigens associated with asthma, and subsequently with 
other respiratory di~orders including sarcoidosis and alveolitis 
caused by M. faeni and Aspergillus Spa 
4. DISCUSSION. 
The diagnostic importance of precipitins against a panel 
of likely antigens has been stressed in a recent report of the 
experience of one laboratory which had tested the sera of 
approximately 10,000 patients for whom EAA was a possible 
diagnosis (Belin, 1981), and similar antigen screening has 
demonstrated a low incidence of positive precipitins in the" 
general population;' with 1.8% of 3047 subjects reported positive 
(Dodge & Barbee, 1977) and 4.9% of a further 1072 subjects 
(Chmelik, Flaherty & Reed, 1974); these antibodies being 
predominantly against ubiquitous "thermophilic Actinomycetes, 
although a small proportion, 0.8%, of the last group had 
precipitins to pigeon serum. There was no reference ~o any 
avian exposure in this small precipitin positive group which 
would have been important to know since there i~ extensive 
antigenic similarity between the sera of different avian species 
(Sennekamp et aI, 1981) mainly due to the albumin fraction. 
Thus, the absorption of dietary hens egg antigens from the gut in 
certain inflammatory bowel diseases (Taylor et aI, 1964; Ferguson 
& Carswell, 1972) could result in serum antibody which would 
precipitate with pigeon serum antigens, however specific 
antigenic determinants on the serum immunoglobulin molecule of 
the pigeon can be used to differentiate antibody production due 
to pigeon exposure from these dietary antigens (Faux, Hendrick & 
Anand, 1978). This specific pigeon gammaglobulin antigen was 
used in the present study. However, false positive precipitin 
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reactions could occur against teichoic acids present in various 
antigenic extracts particularly pigeon droppings extract (Faux et 
aI, 1910) and non-specific, calcium-dependent precipitations by 
the serum acute phase p~otein, C-reactive protein (Longbottom & 
Pepys, 1964). 
The various reported prevalence of precipitins have been 
discussed earlier (Chapter 1, 4f), and in the study population of 
this report, using a more sensitive assay method, the prevalence 
was 51%. About half of the subjects therefore were 
non-responders to inpaled avian antigens despite similar rates of 
avian exposure as in the antibody positive group. The questions 
which now arise include (a) what factors determine whether a 
subjects will be an antibody responder or non-responder; (b) what 
factors affect the extent of the antibody response; and (c) is 
the presence of serum antibody of any diagnostic significance? 
The ability to mount an antibody response is controlled 
fundamentally by the Ir genes (Munro & Waldmann,1918) and 
subsequently by T-lymphocytes (Virelizier et aI, 1914). The 
genetic disposition of subjects with alveoli tis has been 
investigated and association have been reported with various HLA 
haplotypes (discussed in Chapter 1,4g), however, previous work 
from this laboratory (unpublished observations) and other centres 
(Schatz et aI, 1916: Rodey et aI, 1919), did not support an 
association between a particular HLA haplotype and disease. 
Nevertheless, like the genetics of the immune response to 
allergens (Marsh et aI, 1980), the responsiveness to inhaled 
antigens and the development of extrinsic allergic alveoli tis are 
likely to be a function of several genetic factors, both antigen 
specific (Wilson et aI, 1982) and antigen non-specific (Wilson et 
aI, 1982; Keller, Calvanico & Stevens, 1982). These control 
firstly the ability to mount an antibody response to specific 
inhaled antigens, and the extent of this response, and secondly 
the development of alveoli tis. 
The pu~pose of the present study was to investigate other 
parameters th~ught to affect this antibody response. One of the 
strongest environmental facto~influencing the development of a 
serum antibody response to inhaled antigens was the smoking 
habit. Cigarette smoking was associated with a lower incidence 
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of antibody-responsiveness, and even in the few responders the 
extent of the response was significantly lower. The reasons for 
this are obscure; it has been reported that smoking causes small 
airways obstruc~ion (Dolovitch et aI, 1976) resulting in more 
proximal deposition of inhaled particles (Bohring et aI, 1975). 
Thus, the access of organic dusts to the alveoli where the 
disease process of avian hypersensitivity is most evident 
(Hensley et aI, 1969) may be hindered. 
There are, however, more fundamental effects of smoking on 
the development of antibody. The products derived from 
cigarette smoke have immunosuppressive activity (Roszman & 
Rogers, 1973) in vitro, and in vivo (Thomas, Holt & Keast, 1974), 
and smokers have an increased susceptibility to infection 
(Haynes, Krstulovic & Loomis, 1966: Nymanol, 1974), with lower 
subsequent antibody titres (Finklea et aI, 1971) and a general 
supression of total'IgG and IgA has been reported (Gulsvik & 
Fagerhod, 1979). Within the lung compartment, smoking has been 
shown to markedly increase the local number of alveolar 
macrophage (Warr et aI, 1976) and one consequence of increasing 
the alveolar macrophage: lymphocyte ratio was immuno-suppression 
in vitro (Schuyler & Todd, 1981). These mechanisms may be 
responsible for the impaired ability of smokers to respond to 
inhaled avian antigens. 
The age of the individual did not determine the antibody 
responsiveness, as has been shown experimentally in mice 
(Crousle, Miller & Grove, 1981). However other literature would 
suggest that older subjects have a decreased capacity for humoral 
responsiveness (Heidrick & Makinodan, 1973: Pahwa, Pahwa & Good, 
1981). In fact, the proportion of responders in the older group 
in this study, i.e. older than the mean of 44.9 years, was higher 
than the younger group (40.3% vs 31.9%, Chi-sq=2.9, 0.05<p<0.1), 
however, the extent of this antibody response,was less, (38.6 
ug/ml vs 44.0 ug/ml, p=ns). 
Having established, therefore, that there was no 
significant effect of age on the antibody response, it was 
possible to measure the effects of varying lengths of time rif 
avian exposure on the antibody response. With increasing years 
of exposure, and with increasing numbers of birds kept, the 
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incidence of antibody-responders increased. However, the extent 
of the antibody response diminished significantly with continued 
exposure. This effect was also noticed in the daily exposure 
rates where subjects who spent more hours per day with their 
pigeons had significantly reduced antibody levels. Since these 
changes in antibody level were not due to either age or smoking 
habit then it is possible that the decreasing levels of antibody 
with time may be due to a desensitising process as described in 
animal models of the disease by Richerson and colleagues (1981) 
and Wilkie & Neilson (1981). 
~ 
There was, however, evidence, that subjects with symptoms 
of extrinsic allergic alveoli tis had reduced daily exposure to 
birds (Banham et al, 1984). This EAA group did not differ 
significantly from the whole study population in age, number of 
birds kept, nor years of avian exposure, but the lower mean 
hours-per-day exposure (2.3 hr. vs. 4.2' hr. for the whole group) 
would suggest that they were aware of their symptoms and that 
this reduction in exposure-time was a compromise between their 
health and their hobby. It may be appropriate at this point to 
underline the inten~e committment these pigeon fanciers have for 
their birds. It is often a life-long pastime that has been in 
the family for generations, and apart from the considerable 
financial investment involved, the sport is often the main focus 
for social activity. This means that they generally ignore any 
advice to give up the hobby until their allergy is particularly 
troublesome; or they may find an arbitrary balance by wearing a 
mask and reducing their daily exposure, thereby remaining 
asymptomatic. 
The antibody levels against pigeon derived antigens were 
shown to be a good indicator of the probability of having pigeon 
breeders disease, and also to be a useful parameter to monitor 
clinical progress. However, the value of antibody measurement 
using precipitin techniques was questioned (Salvaggio, 1972) 
principally d~e to the high incidence of precipitins in 
asymptomatic subjects (Fink et aI, 1972). The present study has 
shown that 52.6% of subjects with significant antibody levels 
were asymptomatic, however, when the level of this antibody 
response was quantified, a clear association between increased 
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. disease incidence and progressively higher antibody levels became 
apparent. Furthermore, several subjects with high antibody 
titres developed functional and serological ch~nges following 
__ controlled inhalation challenges with nebulised pigeon_ serum, 
without overt symptoms (see Chapter 5), and other workers have 
reported the association of antibody in asymptomatic subjects 
with pulmonary function abnormalities (Allen et aI, 1975, 1976; 
Braun et aI, 1980; Hapke et aI, 1968), and with evidence of an 
inflammatory process (Sennekamp et aI, 1978, Turton et aI, 1981). 
It would seem theref~re that the antibody positive subjects, 
particularly those with high titres, form more of an "at-risk" 
population than is presently considered. 
By far the exceptonal situation was the antibody-negative 
subjects with alveolitis; 3.7% of our study group fell into this 
category, and it has been described also by Edwards, Baker & 
Davis (1974); Sennekamp et aI, (1978) and Canet et al (1980). 
Again, confirmation by positive late alveoli tis reactions to 
inhalation challenges with appropriate antigen, in subjects who 
were antibody-negative by radio-immunoassay, would resolve the 
controversy about whether or not antibody-negative subjects have 
disease. 
These observations reaffirm the importance of determining 
the presence and quantifying the serum IgG antibody in the 
investigaton of the epidemiology and natural history of 
extrinsic allergic alveolitis. Moreover, these measurements are 
a clear guide to the therapeutic progress of patients with acute 
disease, and are of value in monitoring subjects who may 
otherwise develop insidious disease. 
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CHAPTER 4 
THE ASSOCIATION OF SOME SEROLOGICAL MEASUREMENTS WITH ALVEOLITIS 
- AND WITH ANTIBODY RESPONSIVENESS TO INHALED ANTIGENS. 
1. SERUM IgM and IgA ANTIBODY. 
a) Introduction. 
The serum antibody of alveoli tis patients is usually 
demonstrated by precipitin reactions using the appropriate 
causati ve antigens. The precipitin technique precludes 
quantitative measurement of the serum antibody, as discussed in 
Chapter 3, and furthermore it gives no information of the 
immunoglobulin class distribution of the antibody activity. The 
presence of IgG antibody against avian antigens did not correlate 
directly with the presence of alveoli tis among pigeon breeders, 
therefore, the serum antibody in the other major classes IgA and 
IgM was measured to see if they could better discriminate between 
symptomatic and asymptomatic subjects. Moreover, the an~ibody 
activity was measure~ in IgA and IgM classes in a large population 
of pigeon breeders, and was compared with their IgG antibody 
levels (and IgE antibody - see section 3) in order to obtain a 
full profile of the antibody responsiveness against inhaled 
antigens. 
b) Antibody activity in the major classes. 
The serum IgG, IgM and IgA antibody acti vi ty against 
pigeon gamma-globulin antigen was measured by an amplified 
enzyme-linked immunosorbent assay, ELISA, using class specific 
antisera (Appendix B). Serum was obtained from 54 pigeon 
breeders and from 58 control subjects with no avian contact. The 
antibody measurements in optical density units are graphed on 
Figure 16. Forty subjects (74.1%) had higher than normal IgG 
antibody levels, and 20 (37.0%) and 5 (9.3%) had significantly 
raised IgA and.lgM antibody levels respectively. 
Having established that there was antibody activity in 
the IgM and IgA classes, the levels of these were compared in two 
groups of pigeon breeders - with and without alveolitis. The 
results using pigeon gamma-globulin antigen are illustrated on 
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FIGURE 16: 
The serum antibody activity in the 3 major classes against 
avian antigens in 54 pigeon breeders and 58 control subjects 
with no avian exposure. 
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Figure 17, and using purified pigeon droppings sIgA antigen on 
Figure 18. There were significant differences between the two 
groups in all the antibody classes, and despite this, there are 
still areas of overlap between the r~nges of the antibody levels 
between the two groups. 
It became apparent that the subjects with the highest 
antibody activity in the IgG class also had the highest antibody 
titres in the other classes. The relative extent of the antibody 
activity in all three classes was compared in 102 pigeon breeders 
against gamma-globu~in antigen. The correlations between the 
classes were, IgG and IgA:- r=0.83, IgG and IgM:- r=0.70, and for 
IgA and IgM:- r=O. 77. These were all highly significant, and 
similar correlation coefficients were measured for the class 
specific antibody titres to the other major antigens. 
c) Discussion. 
Antibody activity against avian antigens can be measured 
in the IgA and IgM classes in the serum of pigeon breeders if a 
sui tably sensi ti ve technique is used. Pa t terson and colleagues 
(1976) using a tube radioimmunoassay method and Faux and 
colleagues ( 1971 ) (using a radioimmunoelectrophoresis technique 
also demonstrated antibody activity in the three major classes 
against avian antigens. These workers commented that the 
measurement of IgM and IgA antibody may have diagnostic value. 
In this section it would appear that measuring these 
antibody classes does not resolve the paradox of antibody-positive 
subjects who are asymptomatic and equally, the subjects with no 
antibody but who describe typical symptoms. In quantitative 
terms, these antibody levels are indeed significantly higher in 
symptomatic subjects, but they provide no better discrimination 
between subjects with and without disease than the simple IgG 
antibody measurements. 
The titres of serum IgM and IgA antibody would appear to 
be considerably lower ~han IgG, based on the numbers greater than 
the normal ~ange. However, the extent to which an individual 
will make an antibody response in the IgG, IgM and IgA class seems 
to be related. Therefore the high-responder subjects will have 
the highest titres of all ~ntibody classes, and the low-responders 
will have low or absent titres of antibody in all three 
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immunoglobulin classes. 
The ability to mount such a broad antibody response to 
antigens which are inhaled was of interest because it might be 
expected that the response would be more localised in the lungs, 
and that the immune-response of the osecretory system would have 
been preferentially stimulated. The predominant class of 
antibody stimulated at mucosal surfaces is IgA, and antibody 
activity in the IgG and IgA classes directed against pigeon 
antigens was measured by RIA in bronchial lavage fluid from 6 
symptomatic and 10 a,.symptomatic pigeon breeders who volunteered 
for fibreoptic bronchoscopy (Patterson et aI, 1919). These 
workers found local levels of OlgA antibody in proportionally 
higher titres than serum, and reported differences between 
symptomatic and asymptomatic subjects based on this local IgA 
antibody titre. Local lung IgG antibody was also measured but no 
comparisons between the IgG and IgA titres were possible. This 
approach is unrealistic in practical terms for repeated individual 
measurements, for large scale studies, nor indeed for individuals 
who have compromised pulmonary function. It was of interest to 
note that the serum IgG and IgA antibody activi ty in _these 
subjects were approximately of the same proportional titre as the 
bronchial fluid titres. This suggests strongly that serological 
investigation of these subjects' serum is far easier and gives a 
reasonaole approximation to the parameters in the lung. 
2. TOTAL IMMUNOGLOBULINS. 
a) Introduction. 
Hypergammaglobulinaemia has been frequently documented in 
extrinsic allergic alveoli tis (Elgefors , Belin & Lanson, 1911 ; 
Molina, 1916; Haslam, 1918). However, there have been few 
attempts to explain this, other than as a generalised 
hypersensi ti vi ty response following host tissue damage. Other 
conditions with raised polyclonal immunoglobulins include chronic 
active hepat.itis and cirrhosis (Thomas, McSween & White, 1913), 
infectious :diseases, some neoplastic conditions and autoimmune 
diseases (Hobbs, 1910); and the fundamental mechanism proposed 
for these was as a response to chronic antigenaemia. 
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The purpose of this study was to establish the effect of 
continuous avian antigen exposure on the immunoglobulins G, M and 
A~otal IgE is to be discussed in the next section). The pigeon 
breeders under investigation could be divided into two groups; the 
antibody responders and non-responders against these avian 
antigens. This specific responsiveness, as well as the extent of 
the response, was compared with the total immunoglobulins. The 
incidence of raised immunoglobulins was also measured in the 
various hypersensitivity diseases associated with avian exposure 
and during the differ~nt phases of disease. 
b) Total immunoglobulins in a groups of 
pigeon breeders with extrinsic allergic alveolitis. 
A group of 32 pigeon breeders with alveoli tis of varying 
degrees of severity had their total serum IgG, IgM and IgA 
measured. Using the normal range for IgG (5-16 mg/ml), IgM 
(0.5-1.9 mg/ml) and IgA (0.5-3.5 mg/ml) established by Brown 
(1982), there were 16 subjects with raised IgG and 11 with raised 
IgA (Figure 19). The IgM was raised in only three cases, the 
res t were normal. There was an indication from the graph that 
the IgG and IgA levels were correlated and this was statist~cally 
significant (r=0.60, t=4.40, p<0.01). 
c) Correlation of the total immunoglobulins with the 
specific antibody response to inhaled antigens. 
The total IgG and IgA levels were measured in 230 and 210 
subjects respectively, and 146 and 139 of these were positive for 
serum IgG antibody against avian antigens. The incidence of 
antibody-responders was measured in increasing levels of total 
immunoglobulin as outlined on Figure 20. This suggested that 
higher levels of total IgG and to a lesser extent, higher levels 
of IgA, were associated with increased responsiveness to inhaled 
avian antigens. 
This correlation between specific IgG and total 
immunoglobulins was investigated further in 102 subjects. In the 
antibody positive group the mean titres of IgG, IgM and IgA were 
higher than,the antibody negative group (IgG = 14.1 and 11.0, IgM 
= 1.08 and 0.99, IgA = 2.78 and 2.20 respectively, ~ll values in 
mg/ml). The correlation between the total IgG and the specific 
IgG antibody levels was shown to be st~tistically significant on 
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d) The effect of cigarette smoking on the total 
immunoglobulin levels. 
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During the investigation of the incidence of spec!fic 
antibody .in the raised IgG subjects it became apparen t that 
non-smokers, who comprised the majority of the antibody responders 
(see Chapter 3) had higher IgG levels. The mean values in mg/ml 
for immunoglobulins, and international units/ml for IgE are listed 
on Table '5. The IgG and IgA levels were greater in non-smokers 
( = 3.' 9, p < o. 00 5 ; .. and t = ,. 73 , 0 • 05 < p < O. 1, re s pe c ti vel y) • 
e) Discussion 
Raised serum immunoglobulins, particularly IgG, were 
remarkably common among pigeon breeders irrespective of whether or 
not they described typical, symptoms of alveoli tis. This 
hypergammaglobulinaemia was more closely associated with the 
individual's antibody responsiveness to the antigens associated' 
with pigeons, and because this was primarily a feature of the 
subjects with alveolitis, then these patients also generally had 
raised serum immunoglobulins. 
Many subjeets with no oyert symptoms, who had high serum 
antibody, also had equally high total serum immunoglobulin levels. 
Assuming that raised serum immunoglobulins were a feature of 
inflammatory reaction, this would suggest that there was an active 
process ongoing in these subjects despite the lack of overt 
symptoms. A similar profile of inflammatory parameters including 
acute phase proteins and immune-complexes in these asymptomatic 
antibody-positive subjects has emerged in this chapter (see 
below), which suggests that these subjects have subclinical 
reactivity to the antigens to which they are constantly exposed. 
The raised immunoglobulin titres were primarily a feature 
of the antibody responders, and furthermore the extent of the 
non-specific inflammatory response measured by total 
immunoglobulins seemed to be related to the extent of the specific 
antibody resp~nse. There were no non-specific effects of high 
serum IgG on the assay procedure for measuring the specific 
antibody (Appendix B), so it would seem that there is a common 
stimulatory mechanism for the specific and total IgG. Other 
raised titres of antibody to respiratory viruses in alveoli tis 
patients have been reported (Marx et aI, 1977; Boyd, '978) and a 
IgG antibody" 
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TABLE 15. 
52b. 
Smokers Non-smokers 
n = 23 n = 65 
Mean s.d. Mean s.d. 
10.8 1.8 13.5 3.9 
2.2 0.8 2.7 1.3 
1 • 1 0.4 1. 1 0.7" 
142 106 140 163 
Total immunoglobulin levels in smoking and 
non-smoking pigeon fanciers 
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similar anamnestic response was seen in the sera of sarcoidosis 
patients (Hirshault et aI, 1910; Daniele et aI, 1918). 
The serum IgA levels can also be raised in these 
individuals, and a signifiqant correlation between total IgG and 
IgA levels was noticed. The IgM levels were normal or low. The 
IgA and IgG levels rose and fell in tandem with avian exposure and 
antibody levels in one yearly study of monthly levels of these 
parameters in 20 pigeon breeders (McSharry et aI, 1983), and the 
raised total IgG and IgA fell in tandem in one patient during a 
period of avian antigen avoidance, a short period after the 
" 
antibody titres dropped (Chapter 5). This suggests that there is 
a general immuno-stimulation associated with the extensive antigen 
exposure among pigeon breeders which affects both total and 
specific antibody. 
Other pulmonary diseases which are associated with raised 
serum immunoglobulin include fibrosing alveoli tis where 21 of 32 
patients were reported to have above normal levels of at least one 
class of antibody (Hobbs & Turner-Warwick, 1961). Increased 
serum levels of IgG and IgA was reported in 49 patients with 
chronic bronchitis ,and emphysema (Falk, Siskind & Smith,' 1910). 
Hodson (1911) reviewed 124 cystic fibrosis patients and reported a 
41% incidence of raised serum IgG levels, 33% with increased IgM 
and 23% with increased IgA. Interestingly, he also reported a 
68% (51 of 14) incidence of raised IgE, but found that allergic 
symptoms were uncommon. A high incidence of raised serum IgG 
occurs in pulmonary sarcoidosis and the source of this 
immunoglobulin was suggested to be from intrapulmonary produced 
immunoglobulin, controlled by lung T lymphocytes, (Hunninghake & 
Crystal, 1981). These workers, as well as Lawrence et al (1980) 
described increased local bronchoalveolar IgG secreting cells in 
sarcoidosis and other interstitial lung diseases including one 
patient with EAA. 
In alveolitis, the local lung fluid immunoglobulins were 
measured in higher ti tres than normal subjects (Reynolds et aI, 
1911; Voisin et aI, 1981) and this was suggested' to be 
predominantly locally synthesised because of the high ti tres of 
IgM and the high IgG to albumin ratio (Weinberger et aI, 1918). 
These observations support the histological evidence of increased 
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plasma cells in lung sections from' alveoli tis patients (Boyd, 
1975), and suggest that the lung might be the source of the high 
immuno-globulins associa ted with al veoli tis. In normal 
individuals, the lung has been estimated to synthesis 8% of the 
serum pool of IgG (Deus~hl & Johansson, 1974), which could be 
expected to increase given the large increase in cell numbers in 
the lung of alveolitis patients (Reynolds et aI, 1977). 
The lower serum levels of immunoglobulins among smokers 
supports the data of Gulsvik & Fagerhod (1979). However, the 
mechanism of the effect is unknown. The products derived from 
tobacco smoke have~in vitro immunosuppressive activity (Roszman & 
Rogers, 1973), and this is also seen in vivo (Thomas, Holt & 
Keast, 1974). With respect to the pigeon breeders the habit of 
cigarette smoking seems to abrogate all the immuno-responsiveness 
to avian antigens both in the specific serum antibody (Chapter 3) 
and total immuno-globulins. This may be a local pulmonary 
effect, because one consequence of cigarette smoking is to 
increase the local alveolar macrophage population which is known 
to cause immunsuppression (Schulzer & Todd, 1981). 
3. TOTAL SERUM I&E AND IgE ANTIBODY 
a) Introduction. 
Constitutional factors are thought to influence the 
antibody responsiveness of an individual to inhaled antigens and 
the development of alveolitis. Innocuous antigens when inhaled by 
atopic subjects can result in allergic states mediated by IgE 
antibody~ This mechanism results in the well characterised 
disease picture of immediate hypersensitivity such as asthma and 
hay fever. We sought to evaluate the role of atopy in the 
disease process of alveolitis by measuring IgE in a large number 
of pigeon breeders some with different hypersensitivity diseases 
associated specifically with avian exposure. 
b) Total IgE. 
Th e IgE level was measured ini tially in 164 sera from 
pigeon breeders being investigated for alveolitis. Of these, 22 
. (13.3%) had raised total IgE greater than 200 International 
Units/mI. 
A further 102 
extensively concerning 
pigeon 
their 
fanciers were interviewed 
hypersensitivity symptoms 
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specifically related to avian exposure (Appendix A). The symptom 
categories and the total IgE are listed on Table 16. The "hay 
fever" subjects were a sub-group of the indeterminate symptom 
group, who described bot.h rhinitis and conjunctivitis immediately 
(within 30 minutes) of contact with pigeons. 
The subjects with alveoli tis had an incidence of 
individual raised IgE (and group mean IgE levels) which did not 
differ significantly from the whole study group. 
The study group was divided into antibody responders and 
non-responders to inhaled avian antigens, and the mean and 
'"', 
standard deviation of the total IgE levels in these two groups 
were 144 iu/ml (sd = 177) and 113 iu/ml (sd = 109) respectively (t 
= 1.2, P = ns). The extent of this antibody response did not 
correlate with the individual IgE levels (r = -0.05, t = -0.47, P 
= ns). 
c) Total IgE, IgE antibody and immediate symptoms 
related to avian exposure. 
The total IgE (and IgE antibody) in subjects who describe 
an increasingly complete picture of immediate symptoms related to 
avian exposure is illustrated on Figure 22. This demonstrated an 
association of immediate symptoms with IgE and not IgG antibody. 
T~e serum IgE antibody to avian antigens was measured by 
RAST using sepharose-pigeon globulin an"tigen (Appendix B) and 
commercially available antigen discs coated with pigeon droppings 
extract (Pharmacia, e7 discs). Using these, 14 of the above 102 
subjects w~re positive. These were:- 4 with a low level (RAST 
grade 1) of IgE antibody against droppings extract, and 12 
positive against pigeon globulin; 9 grade 1, and 3 grade 2 
(moderate level of IgE antibody). Two subjects were positive for 
both antigens and those were included in the asthma group (Table 
16). The other RAST positives included 5 with EAA, 1 with 
asthma, 4 with rhinitis-conjunctivitis and 2 with no symptoms. 
d) Discussion. 
Serum IgE is raised specifically in allergic diseases 
"( Johansson et aI, 1968) and non-specifically in allergic 
bronC?hopulmon~ry aspergillosis (Patterson, Rosenberg & Roberts, 
1977) and in patients with some tropical parasitic infections such 
as filariasis and schistosomiasis. Our investigation into 
Number Mean IgE (sd) 
All 102 138 (159 ) 
Asthmatic 8 327 (332) 
Asymptomatic 29 108 ( 95) 
Alveolitis 33 144 (138) 
( 
Indeterminate 32 109 (135) 
(Hay Fever) 8 268 (296) 
TABLE 16. Serum IgE levels (iu/ml) in pigeon 
breeders according to their symptomatic 
status 
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The total serum IgE and specific IgG antibody levels 
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symptomatic profiles-of immediate hypersensitivity 
following avian contact. 
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abnormalities of IgE levels in subjects with EAA caused by avian 
exposure revealed no particular role for this class of immuno-
globulin in the disease process of alveolitis. This is in 
general agreement with Patterson and colleagues (1973). 
Similarly, the sera from alveolitis patients had no IgE antibody 
activity, thus confirming the reports of Patterson et al (1976), 
Warren et aI, (1977); Cohen, Yunginger & Fink (1979); Faux, Wells 
& Pepys (1971). This last group did find IgE antibody in some 
subjects but this was associated with symptoms of immediate hyper-
sensitivity. The present report confirmed the general lack of 
", 
IgE antibody among pigeon fanciers and also that the few positive 
IgE antibody subjects had immediate symptoms associated with avian 
exposure. These subjects will be discussed in terms of skin 
testing and IgE antibody in Chapter 6. 
4. TOTAL AND SPECIFIC IgG SUBCLASSES 
a) Introduction. 
Human serum IgG is made up of at least 4 subclasses which 
have structurally different heavy chains, and consequently each 
can have differen~ effector functions following combination with 
antigen (Shakib & Stanworth, 1980). These authors reviewed the 
selective changes in IgG subclasses which were noticed in 
associa tion with many clinical conditions and the IgG subclass 
restriction which could be demonstrated during immunization with 
various antigens. 
Since the route of antigen administration was suggested 
to alter the subclass distribution of the IgG antibody, and 
because there was no information on the effect of immunizing via 
the respiratory tract then the antibody activity in the IgG 
subclasses was measured against the major inhaled avian antigen in 
a population of pigeon bree~ers. This was also undertaken to 
quantify any qualitative difference in the antibody response 
between pigeon breeders with and without alveolitis. 
Allergic alveoli tis is associated with raised total IgG 
. (see above), and because of the apparent independence of synthesis 
of ~ach IgG subclass, the level of each was measured to ·clarify 
which would account for the raised total levels. 
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b) Total subclases. 
The levels of the total serum IgG subclasses were 
measured in 99 pigeon breeders by radial immunodiffusion (see 
Appendix B). The sum of the individual subclasses correlated 
very closely with the total IgG immunoglobulin (r = o. 19, p < 
0.n01). This was primarily due to the contribution of IgG1, which 
correlated significantly with the total level (r = 0.15, p < 
0.001), and to a lesser extent due to the contribution of IgG2 
which again correIa ted. significantly with the total IgG, (r = 
0.56, p < 0.001). The values of these individual subclass totals 
are listed on Table 11. The levels of subclasses 3 and 4 did not 
make a significant contribution to the total IgG fluctuations. 
Of the 99 subjects investigated, 51 had detectable serum antibody 
to the inhaled avian antigen. These positive responders had 
significantly higher mean levels of total serum IgG and total 
subclasses 1 and 2 (Table 18). There were no significant mean 
differences between the groups in the IgG 3 and 4 subclasses. 
Within these antibody responders there were 22 subjects 
with alveoli tis and 29 without. The distribution of total 
subclasses within ,(these disease subgroups is listed ~n Table 19. 
The mean values for IgG1, 2 and 4 were similar for both groups but 
the group wi th alveoli tis had a significantly higher mean IgG3 
than the group with no disease. 
c) The subclass distribution of antibody activity. 
The specific subclass antibody activity against pigeon 
gamma-globulin antigen was measured by an amplified ELISA method 
(see Appendix B). Using this technique antibody activity could 
be measured in all 4 subclasses and the extent of the response in 
each subclass was quantitatively related to the total IgG antibody 
activity (Figure 23). The correlations between each of the 
subclasses (1-4 on the figure) and the total were all highly 
significant, with the closest being IgG3, r = 0.92. 
Supporting date from antibody measurement by 
radioimmunoassay (Appendix B) in 102 subjects using radiolabelled 
. prot~in A (specific for IgGI, 2 and 4), has shown a close 
correlation between this and the total IgG (all subclasses) 
measured by ELISA (r = 0.96). Furthermore, using the avian red 
cell agglutination test (Appendix B), with positive sera at 
Subclass 
1 - 4 
1 
2 
3 
4 
Correlation 
Coefficient 
0.79 
0.75-
0.56 
-0.13 
0.01 
t 
6.0 
5.37 
3~17 
-0.61 
0.05 
57a. 
p 
0.001 
0.001 
0.001 
n.s. 
n.s. 
TABLE 17. Correlation between the levels of each of the total 
IgG su~classes, including the sum of these, and the 
total IgG. 
Antibody Antibody 
Positive Negative 
n=51 n=48 
Total IgG 14.1 11.0 p<0.001 
IgG - 10.7 9.5 p<0.001 
IgG - 2 6.8 5.4 p<O.01 
IgG 3 0.511 0.472 p = n.s. 
IgG 4 0.766 0.955 p = n.s. 
TABLE 18. Immunoglobulin G subclass levels (mg/ml) in subjects 
with and without avian antigen specific serum IgG 
antibody. 
Alveolitis No Alveolitis 
n=22 n=29 
IgG 1 10.8 10.6 p = n.s. 
IgG 2 7.1 6.8 p = n.s. 
IgG - 3 0.57 0.46 p < 0.02 
IgG -4 0.77 0.78 p = n.s. 
TABLE 19. IgG .subclass levels in antibody positive pigeon 
breeders with and without alveolitis. 
>. 
-a 
0 
.Q 
.. 
C 
ct 
en 
en 
"' U 
.Q 
:::s 
(/) 
C> 
CI 
57b. 
1 
E •• s 2 r=0·88 
3 r =0·92 
4 r = 0·87 
1 r = 0·83 
o 1 2 
IgG Antibody 
FIGURE 23: 
Correlations between the extent of the serum antibody 
activity, in each of the £our IgG subclasses with the 
total IgG antibody activity against avian antigens. 
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subagglutination titres and using subclass specific antisera as a 
Coombs reagent, agglutination could be demonstrated equally by all 
4 subclass antisera at low dilution. 
d) Discussion. 
The close correlation between the sum of the individual 
IgG subclasses and the total IgG measured independantly was an 
indication of the validity of the system. The commercial source 
of the subclass antisera also supplied standard sera with 
reference levels of IgG subclasses, however the consistent finding 
that quantitatively the sum of the subclasses was approximately 
., 
25% greater than the total IgG suggested that either the reference 
values were not accurate or that the antisera have some cross-
reacti vi ty. On discussion with the suppliers it would appear 
tha t the former reason may prevail. However, for comparisons 
within the study group on which this section is based, the 
absolute values are not necessary so long as each individual's 
results are calculated similarly using the same standards. 
The good correlation between IgG1 and the total IgG 
confirms that the hypergammaglobulinaemia associated with 
alveolitis was du~ to increases in IgG1 and to a lesser extent 
IgG2. There was no significant contribution from IgG3 and IgG4 
to the IgG fluctuations. 
The individuals who had serological evidence of an 
antibody response to inhaled avian antigens also had a clear 
association with raised total IgG, and this was significant for 
raised mean levels of IgG1 and 2. It would appear therefore that 
the genetic or constitutional disposition to respond to inhaled 
antigens is associated with the production of increased amounts of 
IgG1 and 2. The production of subclasses is known to be partly 
under genetic control (Morrell et aI, 1972) and it :is possible 
also that the antibody responsiveness to inhaled antigen is also 
under similar genetic control although the nature of this at 
present in humans is obscure. Experiments in mice have shown 
multigenic control (see Appendix D) involving both H-2 and non H-2 
linked genes. However, i~ could equally follow that during 
continuous antigen exposure, the subjects with serological 
evidence of an immune response, i.e. with antibody, may mount an 
inflammatory response, one consequence of which would be a 
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generalised increase in total IgG, predominantly IgG1. 
Notwithstanding these differences between antibody 
responders and non-responders, the distribution of IgG subclasses 
between antibody positive subjec~s with and without alveoli tis has 
shown a difference in total IgG3, which was significantly higher 
in the disease group. Although the reasons for this are obscure, 
a similar finding was reported for farmers with and without 
alveolitis (Stokes, Turton & Turner-Warwick, 1981). It would 
appear therefore that over and above the genetic control of 
antibody production ~o inhaled antigen which may also control IgG1 
and IgG2 synthesis, there may also be a genetic link between IgG3 
production and susceptibility to hypersensitivity reactions to 
inhaled antigens. It is of interest that the IgG3 subclass is 
structurally dissimilar to the other subclasses and has a much 
faster turnover rate with an average biological half-life of 7.1 
days compared with 21 days for the other subclasses (Morrell, 
Terry & Waldmann, 1970) suggesting perhaps a separate genetic 
control. This subclass is also known to be the most potent 
activator of complement, underlining the importance of the role of 
antibody acti vi ty {in this subclass in a disease process which 
involves immune complex formation and complement mediated tissue 
damage. 
An increase in total IgG4 within fluid obtained from lung 
lavage from symptomatic as opposed to asymptomatic pigeon breeders 
was reported by Calvanico et al 
significance of this observation was 
not measure the other subclasses. 
(1980). However, the 
uncertain because they did 
The most relevant investigation was the measurement of 
antibody activity in each subclass against the specific antigens 
relating to pigeon breeders disease. There was antibody activity 
measurable in all 4 subclasses in the subjects where the antibody 
was found in the total IgG. Furthermore, the extent of the 
acti vi ty in each subclass was closely rel~ ted to the titre of 
total IgG ant~body. However, it was not possible to estimate the 
relative titres of antibody activity between each subclass, which 
would be of interest to determine which subclass contributed the' 
highest specific activity. 
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Subclass restriction has been reported in the antibody 
response to defined antigens, for example the human antibody 
response to dextrans and certain polysaccharides are restricted to 
IgG1 and IgG2, anti-rhesus antibodies are' IgG1 and IgG3, 
anti-tetanus toxoid in IgG1, and haemolytic disease is apparently 
mediated by IgG3 antibody alone. However, when suitably 
sensitive techniques are used then antibody activity is usually 
demonstrable in all subclasses (Urbanek, 1980; Shakib and 
Stanworth, 1981). 
5. IMMUNE COMPLEXES 
a) Introduction. 
The role of immune complexes in disease has been the 
subject of numerous general reviews (WHO Scientific Group ,Report, 
1977; Theofilopoulos & Dixon, 1980; Inman & Kay, 198; ), and 
several reviews of the involvement of immune complexes in lung 
diseases have been published (Cooper, Moore & Hilton, 1981; ~-
Lewiston, 1981; Daniele, 1981). More specifically, serum immune 
complexes have been measured in the following: 
Sarcoidosis:- Hedfprs & Norberg, 1974; Gupta et aI, 1977; 
Daniels et aI, 1978; Selroose et aI, 1980; Johnson et aI, 1980. 
Cryptogenic fibrosing alveolitis (or idiopathic pulmonary 
fibrosis in the American Literatur~:-
Nagaya, Elmore & Ford, 1973; Dreisen et aI, 1978; Haslam et aI, 
1979. 
Cystic fibrosis:- McFarlane et aI, 1975; Church et aI, 1981. 
Tuberculosis:- Johnson et aI, 1981. 
Aspergillus infections:- Katz & Knicker, 1973; Geha, 1977. 
Pulmonary aspects of the collagen vascular diseases:-
Hunninghake & Fauci, 1979. 
These authors have implicated immune complexes in the 
various disease processes based on their detection in the 
patients' sera. The same approach therefore was used here to 
demonstrate the presence of immune complexes in the sera of pigeon 
'breeders. "A ,role for circulating immune complexes in the 
pathogenesis of extrinsic allergic alveolitis AS then discussed. 
b) Immune complexes in control and test sera. 
The serum immune complexes were measured by protein A 
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binding activity (prAba), according to the method of Barkas 
(1981). The details of this technique are outlined in appendix 
B, but briefly it involves the precipi ta tion of high molecular 
weight protein from serum using polyethylene glycol, adsorbing the 
soluble component. of . this precipitate which contains 
immunoglobulin onto the surface of protein A-rich staphylococci 
(solid phase) and rendering this measurable by the extent of 
binding of radiolabelled free protein A. 
To validate this method, sera from 23 normal heal thy 
blood donors was pr~cessed to establish a normal range. -. This was 
measured as the percentage of added radiolabelled protein A which 
bound, and a low mean level was recorded, mean = 6.9%, standard 
deviation 3.3%. A normal range of the mean plus three standard 
deviations was established, and sera with prAba of greater than 
16.8% were considered positive. Sera from patients with diseases 
associated with high levels of serum complexes were included as 
positive controls. Ten SLE patients and 42 myeloma patients were 
studied, and pathological sera from 40 asthmatics were also 
measured. The results for these control groups are listed on 
Table 20. .( 
The sera from 101 pigeon breeders divided into groups 
according to their clinical assessment (see Appendix A) were 
measured for prAba. The results are listed on the upper half of 
Table 20. It appeared that there was a high incidence of complex 
activity in the group as a whole (39% positive) and this was 
accounted for primarily by the high incidence of activity in the 
sera of the alveoli tis patients (61% positive). 
The mean prAba for the EAA group was significantly higher 
than the asymptomatic group (p < 0.025), and the asthmatic group 
(p < 0.02), and higher (p = n.s.) than the indeterminate group. 
c) Relationship between protein A binding and specific 
IgG antibody. 
It became apparent that within the subgroups or symptom 
categories the subjects with positive prAba had specific antibody • 
. There was a strong association between the presence of specific Ab 
(>4 ug/ml) and the presence of immune complexes (serum ~rAba > 
16.8%) illustrated on Figure 24. This relationship proved to be 
quantitative (Figure 25). These parameters were significantly 
correlated (r = 0.71, t = 10.0, p < 0.001). 
O.Ld.. 
Group Number Mean S.D. Positive 
Subjects 
EAA 32 21.8 14.8 20 61 
Asymptmatic 29 13.9 10.5 8 28 
Asthma 8 8.5 6.4 1 12 
Indeterminate 32 15.5 12.1 10 30 
Controls 
Normal 23 6.9 3.3 0 0 
Myeloma 42 23.9 13.3 26 62 
SLE 10 21.2 13.6 7 70 
Asthma 40 13.4 8.3 12 30 
TABLE 20. ·Serum immune complex activity, measured as percentage 
protein A binding, in pigeon breeders with different 
clinical presentations and in control groups of sera 
from healthy normal donors and pathological sera. 
61b. 
FIGURE 24: 
Serum immune complex activity in pigeon breeders 
with and without antibody to avian antigens. 
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FIGURE 25: 
Correlation between the level of serum immune complex activity 
and the serum IgG antibody titre against avian antigens. 
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d) Discussion. 
Experimental lung disease can result from direct 
intratracheal administration of performed immune complexes 
(Scherzer & Ward 1978a) or as a consequence of high serum titres 
of . immune complexes maintained by daily infusion of sufficient 
antigen in hyperimmune rabbits (Brentjens et aI, 1974) • The 
extent of pulmonary injury is related to the antigen content of 
the complex (Scherzer & Ward, 1978b) and is maximal at antigen 
equivalence, correlating with optimal complement fixing activity, 
as has been described in other tissues (Ishizaka, 1963). 
The role for such a mechanism in extrinsic allergic 
alveoli tis is unresolved. The acute alveoli tis reaction in 
sensitized guinea pigs on inhalation of nebulised pigeon serum is 
seen to be a complement dependant, humoral immune process 
consistent with immune complex disease (Roska et aI, 1979). 
Immunofluorescent studies on lung biopsy tissue from alveoli tis 
patients with pigeon breeders disease (Hogan et aI, 1978, Barrios 
et aI, 1979) and farmers lung (Ghose et aI, 1974) have 
demonstrated diffuse deposits of immunoglobulin and complement in 
alveolar spaces. Other workers have reported negative fIndings 
-( 
in similar biopsy specimens of pigeon breeders disease and farmers 
lung (Emanuel et aI, 1964; Wenzell et aI, 1971; Hensley et aI, 
1969) • These could be explained in part by rapid clearance of 
intra-alveolar immune complexes by macrophage (Cochrane & Koffler, 
1973; Pratt et aI, 1979). 
Only very rarely would taking a trans bronchial biopsy be 
justified in the diagnosis of EAA, therefore we sought indirect 
evidence for the presence of immune complexes in the serum of 
subjects regularly exposed to pigeons and therefore at risk of 
developing alveoli tis following inhalation of avian antigens. The 
data presented here concerning serum protein A binding activity 
would suggest that thirty-nine of a group of 102 pigeon breeders 
had circulating serum immune complexes and that these were 
predominantly subjects with evidence of EAA. 
Subjects were assessed for serum IgG antibody to pigeon 
gamma-globulin; a major specific antigen for pigeon breeders' 
disease (Faux et aI, 1971). Despite claims that precipitins are 
of limited diagnostic value in extrinsic allergic alveoli tis 
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(Salvaggio, 1972), we have found a good correlation between 
disease and specific antibody levels using quantitative radio-
immunoassay (Chapter 3). Similarly the alveoli tis subgroup of 
_the pigeon breeders investigated here had a higher ipcidence and 
mean titre of IgG antibody than similarly exposed subjects with 
mainly asthmatic symptoms, indeterminate respiratory symptoms, or 
nos ym p tom sat all. Pat hoI 0 g i cal s era fr om pat i e n t s wi t h 
unrelated respiratory problems, mainly asthma, had a mean specific 
IgG level wi thin the normal control range, and any non-specific 
effects that high to:al immunoglobulin and immune complexes had on 
this assay were discounted when sera from myeloma and SLE patient 
were found to have insignificant amounts of avian antigen specific 
IgG. 
Protein A binding activity was measured at low levels in 
serum from heal thy control subjects and was raised in sera from 
" " 
SLE" and myeloma patients, confirming the results of Barkas (1981). 
These sera were therefore used as negative and positive controls. 
The prABA was measured in a group of asthmatic patients and a low 
positive incidence of immune complexes was noted similar to the 
results of Cooper e~ al (1981). In the 102 pigeon breeders under 
investigation the highest prABA was associated with the group 
describing extrinsic allergic alveoli tis where 20 of the 32 
subjects (61%) had evidence of circulating immune complexes. 
However, 10 of the 32 subjects describing indeterminate symptoms 
had significantly raised prABA, perhaps related to infections 
common amongst bronchi tics , and 8 of the 28 asymptomatic subjects 
also had raised prABA despite observation of low serum immune 
complex levels in the general healthy population (Walker & Al 
Khateeb, 1981). 
On closer examination, most subjects with significant 
prABA, were those with a high titre of serum antibody to avian 
antigens. These included the majority of the EAA group, although 
the presence of specific antibody and immune complexes in the 
serum of subjects who described no symptoms may be an indication 
of subclinical immunological and inflammatory events. Insidious 
development of alveoli tis has been described (Hensley et aI, 1969) 
and workers have looked for humoral parameters to monitor this 
subclinical disease (Turton et aI, 1981). The role of the 
64 
measurement of specific antibody levels and immune complexes in 
these cases would seem appropriate and some prospective studies 
are discussed in Chapter 5. 
Previously, the only data on immune complexes in 
extrinsic allergic a1veo1itis was provided by Girard et a1 (1978). 
Using a Clq binding assay this group demonstrated serum immune 
complexes in 13 of 15 subjects with EAA related to various avian 
exposures and also in 6 out of 23 asymptomatic controls; these 
six being precipitin positive. A short communication by Yang et 
a1 (1978) demonstrated immune complexes in only two of ten bird 
", 
breeders with a1veolitis, also in two out of 10 bird breeders 
without alveoli tis and in one out of eleven farmers lung patients. 
This group used an Fc binding assay with Raji cells and murine 
L-1210 cells, and a low incidence of complexes was found despite 
initially heat decomp1ementing the sera, which would aggregate the 
IgG (Sol tis et aI, 1979), especially since raised total IgG is 
common in alveolitis. 
There is a correlation between the prABA and total IgG, 
which may be a feature of polyethylene glycol (PEG) precipitation, 
as seen in other reports (Haslam et aI, 1978). However, Johnson et 
a1 (1981) found that the absolute amount of immunoglobulin 
precipitated by 2% PEG was largely independent of serum 
immunoglobulin levels. The total IgG levels in myeloma sera did 
not correlate significantly with prABA as has been described also 
by Barkas (1981), so it is possible that both hyper-gamma-
globulinaemia and immune complex formation are a feature of the 
inflammatory reactions due to the chronic antigen exposure 
associated with extrinsic allergic alveolitis. 
A central role for immune complexes in the disease 
process of extrinsic allergic alveoli tis could be postulated, 
similar to the mechanism of. 'immune complex mediated pulmonary 
injury in vasculitis (reviewed by Hunninghake & Fauci, 1979) • 
The main histological features in common include granuloma 
formation, a small mononuclear cell infiltrate and macrophage 
activation; all features which can result from immune complex 
formation (Spector & Heesom, 1969; Fauci & Wolff, 1977, Pestel et 
aI, 1981). 
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Data reported here would suggest that immune complex 
formation can occur among antibody positive pigeon breeders, 
presumably related to the constant inhalation of the appropriate 
antigens. However, ingestion of related antigel'!~' e.g. hens 
~ggs, is a possibility that cannot be discounted, since antigenic 
similarity has been shown between the hen, Gallus domesticus, and 
pigeon, Columbia livia, (Sennekamp et aI, 1981), and post-prandial 
immune complexes have been demonstrated in normal and atopic 
subjects (Paganelli et aI, 1979). 
The role for immune complexes in the active disease 
process requires further study and parallel involvement of 
sensi tisied lymphocytes must also be considered. The marked 
steroid sensitivity of the disease (Pepys, 1969) may perhaps 
underline an immune-complex pathology, however prospective studies 
with subjects in various phases of the disease are necessary to" 
clarify this further. 
6. COMPLEMENT. 
a) Introduction. 
The role pf cQmplement in the disease process of EAA is 
described as "enigmatic" (Schatz et aI, 1976). The subject's 
serum IgG is complement fixing (Caldwell, 1973; Moore & Fink, 
1975; Boren, Moore & Abramoff, 1977), al though the ti tres are 
reported to be as high in some asymptomatic subjects as in most of 
the subjects with EAA. Furthermore, tissue deposits of 
complement" are only rarely visualised by immunofluorescence in EAA 
pa tients (Emanuel et aI, 1964) most probably related to their 
removal by phagocytic activity following the rapid influx of 
inflammatory cells (Pepys et aI, 1968; Cochrane & Koffler, 1973; 
Richerson, 1974). 
Various groups of workers report conflicting results of 
the fluctuations in serum complement levels and CH-50 in 
experimental antigen inhalation provocation challenges in man and 
animals (reviewed in Chapter 5), and the inflammatory process 
following these challenges in animals has been successfully 
inhibited by prior decomplementation with cobra venom factor 
(Olenchoch & Burrell, 1976; Roska et aI, 1977). 
66 
These observations plus the previous data from immune 
complex involvement appear to be compelling evidence for the 
involvement of complement in the disease process of EAA, however, 
only one published report has indicated reduced resting complement 
levels in only four patients (Baur, Dorsch & Becker, 1980). 
this section is concerned with the measurement of the 
serum profile of complement proteins, C1q, C3, C4 and Factor B in 
various groups of pigeon breeders, with and without serum 
antibody, and relates the C4 level to the extent of this antibody 
response. 
b) Experimental. 
Fifty-eight pigeon fanciers donated a blood sample from 
which the serum was separated by centrifugation, snap frozen and 
o 
stored at -70 C. The serum levels of the complement proteins 
C1q, C3, C4 and Factor B were measured by radial-immunodiffusion. 
The subjects were divided into those who mounted a significant 
serum IgG anti.body response to the inhaled antigens associated 
with pigeon breeders disease and those who did not. The profile 
of the complement levels in these two groups is outlined on Table 
21. There were no significant differences between these 'groups 
( -
in age and years of avian contact, but there were lower mean 
titres of all the complement components in the antibody positive 
group, which was statistically significant for C3c, and Factor B. 
Most individual values were within the normal range, but five of 
the antibody positive group has significantly low levels, below 
the normal range, for at least two of the four components. 
The fourth complement component is reported to be 
depleted in proportion to the levels of immune complexes in 
disease (Scullion et aI, 1979) therefore, we investigated the 
quantitative relationship between the extent of specific antibody 
production as a measure of disease susceptibility, and the C4 
level in a further 102 subjects. The C4 level is plotted on the 
abscissa of Figure 26, with the quantitative value of serum IgG 
against avian antigens on the ordinate. The lower mean level of 
C4 in the antibody positive group was confirmed, again not 
statistically significant, (24.9mg%, s.d. = 6.8, and 29.1, s.d. = 
8.8 respectively). There was no correlation between the extent 
of the antibody response and the C4 level. 
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Antibody 
Positive Negative t p 
Number 35 23 
Age 42.8 38.9 1.0 NS 
Exposure 1.9.7 17.8 0.4 NS 
C1q (% normal) 98.5 106.7 1.0 NS 
C3c (mg/dl) 64.4 72.4 2.2 0.05 
FacB (mg/dl) 34.4 39.1 2.2 0.05 
C4 (mg/dl) 29.7 33.3 1. 1 NS 
TABLE 21. The serum complement profile in pigeon breeders with 
and without serum antibody. 
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Levels of serum complement C4 in 102 pigeon breeders compared 
with their serum IgG antibody level to avian antigens. 
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c. Discussion. 
Local lung fluid contains adequate complement proteins to 
mediate an inflammatory reaction (Reynolds & Newball, 197~). 
These proteins can be serum derived or locally synthesised 
(Colten, 1976; Alpert et aI, 1978). This, therefore, with the 
presence of high titres of local specific antibody (Warren & Tse, 
1974) would allow complement activation within the lung 
compartment following inhalation of the appropriate antigens 
associated with alveolitis. Some evidence for this local 
hypersensi ti vi ty reaction involving complement was suggested by 
" 
observing positive immunofluorescence for deposits in a few lung 
biopsies of farmers with alveolitis (Emanuel et aI, 1964; Seal et 
aI, 1968; Barrowcliff & Arblaster, 1968; Wenzel et aI, 1971; 
Ghose et aI, 1974) and pigeon breeders with alveoli tis (Hogan, 
1978; Barrios et aI, 1979), and some animal models of disease 
(see Appendix C). 
We sought in this section to quantify differences of 
serum complement levels between pigeon fanciers with and without 
antibody in order to investigate the involvement of complement in 
alveolitis. Th~ mean levels were markedly lower in those 
subjects with evidence of an antibody response to the inhaled 
antigens associated with the disease. The C1q level was reduced 
by 8%; c4 by 11% (and by 14% in a further population of 102 
subjects) ; C3c by 11% and Factor B by 12%. The reductions in 
C3c and Factor B were statistically significant. Moreover, all 
the individuals with significantly reduced levels of at least two 
components of complement were antibody responders. This suggests 
that there was evidence of an inflammatory response associated 
with a low level of complement consumption in subjects who have 
actively responded by making antibody to inhaled antigen. The 
measurement of these complement levels at one point in time 
reflects the product of activation, catabolism and synthesis. 
Confirmation of complement involvement in acute alveolitis 
therefore would require an index of complement activation; for 
'example th~ production of a stable end product C3d, and also 
serial measurements correlating with the various dynamic stages of 
disease. These are discussed 1n Chapter 5. 
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Only very rarely are complement levels reduced in lung 
diseases unassociated with other organ involvement (Turner-
Warwick, 1978) and indeed C3 levels are increased in cryptogenic 
fibrosing alveoli tis and sarcoidosis. Complement levels in 
asthmatics are normal, but intrinsic asthmatics have significantly 
higher levels of complement components C1s, C4, C5 and C3b 
inactivator, than atopic asthmatics, with both groups having 
normal C3 turnover as measured by free C3d (C. J. Lewis, personal 
communication). Patients with bronchitis have lower levels of 
serum complement co~ponents (Millar, Kueppers & Offord, 1980) and 
Cigarette smokers have increased serum levels of C5, C9 and 
C1-inhibitor (Wyatt, Bridges & Halater, 1981) and increased local 
pulmonary levels of C3 and C4 (Bell et aI, 1981). To this list 
of complement levels in pulmonary disease should be added the 
reduced levels associated with alveoli tis reported here. 
antigens associated with . extrinsic allergic 
alveoli tis have been reported to directly activate complement when 
added to normal human serum (Marx, Boren & Moore, 1977). These 
antigens include soluble extracts from Micropolyspora faeni and 
Thermoactinomyces vulgaris (Edwards, 1976), antigens from bacteria 
and fungi associated with EAA (Marx & Flaherty, 1976; Huis in't 
Veld & Berrens, 1976) and avian antigens (Berrens, Guikers & Van 
Dijk, 1974; Moore & Fink, 1975; Marx, Boren & Moore, 1977; 
Boren, Moore & Abramoff, 1977; Berrens, 1978). Activation is via 
the alternative pathway although there is some evidence to suggest 
that the antigens can act directly at the level of C4 of the 
classical pathway (Marx, 1978). This worker describes one further 
unusual feature that these antigens do not activate guinea-pig 
complement despite their efficiency in activating human 
complement. The mechanism of these acti vi ties awaits 
clarification by their proponents. The proteolytic enzymes from 
bacteria and fungi and the hydrolytic enzymes from avian droppings 
were initially implicated in the activation sequence (Berrens & 
Guikers, 1972) but this has now been discounted (Marx, 1978). 
The inactivation of complement by adding soluble antigeQ 
to patients serum was considered a sensitive test for pigeon 
breeders disease (Berrens, Guikers and Van Dijk, 1974). These 
workers also described an "autoantigen", a modified human serum 
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gamma-globulin which stimulated continued production of complement 
consuming antibodies in subjects who had no further avian 
contact. They also suggested that subjects "predisposed" to 
having pigeon _ breeders disease had an intrinsically labile 
complement system (Berrens, Guikers & Van Dijk, 1974; DeRidder, 
Van Dijk & Berrens, 1979), however, these results could also be 
explained by the presence of low titres of complement fixing serum 
antibody in these patients. Equally, where alveolitis has been 
described in precipitin negative subjects, the possibility of 
direct complement ~ctivation was postulated (Edwards, Baker & 
Davies, 1974; Sennekamp et aI, 1978; Canet et aI, 1,980). 
However, it is also possible that these subjects had antibody in 
titres less than the detection threshold of precipitin techniques. 
If this non-specific complement activation were involved in the 
pathogenesis of alveoli tis then the symptoms would be more 
prevalent in all exposed subjects dependent only on the dose of 
antigen, and the immunological specificity of the development of 
symptoms would not apply. 
7. NON-SPECIFIC M4RKERS OF INFLAMMATION. 
a) Introduction. 
Many acute phase proteins and enzymes in both serum and 
bronchoalveolar lavage fluid have some diagnostic significance in 
the investigation of pulmonary diseases: for example, 
angiotensin-converting enzyme (ACE) in sarcoidosis (Lieberman et 
aI, 1979), collagenase in idiopathic pulmonary fibrosis (Gadez et 
aI, 1979), rheumatoid factor in rheumatoid lung and alpha I -
antitrypsin in emphysema. In this latter case a genetically 
programmed reduction of this protein is associated with poor 
control of proteolytic enzyme acti vi ty in the lung resulting in 
pulmonary fibrosis. It would be appropriate therefore to assess 
the importance of this protein in the disease process of 
alveolitis. A report by Muller et al (1976) demonstrated 
elevated titres of alpha 1 - antitrypsin in 11 of 15 alveolitis 
cases and transiently diminished level& in 4; 2 of these ·had a 
genetic heterozygous deficiency. 
This enzyme and also ACE are synthesised by activated 
pulmonary macrophage (White et aI, 1981; Hinman et aI, 1979) 
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therefore since activated macrophages are thought to be involved 
in the disease process of alveoli tis (Stankus et aI, 1978) it 
might be appropriate to assess the role of serum ACE in this 
condi tion. Lieberman et al ( 1979) reported that there was no 
significant association· between raised serum ACE and farmers lung 
in 17 patients although 5 of these had raised levels, but there 
was no indication of the stage of disease of these patients. 
Further studies by Turton et al (1981) suggested that serum ACE 
was raised in farmers lung patients compared with control farmers. 
Teuksbury et al (1981) however found a significantly reduced serum 
" ACE level in acutely ill farmers, but during active responses to 
challenge with Micropolyspora faeni in 3 patients there were no 
consistent fluctuations in serum ACE levels, and furthermore there 
were no differences between stable farmers lung patients and 
controls. In a survey of pigeon breeders with (n = 17) and 
without (n = 10) alveoli tis there was no difference in serum ACE 
levels between these groups and normal controls (n = 32), 
(McCormick et aI, 1981). The evidence, therefore, is strongly 
against involvement of this particular enzyme in disease, and for 
this reason it was opt pursued in this section. 
Serum C-reactive protein (CRP) is the prototype 
acute-phase plasma protein which can rise rapidly following 
infection or tissue injury resul ting from a variety of 
inflammatory diseases (Morley & Kushner, 1982) and was therefore 
investigated for its usefulness as a disease marker in alveoli tis. 
The serum rheumatoid factor was also measured in order to define 
one parameter of autoimmunity in a population of subjects with 
alveoli tis. 
b) Experimental. 
Rheumatoid factor measured by latex agglutination 
(Appendix B) was undetectable in all but one of a survey group of 
102 pigeon breeders. This subject had particularly high levels 
of serum antibody to avian antigens and raised total 
immunoglobulins, but had no symptoms of alveolitis. 
Raised levels of total serum alpha 1 - antitrypsin, 
measured by radial-immunodiffusion and C-reactive protein, 
measured by late~ agglutination occurred in 17% and 48% 
respectively. The distribution of these parameters according to 
11 
the individuals antibody responsiveness is listed on Table 22(a). 
Raised levels of CRP occurred wi th equal frequency in antibody 
positiv~ and negative pigeon breeders, but the incidence of raised 
alpha 1 - antitrypsin was much higher in the antibody positive 
group. Similarly when subjects with and without alveoli tis were 
compared there was no difference in CRP levels, but again raised 
alpha 1 - antitrypsin levels occurred more frequently in subjects 
with disease (Table 22b). Interestingly when the asymptomatic 
subjects were subdivided into antibody positive and negative, 
Table 22c, then the incidences of raised markers were 
predominantly accounted for by the antibody positive subjects. 
The occurrence of these serum parameters according to the 
individual's smoking habit is listed on Table 23. There was no 
indication that smoking affected the occurrence of raised levels 
in this population. 
c) Discussion. 
The major problems in assessing the diagnostic value of 
acute phase proteins in this disease are that they are modulated 
by many factors and that their levels are very dynamic. .Perhaps 
for these reasons l the CRP levels were a poor discriminator of 
disease. Nothwithstanding, the other obvious stimulus, i.e. 
cigaret te smoking did not appear to alter the serum .profile of 
these proteins. This is in accordance with Warr et al (1918), 
although the activity of the alpha 1 - antitrypsin is suggested to 
be reduced in smokers (Janoff et aI, 1981). 
The alpha 1 - antitrypsin levels were increased in 
subjects with serum antibody to inhaled avian antigens, and this 
association was also true for the enzyme in bronchopulmonary 
lavage fluid from pigeon breeders (VOisin et aI, 1919). The 
extent of the serum antibody response in the 101 pigeon breeders, 
however, was not quantitatively related to the alpha 1 
antitrypsin level (r = 0.13, p = 0.185, not significant). 
Of particular interest is the observation of a high 
incidence of these serum parameters of inflammation in 
asymptomatic pigeon breeders who have' serum antibody to .~inhaled 
avian antigens; these subjects have already been shown to have a 
higher incidence of raised immunoglobulins and immune complexes 
than the antibody negative asymptomatic subjects. This suggests 
ct1 
r-I 
C" 
(a) (b) (c) 
ANTIBODY ALVIDLITIS ASYMPTOMATIC 
POSITIVE NIDATIVE POSITIVE NIDATIVE ANTIBODY POSITIVE ANTIBODY NEJATIVE 
Number 51 50 33 29 9 20 
-
Rheumatoid 
factor 1 0 0 1 1 0 
C-reactive 16 18 15 14 55 15 protein 
I 
Alpha 1- 53 r. 35 63 
'" 
37 57 0 antitrypsin 
TABLE 22: Distribution of positive rheumatoid factor and percentages of raised serum levels of C-reactive protein and 
alpha 1~antitrypsin in pigeon breeders, (a) with and without se~um antibody to inhaled avian antigens, (b) 
with and without symptoms of alveolitis and (c) asymptomatic subjects with and without antibodyo 
i 
! 
.0 
.-I 
I'" 
Number 
Rheumatoid factor 
C-reactive protein 
Alpha 1-antitrypsin 
Non-Smoker 
65 
1 
13.8% 
54.1% 
~ 
Smoker 
23 
o 
13% 
44.4% 
Ex-Smoker 
14 
o 
35.7% 
16.7% 
TABLE 23: Distribution of positive rheumatoid factor and percentages of raised serum 
levels of C-reactive protein and alpha 1-antitrypsin in pigeon breeders 
according to smoking habit. 
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that active inflammation may be present in subjects with evidence 
of an active immune response but without acute symptoms. This 
possibility was also raised by Turton et al (1981) who found 
significantly higher serum lysozyme and ACE levels in antibody 
po~itive farmers lung patients during periods of active antigen 
exposure despite the absence of acute symptoms. 
It would appear that evidence for an inflammatory 
response can occur in subjects who have evidence of an antibody 
response despite symptoms, and this re-emphasises the importance 
of the measurement of serum antibody, even in asymptomatic 
subjects, since the development of alveoli tis can often be 
insidious. 
Over and above any diagnostic use of the acute phase 
proteins they may also have a biological role in limiting the 
pulmonary response following antigen exposure (Baseler & Burrell, 
1981). These workers have found that rabbits exposed to a~rosols 
of appropriate fungal spores demonstrated a significant increase 
in haptoglobin level, and that this was a reliable and consistent 
indicator of pulmonary inflammation. Furthermore, when the role 
of haptoglobin in tpis response was investigate4 it was found that 
rabbi ts with actively or passively augmented haptoglobin levels 
did not respond with typical depressions in arterial oxygen 
tension following challenge. The authors also pointed out that 
haptoglobin was only one parameter of the acute phase response and 
that the apparent protective effect. may be due to a combination of 
any number·of parameters. 
8. P1 ANTIBODY. 
a) Introduction. 
The main phenotypes of the P1 red blood group antigen 
system are P1 (+) and P1 (-), sometimes called P2. The P2. 
phenotype occurs in approximately 20% of the white population and 
the serum of these subjects may contain anti~P1 antibodies. This 
anti-P1 is usually IgM class antibody in low titres and is rarely 
active at body temperature. Various substances have been shown 
to have P1 antigenic activity including hydatid fluid, house dust 
and some Gram negative bacilli. Recently P1 antigens have been 
described on pigeon erythrocytes and in pigeon serum, and a higher 
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incidence of anti-P1 was noted in P1 (-) pigeon breeders. This 
increase in P1 antibody however was thought to have no bearing on 
the incidence of disease. 
This section examines the P1 phenotyp~ ofa population of 
pigeon breeders and the extent of the P1 antibody response was 
compared with the antibody levels against pigeon serum antigens. 
The bearing of this genotype on the disease incidence of 
alveolitis was also examined. 
b) Results and discussion. 
The incidence of P1 was established by erythrocyte 
agglutination using anti-P1 antisera on fresh heparinised blood 
from 223 pigeon breeders. The incidence was not significantly 
different from controls (Table 25), and both were similar to the 
general published phenotype distribution of 80% P1 (+) and 20% 
P1(-). 
The incidence of the cold agglutinin antibody (IgM, 
anti-P1) in the P1(-) subjects was much greater among the pigeon 
breeders than the controls (53.9% vs 11.9%), and was particularly 
high in pigeon breeders with alveoli tis (75.0%). In parallel 
wi th this increas~ng incidence, the mean ti tres of the antibody 
increased, thus the extent of the antibody response to Pl antigens 
was much greater in pigeon fanciers, and more so in those with 
alveolitis (Table 25). 
There was no detectable IgM anti-P1 measured at room 
temperature in any of the co~trol subjects, but this was detected 
in 21.2% of the P1(-) pigeon fanciers and in 58.3% of those with 
symptoms of alveolitis. 
The incidence of antibody in populations of pigeon 
breeders and controls and the subgroups with detectable P1 cold 
agglutinins are listed on Table 24. These figures suggest that 
there is a slightly higher, incidence of detectable antibody 
against avian antigens in subjects with "natural" antibody against 
P1 erythrocytes, but the differences are not Significant. 
Sera from five pigeon fanciers with high antibody levels 
to pigeon gamma-globulin antigens w~re extensively absorbed with 
P1(+ve) erythrocytes. There was a reduction of antibody titres 
in post-absorbed sera of between 6% and 37%, with a mean value of 
26%, which was probably due to the dilution effect of adding the 
Pigeon Breeders (n = 501) 
P1 - antibody +ve (n = 25) 
Controls (n = 42) 
P1 - antibody +ve (n = 25) 
73a. 
IgG Antibody to Pigeon 
Serum Antigens 
Positive 
251 (51%) 
15 (60%) 
o (0%) 
3 (12%) 
Negative 
250 (49%) 
10 (40%) 
42 (100%) 
22 (88%) 
TABLE 24: A comparison of the antibody responsiveness 
against pigeon antigens and IgM anti-P1 among 
pigeon breeders and control unexposed individuals. 
· 
..Q 
C"") 
I' 
Control Scottish Pigeon Fanciers 
Blood Donor Pigeon Fanciers Symptomatic Asymptomatic 
Number 200 223 
P1 (-) individuals 42 (21.0%) 52 (23.3%) 12 37 
0 P1 - antibody (4 C) 5 (11.9%) 28 (53.9%) 9 (75.0%) 19 (51.4%) 
P1 - antibody (ambient temp.) o (0%) 11 (21.2%) 7 (58.3%) 4 (10.8%) 
Mean titre score of 
0 P1 - antibody (4 C) 11.0 23.3 31.6 19.4 
TABLE 25: The incidence of P1 (-) phenotype and anti-P1 antibody among normal adults, and pigeon 
fanciers with aQd without alveolitis. 
'-: 
14 . 
red cells. This suggest that the P1 antigenic determinant on 
human red cells is different from the main antigen in pigeon serum 
and that the associated "natural" IgM cold agglutinin antibody in 
P1(-ve) subjects is unrelated to the IgG anti-pigeon 
gamma-globulin response, and that the P1 phenotype had no bearing 
on pigeon breeders disease. 
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CHAPTER 5 
FLUCTUATIONS OF IMMUNOLOGICAL PARAMETERS DURING VARIOUS DISEASE 
PHASES OF ALVEOLITIS 
1. INTRODUCTION. 
The association between various immunological parameters 
and the incidence of alveoli tis which were discussed in Chapters 3 
and 4 were derived from the symptom patterns and serology of 
individuals at one point in time. In order to confirm these 
"" 
associations, they were followed prospectively in individuals 
during various phases of disease. The most clearly defined 
phases of alveoli tis include firstly the acute phase which occurs 
in sensitized subjects 4 to 8 hours after contact with antigen 
which consists of a typical symptomatic period, the duration and 
severity of which is variable but usually resolves within 24 hours 
and secondly the convalescent phase, where the various clinical, 
physiological and serological parameters could be followed during 
the recovery period of sensitized individuals over several weeks 
following completer avian antigen avoidance. These phases of 
disease were followed in this chapter to assess the involvement of 
the immune system in both the development and resolution of 
disease. 
2. THE ACUTE PHASE: ANTIGEN INHALATION PROVOCATION TESTS. 
The study of allergic lung disease is facilitated by the 
availability of the lung and skin as experimental target organs 
for antigen challenge. Skin testing can only be considered as an 
extrapolation of reactions occurring locally in the lung, but can 
give complementary information, and furthermore the skin is 
readily accessible for simple investigative procedures. The role 
.of skin testing in alveolitisis discussed in Chapter 6. 
This section is concerned with the use of allergen 
inhalation provocation tests in the investigation of the 
immunological and physiological events associated with acute 
alveoli tis. These inhalation provocation .tests can consist of a 
'natural' exposure to the causative allergens in their normal 
environment, e.g. farmers with alveoli tis strewing hay on the 
farm, or patents with PBD in contact with pigeons during normal 
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husbandry procedures in a pigeon loft. However, the allergen 
exposure can be more closely regulated in the laboratory, and this 
more controlled environment allows better observation of the 
subsequent changes of symptoms, pulmonary function, physiology, 
haematology .and serology. The primary concern during these 
challenges was the safety of the patient, and very conservative 
protocols were ·drawn up controlling the exposure to potentially 
potent allergens. The various resonses to antigen inhalation 
provocation to challenges are summarised on Table 26. The 'late' 
reactions of acute ~lveolitis are the concern of this section. 
a) Natural challenge in a pigeon loft. 
Pulmonary function, white blood cell count, oral 
tempera ture and serological changes were followed for up to 24 
hours in a group of 12 active pigeon breeders, with the clinical 
criteria for alveolitis, following a natural exposure consisting 
of one hour in a loft with 50 birds. All these subjects had 
serum antibody to avian antigens (this and other details are 
listed on Table 27). 
Only one subject (TC) described typical symp~oms of 
chills, fever, muscle pains and ge_neral malaise four hours post 
exposure. These symptoms were accompanied by leucocytosis, fever 
and a decrease in pulmonary function as measured by a significant 
decrease of both vital capacity (Ve) and carbon monoxide diffusing 
capacity (TLeO), see Table 27. This table also lists these 
parameters in the other individuals who, despite'similar antigen 
exposure, did not develop any recognisable symptoms of acute 
alveolitis. 
Despite the lack of overt symptoms, individuals developed 
pyrexia, leucocytosis, and pulmonary function abnormalities during 
the 8 hour period after exposure. Four subjects had a 
significant decrease (by more than 20% of the initial, 
prechallenge value) of both ve and TLeO and two others changed in 
o 
one each. Six subjects developed a temperature of 37.2 e or 
greater (Hendrick et aI, 1980) and five had a leucocytosis of 
greater than a 30% increase above the prechallenge counts. No 
subject had changes in all three parameters simultaneously. In 
fact, although there was a very close correlation between the 
development of both pyrexia and leucocytosis together, these did 
rt:S 
\D 
('-
ONSET 
DURATION 
SITE OF REACTION 
PULMONARY DEFECT 
IMMUNOPATHOGENESIS: 
ANTIBODY 
CELLS 
THERAPY: 
STEROIDS 
BETA AGONISTS 
ADRENAL IN 
DSCG 
GENETIC FEATURES: 
SYSTEMIC FEATURES: 
PYREXIA 
LEUCOCYTOSIS 
SYMPTOMS 
IMMEDIATE 
10-30 min 
1 - 2 hr. 
Central airways 
Obstruction 
Wheeze 
IgE 
Mast cell 
Not acute asthma 
+ 
+ 
+ 
No HLA link 
A S T H M A 
Multigenic control of 
a)IgE production 
b) bronchial hyper-
reactivity 
Eosinophilia, 24hr 
LATE 
6-12 hr. Requires pre-
ceding immediate reaction 
24 - 48 hr. 
Central airways 
Obstruction 
Wheeze 
IgE 
? 
Stabilises chronic asthma 
+ 
+ 
+ 
'" 
ALVEOLITIS 
4 - 8 hr. 
Usually less than 24 hr. 
Peripheral airways 
Restriction 
Dyspnoea. Crepitations. 
IgG 
Lymphocytes 
YES 
+ 
No HLA link 
Presumed multigenic 
control of 
a)IgG antibody respon-
sivenes 
b)disease susceptibility 
+ 
Polymorph.leucocytosis,4-8 hr. 
General malaise, Flu-like 
symptoms. 
TABLE 26. Summary of the features associated with the acute pulmonary responses following exposure to antigen. 
· 
..Q 
1.0 
(' 
ResEonse to Challen~e 
Subject Age Duration IgG WBC Temperature Pulmonarl Function 
years of disease antibody °c V.C. ~ TLCa 
years ug/ml 
1. AW 63 7 113 no change 36.9 + .. + 
2. HM 31 5 63 no change 37.0 
3. wa 41 1 62 increase 68% 37.2 
4. AB 60 7 54 no change 36.5 
5. JBr 58 4 48 no change 37.0 + + 
6. JH 63 1 36 increase 62% 37.7 
7. JBe 57 5 30 increase 26% 37.0 + + 
8. PB 67 2 21 increase 12% 37.5 + + 
9. TC' 32 1 17 increase 30% 37.4 + 
10. JMK 55 1 14 increase 33% 37.2 
11. WR 59 1 11 increase 38% 37.3 + 
12. JM 52 1 9 increase 16% 36.9 
• symptomatic '" 
TABLE 27. Individual details and response to natural challenge in 12 symptomatic pigeon breeders. 
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not occur with the pulmonary function defects. Only three 
subjects did not show any of these responses. Therefore, 
although symptoms of alveoli tis were uncommon, even in sensitized 
subjects, to a mild although typical episode of avian exposure, 
there were changes.suggestive of subclinical reactions. 
Although this study group was small there was some 
suggestion of trends of reactivity. For example, the subjects 
with the highest antibody levels were not the most florid 
reactors. The mean antibody levels of the 6 subjects who 
developed pyrexia a~d the 6 who did not were 27 ug/ml and 53 ug/ml 
respectively. The mean antibody levels of the 5 subjects who 
developed a leucocytosis and the 7 who did not were 28 ug/ml and 
48 ug/ml respectively. However, the trend was opposite for 
pulmonary function changes, the four subjects who developed a 
significant deterioration in lung function had a mean antibody 
level of 52.5 ug/ml whereas the eight subjects with no 
deterioration had a mean antibody level of 33.3 ug/ml. 
It also appeared that the most acute reactions (involving 
both fever and leucocytosis) occurred in 5 subjec~s with 
comparatively recent onset of disease; ~ll claimed to have first 
noticed symptoms about one year before the challenge. The 4 
subjects who only had pulmonary function changes with no 
leucocytosis and only one pyrexial response, had durations of 
disese of 2,4,5 and 7 years, and these could be considered as a 
more chronic disease group. 
b) Complement and immune complexes. 
Serial measurements of complement components C3, C4 and 
Factor B, along with a measure of serum immune complex activity 
were made in these 12 subjects before, and 4 hour and 8 hour 
post-exposure (Figure 27). The values of each complement 
protein were remarkably constant over the 8 hour period for each 
individual, and all were within normal limits except for subject 
TC, (who responded positively to exposure) and one other, both of 
whom had significantly low Factor B. The immune complex levels 
fluctuated m~rginallY in all subjects but there was no discernable 
O I the symptomatic subject TC demonstrated a pattern. n y 
distinctive change with an increase during the study period. 
This, along with the values of complement components of TC 1s 
C3 
140 
Fac B 
24 
20 
r-f 
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tTl 
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FIGURE 27: 
Serial measurements of serum complement components C3, 
C4 and Factor B along with immune complex activity (%) 
before a natural antigen-exposure challenge and during 
the 8 hour period post-challenge, for 11 asymptomatic 
pigeon breeders (mean + S.D.) and one symptomatic 
responder (-----). 
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compared with the mean plus standard deviations of these 
parameters of the other 1 1 individuals who did not have a 
symptomatic response to exposure, and is illustrated on Figure 21. 
Subject TC had a marked drop in C3 and C4 levels, with a modest 
drop in Factor B level along with a marked increase in circulating 
immune complexes coincidental with the development of symptoms of 
alveolitis. These fluctuations were particularly marked in 
comparison with the stable values of the rest of the study group. 
It might have been optimistic to expect any marked 
changes in serum complement levels caused by such modest antigen 
". 
exposure in basically heal thy individuals. However, the minor 
fluctuations in the one symptomatic subject suggested that perhaps 
more sensitive measurement of complement activation, for example 
turnover of complement or the appearance of stable fragments of 
complement activation might be useful, especially since minor 
changes in complement levels across the pulmonary circulation, 
which would be undectable by venous sampling, have been measured 
following inhalation challenge (Halprin et aI, 1973). 
c) Treatment with disodium cromoglycate (Intal). 
These natural exposure challenges were designed to 
include preliminary experiments in the investigation of disodium 
cromoglycate therapy (Boyd et aI, 1980). Each subject was 
pretreated with either 40mg disodium cromoglycate or pla~ebo 
(supplied by Fison's Pharmaceuticals PLC) administered by 
inhala tion. These were given in double blind fashion. The 
various measurements post-challenge in the active and placebo 
groups are listed on Table 28. There appeared to be a net 
protective effect conferred by this drug since the reaction 
"score" was reduced in the treated group and none developed 
symptoms. Without treatment, 9 of the 12 subjects showed some 
degree of reaction, and this. was reduced to 4 following Intal 
administration. The main effect was to reduce the pulmonary 
function abnormalities associated with exposure. 
There was no follow-up of complement or immune complexes 
because there was little change observed in the untreated 
subjects. The subclinical changes of temperature and leucocytosis 
observed in the treated group were again closely associated. The 
protective role of cromoglycate is well documented for asthma 
78a. 
SUBJECT PLACEBO ACTIVE 
Temp. WBC PFT Temp WBC PFT 
1 • AW - - + - - -
2. HM - - - + + -
3. WO + .. + - - - -
4. AB - - - + + -
5. JBr - - + - - -
6. JH + + - - - -
7. JBe - - + - - -
8. PB + - + + + + 
9. TC ++ + - - - -
10. JMK + + - - - -
,( 
11. WR + + - + + -
12. JM - - - - - -
Reaction 
"score" 7 5 4 4 4 1 
Net Score 16 9 
TABLE 28. The effect of pretr~atment with disodium cromoglycate 
or placebo on the development of significant changes 
in temperature, white blood cell count (WEC) and 
pulmonary function tests (PFT) in 12 symptomatic pigeon 
breeders following a natural challenge. 
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(Altounyan, 1967) but has had no serious investigation in 
alveolitis despite the obvious economic benefits. 
The mechanism of the protection which is suggested by the 
current small study on 12 subjects is speculative, primarily 
because the actual protective role of cromoglyca te in asthma is 
still unresolved. One reported activity of cromoglycate is the 
inhibition of chemotactic factor release and this may have a 
bearing in the case of alveolitis, where the pathogenesis is 
thought to involve an influx of cells into the lung as part of the 
inflammatory proces~. This influx would compromise the lung 
function, and is in keeping with the observation that it is the 
lung function which appears to be most protected by cromoglycate 
in the treated group. 
3. LABORATORY CONTROLLED ANTIGEN INHALATION CHALLENGE. 
To obviate the problems of controlling the administered 
antigen dose and for closer monitoring of ' the subsequent reaction, 
particularly for any immediate changes, each subject was 
challenged individually in a controlled laboratory environment. 
The antigen dose was determined by first performing a skin prick 
test with the antigen preparation (sterile pigeon serum, 
, approximately 50 mg/ml protein). This identified any individuals 
at risk of developing immediate hypersensitivity reactions 
(Hendrick, Marshall, Faux and Krall, 1980). Depending on this 
skin reacti vi ty, subjects were given between O. 1 to 0.5 ml of 
pigeon serUm, diluted in 5 ml sterile saline, and nebulised via a 
mini-nebuliser and face mask with air at 8 L/min. Following 
baseline pre-challenge pulmonary function tests and physiological 
measurements, the nebulised antigen was administered for 2 
minutes. After 10 minutes, if there were no changes in peak 
expiratory flow rate (PEFR), the antigen was given for a further 3 
minutes and the PEFR was checked every 5 minutes over the next 20 
minutes. The physiological measurements included helium dilution 
lung volumes, single breath TLCO, spirometry (including 
'flow-volume loop), oral temperature and peripheral blood white 
cell count. Regular venous blood samples were taken. In 
addi tion some subjects had an indwelling arterial cannula and 
blood gas measurement were recorded over a 4 hour period. Local 
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hospital ethical committee approval was obtained for these 
studies. 
Fourteen subjects with documented EAA caused by avian 
exposure w~re challenged by inhaling a set volume of pigeon serum 
(listing on Table 29). This table summarises each individual's 
details and their responses to this challenge. 
a) Clinical response. 
Nine subjects (Nos. , - 9) developed clinical symptoms 
which they recognised as typical of an acute response following 
prolonged avian contact. Five others (Nos. '0 - '4) had no 
" 
symptoms. The severity of the symptoms ranged from mild (feeling 
warm and uncomfortable, see Table 30) in two subjects, to marked 
general malaise and dyspnoea. In general the reactions did not 
proceed this far; they were either self-limiting or were 
terminated by oral prednisolone. No reactions were unduly 
untoward, and all subjects were symptom-free the next morning. 
No subject had any significant immediate symptoms within 
30 minutes of challenge. 
b) Leucocytosis and pyrexia. 
Eleven of1the fourteen subjects developed an increase in 
blood leucocytes of greater than 30% of the pre-challenge counts 
during the eight hour period post-challenge. These included all 
9 symptomatic subjects. Eight subjects had a pyrexia of greater 
than 37.2oC, these were all in the symptomatic group and all of 
them had a significant leucocytosis. 
c) Pulmonary function. 
During the first '5 minutes post-challenge the peak 
expiratory flow rate (PEFH) was monitored and this remained 
I 
constant in all but two subjects. Some further sensitive indices 
of airway obstruction, viz, HV, FEV,/FVC ratio and Vmax25/Vmax75 
ratio from flow-volume loops were measured at frequent intervals 
in the 4 hours after exposure and these did not appreciably alter, 
even in the individuals who had marked immediate prick test 
responses to pigeon serum, or those with an atopic history. 
Over the eight hour period following challenge there was 
an "% drop in forced vital capacity compared with pre-challenge 
a whole (p = n.s.). This was evident in levels in the group as 
I di 11 but one of the symptomatic '0 of the ,4 subjects, inc u ng a 
. 
((j 
0 
:0 
RESPONSE TO CHALLENGE 
Our. IgG Skin test(mm) Challenge Pulmonarl function Leuco- Pyrexia Sympt. 
Sub • Age of antibody Atopic pigeon serum dose of PEFR VC SB cytosis 
dis. ug/ml 1150 1/10 pigeon 
years serum(ml)· 
1 FB 30 8 205 yes 0 0.2 n.k. + + + + + 
2 JS 45 3 . 173 no 0 0 0.4 + + + + 
3 RS 33 7 152 yes 0 3 0.25 + + + + 
4 TP 50 122 yes 0 4 o. 15 + + + + 
5 HM 33 7 95 yes 0 2 0.25 n.k. + + + + 
6 RO 35 3 89 n.k. 0 0 0.2 n.k. + + + + 
7 JP 25 1 35 yes 0 2 o. 15 + + + + 
8 wo 43 3 32 yes 0 1 0.3 + + + + 
9 JMK 59 5 18 yes 0 7 0.2 + + n.k. + 
10 OS 32 1 121 no 0 5 0.2 + + + 
11 JB 60 6 55 no 1 3 o. 15 + n.k. 
12 JC 50 2 39 n.k. 0 0 0.25 n.k. + 
13 WR 61 3 16 no 0 3 0.2 '-: 
14 RJ 37 14 no 0 0.2 
TABLE 29. Individual details and response to laboratory controlled inhalation provocation with pigeon serum in 14 
symptomatic pigeon breeders, 
§ 
CD 
LEUCOCYTOSIS PYREXIA CLINICAL 
I 
SUBJECT WBC3 % Onset Peak Onset Peak Symptoms Onset Peak x10 increase hours post- hrs. °c hrs. hrs. hrs. hrs. 
challenge 
1. FB 11.8 52 3 6 38.2 6 7 a.b.c. 3 7 
2. JS 13..5 69 n.k. 7 37.8 4 7 d(mild.) 7 
-
3. RS 13.7 n.k. 4 n.k. 38.2 4.5 9 a.b.c. 7 
-
4. TP 10.'2 48 7 n.k. 37.4 7 n.k. e(marked).f. 7 
-
5. HM 11.8 103 3 6 37.2 6 7 a.e.g. 4 7 
6. RD 16.0 84 2 7 37.6 6 7 a.e(marked). 4 7 
7. JP 13.2 89 6 n.k. 37.6 6 n.k. e(marked). 7 
-
8. WO I 8.7 34 2 2 37.3 2 2 d(mild). 2.5 2.5 
9. JMK 12.1 69 7 n.k. 37.0 nil n.k. a.e. 12 
-
! 
'--
a. shivering; b. muscle aches; c. cough; d. felt "warm and uncomfortable"; e. general malaise; f.dyspnoea; 
g. headache. 
-Reaction terminated with oral steroids. n.k. not known. 
TABLE 30. Clinical and physiological details of the 9 symptomatic responders following inhalation provocation 
testing. 
I 
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group. However, despite the reports of an association between a 
reduced carbon monoxide diffusing capacity and disease (Dinda et 
aI, 1969; Petro et aI, 1980) this was only found in one subject 
(FB). In the other 13 there were n~ significant changes in the 
coefficient of transfer of carbon monoxide when this was corrected 
for alveolar volume. 
Six subjects had sequential measurements of 
alveolar-arterial oxygen tension (A-a) gradient (Habte et aI, 
1982)," including 3 without a definite clinical response. In 5 of 
these a 191% inc~~ase in the gradient was found indicating a 
degree of ventilation/perfusion mismatching, similar to the report 
of Gaultier et al (1980). 
d) Complement levels. 
The values of complement components C3, C3d, C4, C1q and 
Factor B were measured at intervals during the eight hours post-
challenge. The individual levels fluctuat"ed markedly, presumably 
reflecting both complement activation and simultaneous synthesis 
as part of an acute-phase response associated with the 
inflarnma tory process. Moreover, because these changes would 
presumab~y be temporally related to the active response and since 
this also varied (see Table 30) it would be more meaningful to 
measure these parameters relating to individual responsiveness. 
One of these, RD, is listed on Table 31 along with a full 
description of his other parameters of reaction. This will be 
discussed fully below, but indicates an involvement of the 
complement system. This is also the indication from a summary of 
the values obtained from 5 symptomatic subjects for whom the data 
could be pooled due "to the timing of blood samples (Figure 28). 
This clearly shows a drop in serum C3 levels which 
reaches significance at 3 hours post-challenge compared with 
pre-challenge values. At 7 hours post-challenge the C3 levels 
had recovered, but this would appear to be due to enhanced 
synthesis because the serum levels of C3d,"a breakdown product of 
the activation of C3, continued to rise. There was a marked 
reduction of Factor B levels from pre-challenge levels whi.ch. "las 
maintained during the 7 hours post-challenge. There was very 
little change in the mean C4 levels, and a slight increase in C1q 
over the first 3 hours. 
co 
r-f 
co 
TIME POST CHALLENGE 
PRE-CHALLENGE 15 Min 1 2 3 4 5 6 7 hrs. 
IgG 12.4 12.5 13.1 13.6 13.6 14 14.8 14.9 13.8 
IgA 2.4 2.3 2.3 2.2 2.3 2.3 2.3 2.3 2.3 
IgM 1.4 1 • 1 1.7 1.5 1.5 1.5 1.4 1.4 1.2 
C3 151 186 126 126 177 151 168 . 135 
C4 30 28 28 30 28 28 28 30 
C1q 92 108 124 164 172 100 164 132 
FacB 20 22 23 23 23 25 25 23 
I 
CRP 1 Negative neg neg neg neg neg neg neg neg 
alpha -antit. 220 248 258 266 266 266 272 272 280 
FEV1 4.03 4.09 4.26 4. 14 4.19 3.81 3.5 3.5 5.45 5.28 5.28 4.79 
. '. 4~64 FVC 5.45 5.45 5.07 
Ratio % 74 75 78 . 78 79 75 73 75 
S.B. 9.9 10.2 10.9 10.4 
A-a02 1.2 1.41 1.23 1.37 2.7 3.05 3.41 3.68 
Temperature 36.3 36.6 36.6 36.9 36.8 36.9 37.6 37.6 
WBC 8700 t 9200 11700 126.00 13100 12300 11300 13200 16000 
Symptoms onset (shivering) - progressive 
I 
- - - --
TABLE 31. Serial measurements of various serological and physiological parameters during the course of 
acute alveoli tis in one subject (RD) followng antigen inhalation. 
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Factor B (mgjdl) and C3d, Clq (% Normal) in 5 symptomatic 
responders before and for 7 hr. after antigen inhalation 
provocation testing. 
P = pre-challenge. 
e) A composite view of the changes in the various 
parameters during the acute phase of reaction. 
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e(i): One individual - subject RD - had the most complete 
investigation and the summary of the pulmonary function tests 
during the acute phase is graphed on' Figure 29, and the 
corresponding physiological and immunological parameters are 
listed on Table 31. 
The first parameter to change was the total peripheral 
WEC count. This increased progressively by 34.5%, 44.8% and 
50.6% of pre-challenge levels at 1, 2 and 3 hours post-challenge, 
and at 7 hours, the count had risen by 84%. The sequence of 
events started with an 8% fall in 63 levels at 2 and 3 hours 
post-challenge, followed by a sharp increse in A-a oxygen gradient 
between 3 and 4 hours. Symptoms commenced with shivering at 4 
hours and there was a progressive fall in FEV 1 and FVC from 4 
hours onward. There was a sharp increase in temperature from 
36.9 to 37.6oC between 5 and 6 hours. Symptoms persisted, 
becoming increasingly marked until the reaction was terminated at 
7 hours with oral prednisolone. Throughout the acute phase of 
reaction there was an increase in total IgG of 20% over a -6 hour 
period and this progressive increase was similar to an increase in 
serum alpha 1 - antitrypsin of 21% over the same period. During 
this time there was very little change in serum C4, Factor B, 
total IgA and IgM, and serum C-reactive protein was undetectable 
throughout,. 
e(ii): Group results: 
In general a peripheral blood leucocytosis was the first 
evident change. This tended to precede both the pyrexial 
response and the development of symptoms (Table 30). The time of 
onset of these changes could not be predicted by the antibody 
level nor the challenge dose of antigen. Two subjects with no 
overt sympomatic response also had a leuc~cytosis and in one of 
these there were other pulmonary function changes which together 
t d C
tive response The extent of the leucocytosis 
sugges e an· · , 
'could not ,'be predicted by, either the individuals antibody level 
h 11 e dose, this was true also for the nor the antigen c a eng 
pyrexial response. 
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Changes in pulmonary function FVC, FEVl ., single breath 
carbon monoxide diffusing capacity (KCO and DLeo) and 
the alveolar-arterial oxygen tension gradient ~n one 
symptomatic responder during the 7 hour period following 
antigen inhalation provocation testing. 
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4. THE CONVALESCENT PHASE. 
The converse of the acute-phase reaction discussed above, 
where the various Rarameters of physiology and serology were 
measured during an induced episod~ of disease, is the convalescent 
phase where these parameters are measured in symptomatic subjects 
who are completely removed from the antige~ contact to which they 
had previously been continuously exposed. This was the case in 
three subjects who had been hospitalised due to the severity of 
their symptoms of alveoli tis, thus guaranteeing complete antigen 
avoidance, and 4 others who accepted medical advice to avoid 
further avian contact. 
a) Serial antibody mesurements. 
The IgG antibody level against pigeon gamma-globulin 
antigen was measured serially in 1 subjects with alveolitis who 
avoided further avian contact. Figure 30 illustrates the decrease 
in the specific antibody levels in all subjects. The maximum 
rate of decrease was soon after the initial antigen avoidance, and 
the rate of decrease was more pronounced in subjects with the 
highest antibody levels. In several of these subjects (JSI, SH 
and JW) there wa~ a suspicion that avian contact was reduced 
rather than ceased, but in the case of the others (DD, EG and JP) 
the antigen avoidance was complete. 
In most of the subjects the reduction in antibody levels 
was an exponential function rather than linear, and the half-life 
of decay was approximately 22 days for the subjects with complete 
antigen avoidance and 48 days for the others. The antibody 
levels were not followed until they approximated to the normal 
range, but it appeared that they would remain "low-positive" 
despite no further exposure to inhaled antigen. The reasons for 
this are unclear; it could be a low level of turnover of what at 
one time was an active plasm~ cell population or it could be due 
to a low level of cross-reactive stimulation from ingested hen's 
egg antigens (Lee et aI, 1983). 
In the normal situation, however, there is already a 
yearly fluctuation in antibody levels among pigeon breeders which 
is closely associated with seasonal rates of avian exposure 
(McSharry et aI, 1983). There is most contact during the peak of 
the pigeon racing season in August and September, thereafter there 
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FIGURE 30: 
Serial measurement of serum IgG antibody to avian 
antigens in 7 pigeon breeders who avoided further 
avian contact. 
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is minimal daily contact for the purposes of husbandry during the 
winter. The breeding season starts in March and the exposure 
increases until August. The effects of this natural fluctuation 
in exposure on the antibod~ levels were studied in 20 pigeon 
breeders who donated regular blood samples over a one year period. 
The profile of the monthly antibody levels is illustrated in 
Figure 31~ Eight of the subjects with significant antibody 
levels, 6 of whom are illustrated, showed a marked fluctuation in 
antibody levels with maximum values occurring in August and 
September. These peaks coincided with the time of maximum avian 
contact which was between May and September when the averge weekly 
hours spent with pigeons was 22, compared with 9 hours per week 
during winter. The 12 subjects with insignificant antibody 
levels displayed minimal changes despite similar avian exposure, 
and for clarity only one of these,CH " is illustrated. 
Both these situations' of . varying avian exposure 
illustrate clearly the dynamic nature of the antibody response to 
inhaled avian antigen, and also the necessity for continued 
exposure to maintain the antibody titres. During the 
convalescent per~od, where clinical improvement was evident, 
illustrated by the recovery of lung function in 4 subjects (Figure 
32), some further immunological parameters were followed. 
b) Serial measurements of various immunological 
parameters. 
One subject who was hospitalized with acute alveolitis 
and who did not receive steroid therapy had serial blood samples 
taken. The measurements of various immunological parameters 
during the convalescent phase are recorded on Figure 33 and Table 
32. 
There was an ini tial rapid fall in circulating immune 
complex levels, presumably reflecting the lack of antigen, and the 
antibody level at this stage seemed to rise, perhaps the previous 
titre had been reduced by complex formation. Thereafter the 
antibody levels fell exponentially. The total serum IgG fell 
initially in parallel, but levelled off while the specific 
antibody levels continued, to fall. During this early period of 
11 days the patient's serum C4 level was at the low end of normal, 
but increased thereafter. 
clinical recovery. 
During this period there was a gradual 
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The recovery of pulmonary function and the fall in 
serum IgG antibody to avian antigens in 4 symptomatic 
pigeon breeders who avoided further avian contact. 
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The return to normal of various serological parameters 
in-one patient (E.G.) during convalescence following a 
severe episode of alveoli tis. 
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CD 
DAYS OF ANTIGEN AVOIDANCE 
a 2 8 11 13 60 180 
IgG 
Antibody (ug/ml) 156 160 118 95 77 50 25 
IgG (mg/ml) 18.2 18.4 14.4 13.2 12 12.2 13.8 
IgA (mg/ml) 4.2 4 3.7 3.4 3.1 2.8 3.3 
IgM (mg/ml) low low low 1.4 2 1.5 1.6 
IgE (iu/ml) 1500 1700 400 280 160 180 170 
TABLE 32. Prospective changes in serum immunoglobulins and specific IgG antibody to 
avian antigens in one symptomatic subject (EG) during convalescence, with no 
avian contact. 
~ 
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The stimulus which caused the raised total IgG levels, 
and which was removed following antigen avoidance, acted similarly 
on the IgA levels, and apparently inversely on the IgM levels 
(listed on Table 32). This may be the reversal_ of some form of 
polyclonal activation induced by the inflammatory process 
associated with antigen exposure. Interestingly this appeared to 
have a profound effect on the serum IgE levels which fell in this 
patient to 10% of the initial value. 
5. DISCUSSION. 
". 
Longterm inhalation of dusts can have an adverse effect 
on the lungs. This is certainly the case in coal-workers 
pneumoconiosis and asbestos inhalation, where the lung is unable 
to clear the inorganic insoluble dusts. Soluble organic dusts 
from grain (Broder & McAvoy, 1981) and sewage (Mattsby & Rylander, 
1978) can also cause non-specific pulmonary reactions in exposed 
workers and these are thought to be due in the first case to a 
protein in grain which efficiently binds and activates human 
immunoglobulin, and in the second 'case to bacterial endotoxin in 
sewage. Emanue~ et al (1964), during studies on farmer's lung, 
also described non-specific lung reactions following the 
inhalation of dusts, especially to fungi, andllie~called this 
"mycotoxicosis". Similarly, soluble extracts from these fungi 
were equally non-specifically toxic when used in skin testing of 
farmers (Williams, 1963). 
'Despi te these non-specific effects, controlled exposure 
to aerosols of antigens which are considered to cause alveoli tis 
are of value for establishing a diagnosis and for investigating 
the mechanism of disease. Some of the main literature reports 
using this technique are summarised in Appendix C. The method is 
time and effort intensive, requiring one full day per challenge, 
and good patient cooperation is essential, especLally for the 
forced respiratory function manoeuvres. Conservative protocols 
have been devised in order to deliver the minimum inhaled antigen 
dose to elicit a reaction (Hargreave & Pepys, 1972) and this 
procedure was followed 1'n this chapter. Similarly for natural 
challenges, a typical exposure period in a pigeon loft going 
through the normal procedures of husbandry was used. These 
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protocols were considered to be valid since control individuals 
had no symptomatic, physiological or serological responses. 
However, before appropriate antigen doses had been established, 
some workers had overestimated the amounts required and caused 
o pyrexial responses of up to 37.5 C but no symptoms in control 
subjects who inhaled 3ml of neat pigeon serum (Reed et aI, 1965). 
At this dose the symptomatic subjects developed a temperature of 
39.20 C and exertional dyspnoea which persisted for several weeks. 
Similar pyrexial responses to Micropolyspora faeni antigens in 
high doses were also observed in controls (Barbee et aI, 1965). 
" Subsequent workers have tended to use one or two orders of 
magnitude less of antigen, and it has been reported that acute 
episodes of alveoli tis can occur following exposure to minute 
amounts of antigen, for example, as in briefly handling just one 
bird (Fink, 1974; Duchet-Suchaux et aI, 1969). This was a 
reflection of how sensitive some individuals could be. 
Following natural exposure to 50 pigeons for one hour in 
a loft, only one out of 12 pigeon breeders with alveoli tis 
developed overt symptoms. A symptomatic response therefore 
seemed to be uncqmmon following normal day-to-day avian exposure. 
Although this exposure was mild, and almost all subjects remained 
asymptomatic, there were some measurable physiological changes. 
Five subjects developed both a significant pyrexia and 
leucocytosis, these subjects did not have a significant decrease 
in lung function; they had a lower mean antibody level than the 
others, but all had recent onset of disease. The four subjects 
who had pulmonary function changes were a more chronic group in 
that they had a much longer history of disease and also a much 
higher mean antibody level. Interestingly, some of the 
asymptomatic subjects had much more pronounced fever, leucocytosis 
and decrease in pulmonary function than the one symptomatic 
subject. There was no reason in this group for the individuals 
to hide any symptoms, therefore it could be that they were either 
accustomed to mild symptoms which might have been expected with a 
, 0 
pyrexia of'up to 37.7 C and compromised lung function, or that the 
development of symptoms was a separate but related event following 
antigen exposure. Similarly in this group, the pyrexial and 
leucocytosis responses seemed to occur together, but were 
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unassociated with decreases in pulmonary function. 
All these aspects of responsiveness were seen to be 
dose-dependent in that they were all increased in incidence and 
severity when the administered dose of antigen was increased 
during laboratory inhalation challenges. One assumption was that 
the inhalation of pigeon serum in the laboratory was equivalent to 
the natural exposure. This appeared to be the case in that the 
subjects described what would be typical symptoms in both types of 
challenge. Following laboratory challenge 9 out of 14 pigeon 
breeders wi th alveoli tis developed symptoms. The individual's 
serum antibody level' against avian antigens could not be used to 
predict who did or did not develop symptoms in this group. 
Furthermore, the antibody level did not predict the onset or 
severity of symptoms, nor the extent of pyrexia and leucocytosis, 
nor the decrease in pulmonary function. There was an indication, 
which was difficult to tabulate, that the subjects who had most 
recently had an acute episode of alveoli tis were those who reacted 
most vigorously to challenge. 
The changes in pulmonary function were also more marked 
in the laboratory challenge group, and the most common abnormality 
( 
which developed was a fall in forced vital capacity. The loss in 
lung volume associated with this could account for the different 
literature reports of changes in carbon 
capacity following challenge (Appendix C). 
monoxide diffusing 
Where the diffusing 
capaci ty was reduced in the present subjects challenged, this 
could be accounted for by a reduction of alveolar volume in all 
but one subject 
In all subjects the pyrexia and leucocytosis tended to 
occur together and these preceded the development of pulmonary 
function changes and symptoms. The maximum change in pulmonary 
function was a mean reduction of 16% in VC after 6 hours compared 
with pre-challenge levels. However, there was a more immediate 
change noted in 5 of the 6 subjects who had their arterial-
al veolar oxygen tension gradient measured. In these cases a 
clear increase of 4).2% was measured between 2 and 3 hours 
post-challenge, and this was an earlier response than either the 
leucocytosis or pyrexia. There were no'immediate (less than 30 
min) symptoms in any of the subjects despite a high incidence of 
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atopy in the group (58.3%), and despite immediate skin test 
responses to pigeon serum in 11. This is in general agreement 
with Warren et al (1977), who could not find an early response 
even using sophisticated_pulmonary function measurements. 
The sequence of events which appear to follow an 
inhalation challenge on a sensitised subject are firstly an 
increase in the A-a oxygen gradient, suggesting a local pulmonary 
reaction, followed by a systemic reaction of neutrophil 
leucocytosis which seems to slightly preceed the pyrexial 
response. Thereafter there can be development of symptoms and 
then a compromise In pulmonary function. The extent to which 
each individual exhibits these changes will be a function of the 
antigen dose and the individual susceptibility. A positive 
challenge therefore need not go as far as compromising the 
pulmonary function. 
These pulmonary function tests were too insensi ti ve an 
index for following an acute reaction, and this was also the 
conclusion of Hendrick et al (1980). They were, however, a 
useful indicator, along with the antibody level, of the current 
status of an individual with pigeon breeders disease. Persistent 
( 
positive precipitins correlated well with a decrease in CO 
diffusing capacity in one longterm follow-up of farmers lung 
patients (Braun et aI, 1979), and during antigen avoidance the 4 
subjects discussed in this chapter had good recovery of pulmonary 
function over a period of 25 weeks, although one report which 
followed-up 9 patierits prospectively suggested that the lung 
damage could be irreversible, and progressive decrease in lung 
function could occur despite antigen avoidance if the disease had 
been established beyond a critical point (Allen, Williams & 
Woolcock, 1976). This confirmed the work of Nash (1970), Heywood 
(1971) and Riley & Saldana (1973) who stated that the longterm 
effects of established pigeon breeders disease resulted in chronic 
disability, ultimately with respiratory failure. 
The involvement of humoral immune parameters in the 
initiation and development of the physiolQgical responses 
discussed above was suggested by the coincidental changes of serum 
complement and immune-complex levels. The levels of these 
components were remarkably conserved during the eight hour period 
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following a mild natural challenge in 12 subjects, and in contrast 
to this the levels fluctuated markedly in some of the 14 subjects 
who had the more vigorous challenge in the laboratory. When the 
stable breakdown products of complement activation were sought 
following challenge in 5 subjects, C3d was found to increase 
during the first 3 hours coincidental with a significant decrease 
in C3 levels. The C3 levels returned to normal after 7 hours, 
but the C3d levels continued to rise suggesting an increase in 
synthesis of C3, perhaps as a consequence of the inflammatory 
response, occurring along with catabolism. The inability to 
differentiate between synthesis and degradation of complement by 
the simple measurement of total serum levels, or haemolytic 
complement titres, may explain why there is conflicting evidence 
in the literature for the involvement of complement in the disease 
process. A further complication would be that any changes in 
complement would be presumably related to the antibody titre to 
the inhaled antigens, and also the amount of antigen inhaled. 
Other undetermined constitutional factors may also prevail going 
by the observed variability of the physiological responses to 
challenge in the study group. In literature reports of-antigen 
( 
inhalation challenge of alveoli tis patients it was first suggested 
that a drop in CH-50 occurred in non-responders (Moore et aI, 
1974) but then Schatz et al (1976) reported a drop in CH-50 in all 
challenged subjects. Voisin (1979) only reported one out of six 
challenged subjects with a decreased CH-50, interestingly this was 
the subject with by far the most florid symptomatic and 
physiological response. Baur et al (1980) in contrast reported 
an increase in CH-50 in 4 subjects following inhalation challenge 
and he also did not find any C3 split products. The most recent 
reports (Edwards & Davies, 1981; Lozano et aI, 1982) find no 
significant differences in - control or al veoli tis patients 
following exposure to antigen. Thus the situation has not 
progressed much since Schatz et al (1976) described the role of 
complement in alveoli tis as "enigmatic". However, the work in 
this section would suggest that complement is involved, and that 
differences in serum complement are manifest only after relatively 
high challenge doses, or are masked by concomitant synthesis. 
Moreover, minor changes in complement activity have been measured 
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across the pulmonary circulation in association with inhalation 
challenges (Halprin et aI, 1913). These complement changes would 
be too small to be detected by venous sampling alone. 
Further evidence for the involvement of complement and 
immune complexes in the disease process was suggested by the rapid 
fall of serum levels of complexes when the antigen source was 
avoided, and by the return to normal of C4 in one subject 
coincidental with clinical recovery. The serum antibody level 
appeared to require continuous antigen contact, otherwise the 
ti tres fall exponentially. Further non-specific parameters of 
inflammation including total immunoglobulins IgG and IgA and 
interestingly occasionally IgE, but not IgM, seem to rise 
following challenge and fall when the antigen is avoided. 
These parameters are, therefore, at least associated with 
disease, if not actually involved. This is notable in that they 
were also raised in some asymptomatic ~ubjects discussed in 
Chapter 4. Following natural challenge it was noticed that 
symptoms were rarely seen, and only when the challenge dose was 
substantially increased by laboratory challenge did symptoms 
become evident. (These observations suggest that there can be 
definite physiological changes associated with avian exposure 
without overt symptoms and that subclinical disease may be 
prevalent, the extent of which is unknown. However, if humoral 
parameters such as antibody are used as a guideline then incid-
ences of disease may be far greater than indicated in Chapter 1. 
This question could be resolved by subjecting asymptomatic 
subjects who have an inflammatory serum profile to a laboratory 
controlled challenge in order to assess the responsiveness to 
higher antigen doses. This was done in 2 subjects with serum 
antibody to inhaled antigens from a humidifier system, and 
although they had always been asymptomatic, a laboratory challenge 
with an equivalent daily dose of antigen was enough to cause a 
typical alveoli tis response (Edwards & Cockcroft, 1981) • This 
approach would be of value because it is primarily the insidious, 
subclinical disease which results in irreversible lung damage. ~ 
It is highly probable that cellular events also occur 
during the acute phase of alveolitis. Both the lung histology 
and lung lavage demonstrate an increase in total cell numbers, 
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predominantly of mononuclear cells characterised as T lymphocytes 
(Reynolds et aI, 1977; Weinberger et aI, 1978; Godard et aI, 
1981), which is particularly marked during the acute phase (Molina 
et al, 1979; Bern~rdo et al, 1919). The peripheral blood 
leucocytosis during the acute phase of disease was predominantly a 
neutrophilia, with occasional reports of eosinophilia (Hargreave & 
Pepys, 1972; and one patient in this study - subject JC). A 
mild lymphopoenia has also been reported in conjunction with the 
rise in polymorphs (Hargreave & Pepys, 1912; Geller et aI, 1971; 
Voisin et al, 1919; Hendrick et aI, 1980), the inference being 
" that the active lymphocytes are somehow sequestered in the lung. 
This is thought to be the case in pulmonary sarcoidosis where 
local lung lymphocytes are extremely active, but there is anergy 
in the peripheral cells (Hunninghake & Crystal, 1981). A similar 
anergy has been reported against tuberculin in farmers (Fuller, 
1962) and pigeon breeders (McSharry et aI, 1983) and there are 
very few reports of cell-mediated delayed type skin reactions in 
these subjects to avian antigens. This topic will be discussed 
in Chapter 6. 
It is Prarticularly pertinent to note that 'systemic 
delayed hypersensitivity in the guinea pig is characterised by 
fever which begins approximately 2 hours after an intravenous 
challenge (Uhr & Brandriss, 1958) and perhaps after an aerosol 
challenge as well (Miyamoto & Kabe, 1911; Miyamoto et aI, 1911). 
The fever associated with the acute phase may well be related to 
interleukin-1 production by alveolar macrophages (Murphy, Simon & 
Willoughby, 1980). These workers pointed out that the endogenous 
pyrogens were identical to lymphocyte activating factor. This 
suggests that the macrophage could provide the trigger for the 
systemic reaction and also the local pulmonary T-cell activation. 
The depletion of an intracellular biologically active factor such 
as this could account for the refractory periods which were 
reported in humidifier fever (Edwards, 1980), in farmers lung 
(Williams, 1963) and in aspergillosis (Pepys et al, 1968). 
Although a similar refractory period has not been demonstrated 
following inhalaton challenge of pigeon breeders, it could explain 
,the inconsistency of the responsiveness to experimental aerosol 
challenges reported here and in the literature. Some supporting 
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evidence for this was reported by Schuyler et al (1978) who 
noticed that the bronchial lymphocytes were refractory to avian 
antigen stimulation for up to 7 days in one pigeon breeder 
following a particularly vigorous inhalati~n challenge. 
The treatment of alveoli tis would be of considerable 
benefit, and a model for testing the efficacy of drugs using 
challenges on pigeon breeders would appear to be the simplest 
system. Isoprenaline had little effect on the response (Williams, 
1963; Hargreave et aI, 1966; Hargreave & Pepys, 1972), and 
although corticosteroid treatment has been widely used to relieve 
acute symptoms (Em~nuel et aI, 1964; Hapke, Seal & Thomas, 1968) 
and to reduce the circulating antibody levels (Boyd, 1978), it 
seemed to have no marked influence on the course of lung function 
or the prognosis of working capacity in one follow-up study of 93 
patients with farmers lung (Monkare, 1983), however it did 
diminish fibrotic appenronces in chest radiographs. 
There seems to be, therefore, a place for a drug in the 
treatment of this condition. Disodium cromoglycate (DSCG) has 
been extensively used in asthma, and its use in alveoli tis has 
only been report~d by Pepys et al (1968) who inhibited the early 
and late reaction associated with the inhalation of Aspergillus 
fumigatus antigens in two patients and the late reaction in 3 
pigeon breeders after inhaling pigeon serum. In this section the 
use of DSCG was sho~ to reduce the res~iveness to challenge of 
a group of sensitized pigeon breeders These results should prove 
to be a - useful platform from which to conduct a more thorough 
investigation of the efficacy of the drug in alveolitis. 
However, until such time, the only protection afforded to the 
alveoli tis patient is complete antigen avoidance, or at least 
minimal contact, usually by wearing a mask (Siegel & Oullet te, 
1969). 
The diagnostic usefulness of inhalation challenges 
discussed above have been questioned, and-indeed were suggested to 
be dangerous (Hendrick et aI, 1980). In our experience they are 
very time and labour intensive and require considerable goodwill 
on the part of the subje6t under investigation The results can 
be far from conclusive, and therefore better diagnostic aids would 
be useful. These could include along with the serological 
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profile, measuring the arterial oxgyen tension by transcutaneous 
oxygen electrode and gallium-67 scanning to stage the alveoli tis 
(Line et al, 1981) • These techniques however require 
sophisticated machinery, therefore, a more readily available and 
simple technique would be needed. To fulfill this need we looked 
at skin testing of patients using specific antigens. 
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CHAPTER 6 
SKIN TESTING 
1. INTRODUCTION 
The late (4 to 8 hours) skin test reaction which can 
occur in patients with EAA, when the appropriate antigens are 
injected intradermally, has received considerable interest in the 
study of the disease (Fink, Barboriak & Sosman, 1967; Moore et al 
1974; Hargreave & Pepys, 1972). There is a close temporal 
association between this reaction and the late pulmonary 
inflammatory reaction following inhalation provocation test using 
the same antigens, and a common, type III Arthus reaction has been 
postulated (Pepys 'et al, 1968; Pepys, 1969). It has been noted 
that this reaction may be preceeded by an immediate weal and 
flare skin reaction (Hargreave & Pepys, 1972), and although this 
is of considerable diagnostic value in Type I hypersensitivity 
diseases such as asthma and hay'fever (Bryant, Burns & Lazarus, 
1975), the significance of this early reaction in alveolitis has 
received little attention. 
This chapter investigated the prevalence of the immediate 
and late skin reactions following prick testing with, and 
intracutaneous injection of a sterile, non-irritant avian antigen 
( 
preparation among pigeon breeders. The incidence of skin test 
reactions to common inhalant allergens and to tuberculin was also 
investigated. These reactions, together with the atopic status, 
total IgE and circulating avian antigen specific IgG and IgE 
antibody were assessed for their usefulness to the clinician 
investigating respiratory symptoms amongst pigeon breeders and are 
discussed in the light of current views on the disease mechanism 
of extrinsic allergic alveolitis. 
2. RESULTS 
a) Skin testing with common allergens. 
One hundred activ~ pigeon breeders were skin prick tested 
wi th six common allergens, i. e. Derma tophagoides pteronyssinus, 
grass pollen, cat fur, mixed feathers, Sporobolomyces and 
Aspergillu's fumigatus, along with the appropriate skin test, 
control solution (supplied by Bencard Ltd). 
The incidence of positive skin tests to the individual 
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allergens in the test population of pigeon breeders was compared 
with control and atopic populations on Table 33. The incidence 
of atopy was higher compared with the figures from an unselected 
control population. This perhaps reflected the bias caused by 
encouraging as many pigeon breeders with any respiratory symptoms 
to participate in the study. However, the profile of skin-test 
responsiveness among the atopic pigeon breeders was similar to 
that of other atopic groups, and the incidence and profile of 
skin-test responses in the alveolitis sub-group was very similar 
to the whole study group. 
Fifty of the subjects had one or more positive immediate 
weal and flare reactions, however 15 of these had only modest skin 
reactions (1mm or 2mm reaction to only one allergen, or 1mm to 2 
allergens, and these were considered as a separate sub-group on 
Table 34. From this table the skin test reactivity was seen to 
correlate with total IgE levels ·and with a personal history of 
symptoms of atopic diseases. However, the incidence of 
hypersensitivity symptoms related to avian exposure was .only 
marginally greater in the skin test positive group. Therefore, 
atopy, as judged by skin testing with common allergens, was not a 
feature of extrinsic allergic alveoli tis due to avian exposure, 
( 
however, the extent of the IgG antibody response to avian antigens 
was lower in the skin test negative group (t=3.l, p<O.005). 
b) Skin testing with pigeon serum antigens. 
A summary of the main literature reports concerning skin 
testing with specific antigens in extrinsic allergic alveoli tis is 
listed on Table 35. The present study is more comprehensive in 
terms of numbers; 102 pigeon fanciers were investigated and full 
clinical details were taken. Skin prick tests and intracutaneous 
tests were performed using a pigeon serum antigen preparation, and 
the serum antibody levels were quantified. 
c) Prick test. 
Twenty-two of the 102 subjects had an immediate, 15 min., 
weal and flare reaction to neat pigeon serum. This group had a 
. 
significantly higher mean IgG antibody level against pigeon serum 
antigens than the whole group (Table 36), was associated with a 
* 
House dust +/ - D farinae 
House dust 
Dermatophae6ides farinae 
Table 33: Percentage positive skin tests to·common allergens in various 
populations of normal subjects, atopic subjects and nigeon breeders 
I 
Pigeon Breeders 
Unselected* Atopic 
* 
Atopic .** 
Population Asthmatics· Asthmatics Atopic All subjects 
n ::: 1300 n ::: 554 n ::: 220 n ::: 50 n ::: 100 
-
82 74 - -
16 70 72 
- -
- 69 67 - -
Dermatoph~goides pteronyssinu3 14 
- - 72 36 
Pollens 
- 66 53 - -
Grass pollen 10 
-
46 52 26 
Animal dander 
- 38 78 - -
C3.t fur 
- -
61 58 29 
. 
!.1ixed feathers Of 
- . - 55 58 29 
'" 
r.!oulds 
-
21 40 
- -
3poToblomyces 
- -
8 10 5 
Aspergillus fumisatus 4 16 20 18 9 
Food3 
-
16 30 
- -
~---
n ::: 100 
Alveolitis 
n ::: 32 
-
-
-
42 
-
25 
-
25 
31 
-
6 
9 
-
~ 
- ~ 
from Davies, R.J. (1979) ** from skin test clinic, Centre for Respiratory Investigation. Glasgow Royal Infi~mary. 
I 
I 
I 
I 
I 
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Table 34. Skin prick test response to common allergens compared with the total 
IgE~ulml)and the personal history of atopic diseases. Also with the mean specifi 
IgG level (ug/ml) and IgE (HAST positive) for avian antigens, and the incidence 
of immediate and late symptoms following avian exposure. 
Number 
IgE (mean + sd) 
Atopic history 
Avian hypersensitivity symptoms: 
Immediate - asthmatic 
Late - alveoli tis ( 
Avian antigen specific: 
IgG mean + sd 
IgE RAST positive 
Immediate reactions (15 min weal) 
Negative 
50 
75.5 (66.9) 
2($6 
3 (6%) 
16 (32%) 
13.3 (28.4) 
2 (4%) 
Positive 
Marginal 
15 
129.3 (128.0) 
2710 
35.4 (38.7) 
12 (24%) 
Definite 
35 
225.9 (215.4) 
54% 
u 
Lf) 
m 
I 
Precipitin 
I 
I Number Positive 
12 12 
3 3 
22 22 
9 9 
10 
81 32 
30 10 
15 
16 11 
. 
17 
55 38 
.21 
ND -= Not Done 
Prick Test 
Negative 15 min 
5/11 
ND 
7 
ND 
10 ND 
15 
9 
15 0 
~ ND 
5 ND 
17 ND 
ND 
17 1m 
21 ND 
Intradermal 
15 min 6 hr. 
ND 9/11 
1 2 
19 14 
I 
4 9 
0 0 
23/55 29/55 
11 12 
1 0 
10 8 
.1 ~ 1 
0 0 
29 8/14 
1 ND 
1 0/10 
Reference 
-
Hargreave et a1 1966 
Fink et a1 1968 
Pepys, 1969 
Warren, 1972 
Hargreave et a1 1912 
E1-Hefny et a1 1980 
Edwards & 
Davies 1981 
, 
Freedman et a1 1981 
() 
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Table 36. The IgG (ug/ml) and IgE (HAST positive) antibody titres 
to pigeon antigens and the atopic status of 22 subjects prick test 
positive to pigeon serum. 
Test Population .Skin Test Positive 
to Pigeon Serum 
n = 102 n = 22 
IgG antibody (mean + sd) 24.0 (36.1) 52.5 (43.0) 
IgE HAST positive 14 (13.7;6) 8 (36.4%) 
T~tal I~E (mean +, sd) 135.5 (159.0) 215.4 (210.2) 
Atopic history 33% 50% 
Positive prick test 
to common allergens 35% 82% 
Table 37. Avian antigen specific serum IgG antibody titre (ug/ml) 
and alveolit~s~~in relation to tuberculin sensitivity, by Tine 
and Man foux skin testing. . 
( 
Tuberculin (Tine test) reactivity 
Negative Intermediate Positive 
Grade 0 Grades 1 and 2 Grades 3 and 4 
Number· 39 36 16 
IgG antibody 33.8 ··18.8 16.6 
Alveolitis 16 12 2 
Mantoux Skin Test 
Negative Positive 
Number 36 31 
, 
IgG antibody 44.5 24.0 
EAA Positive 27 9 
EAA Negative 9 12 
96 
higher total IgE level (t=3.9, p<O.001) and occurred predominantly 
in subjects with positive skin tests to common allergens. ' 
This immediate skin reactivity was correlated with serum 
IgE antibody by RAST measurements against pigeon dropping extract 
(PDE) and pigeon serum antigens. Of the 102 subjects, 4 had a 
low level (RAST grade 1) of IgE antibody against PDE, and 12 were 
posi ti ve against pigeon serum; nine grade 1 and three grade 2 
(moderate level of IgE antibody). Two subjects were positive for 
both antigens. Of this group of 14 RAST positive subjects, there 
were 8 with a positive prick test to pigeon serum (Chi-squared = 
12.1, p<0.001). 
d) Intradermal testing: immediate, 15 min., skin 
reaction. 
Ninety-eight subjects were skin tested intracutaneously 
on the flexor aspect of the forearm with pigeon serum diluted 1 in 
5 with sterile saline, (0.01ml, approximately 50 ug of protein). 
The reactions were measured at 15 mins. and 6'hours. These 
reactions were graded as follows: - grade 0 was no reaction or 
reaction equal to the control intradermal test, grade 1 was 1-3mm 
greater than control, grade 2 was 3-6mm, grade 3 was 7-9mm, and 
grade 4 was 19rpm or grea ter. The antigen pre para tion was 
non-irri tant when administered by this route and produced only 
grade 0 reactions in control subjects with no avian exposure. 
Sixty-nine subjects (70%) had an immediate weal and flare 
reaction. The extent of this skin reaction as measured by weal 
diameter was quantitatively related to the serum IgG antibody 
level against pigeon serum gammaglobulin antigen (Figure 34), and 
not to total IgE. There was no correlation between this skin 
reaction and immediate skin reacti vi ty to common allergens nor 
with an allergic history. 
The stronger positive skin reactions were progressively 
more selective for subjects with avian induced extrinsic allergic 
alveolitis (Figure 35). Thirteen percent of all subjects with no 
skin reactivity had symptoms of alveolitis and this increased to 
82% of the grade 4 reactors. 
e) Intradermal testing: late 4-8 hour skin reaction. 
Of the 98 subjects skin tested with pigeon serum, 10 
96a. 
Ig~ antibody Total IgE 
J.lg/ml 
70 
50 
"iml 200 
30 
100 
10 ( 
o 1 234 o 1 2 3 4 
Grade of immediate intradermal skin reaction. 
FIGURE 34: 
The mean plus standard error of (a) serum IgG antibody· 
levels specific for avian antigen, and (b) total IgE, 
within each increasing skin reaction grade against 
intradermally applied pigeon serum antigen. 
% 
100 
50 
A- ___ 
o -~, 
................ ...." 
.... 0---_ 
o 
o 1 2 
Reaction 
FIGURE 35: 
...... -
............. -.... ~ 
........ 0 " 
" " ", 
3 
Grade 
" 
96b. 
..... , 
..... ~. 
4 
The percentage of subjects in each of the immediate 
intradermal skin reaction grades with alveolitis (e---o), 
with indeterminate sympt?ms (4---A) and with no 
symptoms (0-----0) related to avian exposure. 
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reported a late skin reaction, maximal between 4 to 8 hours. All 
of these subjects had had strong early reactions and could be 
considered as "dual" skin reactors. This late reaction was a 
feature of subjects with particularly high IgG antibody titres 
(mean = 66. 1 ug/ml). One subject however had insignificant IgG 
antibody to avian antigens but described prominent avian related 
asthmatic symptoms, and 8 of the 9 remaining had symptoms of 
alveolitis. 
f) Delayed, 48-72 hour tuberculin skin reactions. 
The 102 subjects were skin tested with a tuberculin Tine 
test and the reactions were read after 72 hours by each subject, 
who indicated the size, if any, of the reaction on an illustrated 
returnable postcard. The results for the Tine test were graded 0 
for no reaction, grades 1 and 2 for increasingly positive 
\ 
reactions before the 4 individual weals from the 4 small 
tuberculin .- coated spikes coalesce, grade 3 when the weals 
coalesce and grade 4 for any larger reaction. Grades 3 and 4 
were considered as positive reactions. 
There was an 89% return of the score cards and the grades 
of the reactions were listed on Table 37. There was a.markedly 
( 
lower mean avian-antigen specific IgG antibody response in 
tuberculin positive subjects and this was associated with a lower 
incidence of alveolitis. However, due to reports of occasional 
false-negative tuberculin skin reactions using the Tine test, the 
association between antibody responsiveness, disease incidence and 
tuberculin sensitivity was followed up using a 1:1000 Mantoux test 
on a further 57 pigeon fanciers (Table 37). The reaction was 
positive after 72 hours if the reaction was 5mm or greater. The 
lower mean antibody levels in the tuberculin positive subjects was 
confirmed (0.05<p<0. 1) and there was a significant correlation 
between alveolitis and cutaneous anergy to tuberculin (Chi-squared 
= 5.9, p<0.02). 
3. DISCUSSION 
Positive skin tests to common allergens and raised IgE 
levels were no more prevalent among the 32 pigeon·fanciers . with 
extrinsic allergic al veoli tis than the whole ·study group, 
98 
suggesting that the individuals' atopic status (Pepys, 1975) did 
not predetermine the development of alveoli tis caused by avian 
exposure. 
There was however a highly significant association 
between positive skin test responsiveness to common allergens and 
raised serum IgG antibody to inhaled avian antigens suggesting 
that there may be a common control mechanism. This could be 
T-cell mediated because skin test responsiveness is known to 
deteriorate with age (Tuft, Heck & Gregory, 1955) due to decline 
in T-helper cell function (Allison, Denman & Barnes, 1971) • A 
further involvement in T-cell function was suggested ~y the higher 
IgG antibody ti tres against inhaled avian antigens in subjects 
with cutaneous anergy to tuberculin. An early report (Fuller, 
1962), published when positive tuberculin responses were more 
prevalent in the general population, had suggested that extrinsic 
allergic alveolitis amongst farmers (farmers lung) would be 
unlikely if subjects had a positive mantoux. This view was 
confirmed by our results which significantly correlated EAA with 
cutaneous anergy to tuberculin. This would tend to support the 
view that both the humoral and cellular arms of the immune 
response are involved in the pathogenesis of EAA (Roberts & Moore, . 
< 
1977). 
An immediate skin prick test to pigeon serum in this 
study was a feature of atopic subjects with high IgG antibody 
titres, and serum IgE antibody to avian antigens measured by RAST. 
This is in agreement with Faux and co-workers (1971) who described 
IgE antibody and positive immediate prick tests in subjects who 
developed immediate asthmatic symptoms only, when challenged with 
avian antigens. 
In the present study, however, there was little evidence 
of strong IgE responsiveness to avian antigens among all the 
pigeon fanciers, despite a -high incidence of atopy and extensive 
avian contact (mean years exposure = 22 years). Other workers 
have been unable to detect specific IgE among pigeon fanciers 
(Pa t terson et aI, 1976; Cohen, Yunginger & Fink, 1979) however 
this may be explained by the high titre serum IgG antibody 
blocking the RAST system. This potential for IgG to block the 
RAsT test has been discussed by Aalberse et aI, ( 1972), and has 
99 
been demonstrated in patients allergic to Aspergillus and 
budgerigar proteins by Pepys, Parish, Stenius-Aarniala and Wide 
(1979), who showed that short-term sensitizing antibody (IgG S-Ts) 
could interfere with the specific IgE activity by blocking RAST 
tests and passive cutaneous anaphylaxis (PCA) testing in baboons. 
The late (4 to 8 hour), type III skin reaction against 
intracutaneously administered avian antigens has received 
considerable attention in the study of extrinsic allergic 
alveolitis because it has a similar time course to the acute 
pulmonary and systemic reactions which follow inhalation 
challenges with these same antigens (Hargreave & Pepys, 1972). 
These authors demonstrated that the majority of subjects in their 
study with late respiratory symptoms after an inhalation challenge 
with avian antigens had late skin test reactions (85%) and just 
over half had preceding immediate reactions (58%); whereas all 
those with dual, immediate and late, respiratory reactions had 
dual skin tests. 
Of the ten subjects who reported a late skin reaction to 
intradermal pigeon serum antigen in the present study, eight had 
evidence of avian related extrinsic allergic alveolitis, and this 
skin reactivity appeared to be associated with a particularly high 
( 
specific IgG titre to pigeon serum gamma-globulin antigen. One 
subject who had insignificant IgG against avian antigen but with a 
positive RAST had a similar late skin reaction. He described 
significant immediate and late asthmatic symptoms related to avian 
exposure, and it was possible that this late skin reaction was 
mediated.therefore by IgE antibody, as has been described in other 
atopiC conditions (Dolovitch et aI, 1973). 
A high percentage (70%) of the study population developed 
an immediate weal and flare reaction following intracutaneous 
administration of diluted pigeon serum. This skin reactivity was 
not associated with atopy as judged by total IgE levels, allergic 
history or skin reactivity to common allergens, but was 
quantitatively as~ociated with the titre of IgG antibody to pigeon 
serum antigens. Anaphylactic IgG was first described by Parish 
(1970),' and an IgG associated skin sensitizing factor has been 
reported in extrinsic allergic alveoli tis among farmers (Freedman 
et aI, 1981; Edwards & DaVies, 1981). The present work with 
100 
subjects exposed to definable avian antigens which can be 
purified, and in whom the IgG antibody response can be quantified, 
offers an opportunity to isolate the class and subclass of this 
anaphylactic antibody activity (see Chapter 4). 
A role for a possible IgG anaphylactic antibody in the 
pathogenesis of extrinsic allergic alveoli tis should now be 
'considered, perhaps in combination. with the traditionally 
postulated immune complex aetiology (Pepys, 1969). Certainly, 
Fink and his colleagues (1968) found a clear difference in the PCA 
antibody titre between pigeon breeders with and without 
al veoli tis, and Morell-Brotad and colleagues (1981) found that 
positive immediat~ intradermal skin tests using appropriate 
antigens were highly selective for farmers lung patients, more so 
than other diagnostic tests including lymphocyte transformation 
using the same antigens. Similarly, in the present study, strong 
positive immediate intradermal skin tests using pigeon serum as an 
antigen were highly selective for patients with alveolit~s caused 
by avian exposure, and this simple and safe technique may prove a 
useful adjunct in the diagnosis and management of alveolitis. 
( 
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CONCLUSIONS 
1. Pigeon derived dusts which can be readily airborne consist of 
primarily the feather dust and the dust from desiccated droppings. 
The major protein component in soluble extracts from these dusts 
is also the major antigen and this is suggested to be the avian 
equivalent of secreted IgA. This has antigenic determinants in 
common with pigeon serum and antigenic identity between all these 
materials appears to reside in the gamma globulin light-chain. 
Pigeon serUm, therefore, contained the main antigen and 
was a readily available and relatively clean antigen source. 
This material was used successfully in serology, skin testing and 
inhalation provocation testing, and for future coordinated work on 
these aspects of alveoli tis it would be useful to have general 
agreement to use pigeon serum as a standard antigen in 
standardised amounts for each procedure. 
2. The particulate, chemical and aerodynamic properties of the 
pigeon feather dusr makes this a possible vehicle for carrying the 
soluble antigens to the peripheral airways and to initiate and 
stimulate an immune and inflammatory response. 
3. Serum IgG antibody to these avian antigens could be measured 
quantitatively by RIA and ELISA. However, a semi-quantitative 
estimate of antibody could be effiCiently obtained by avian RBC 
agglutination and this rapid technique is probably the best 
compromise betwee~ simplicity and sensitivity for use in a routine 
laboratory. 
4. The distribution of serum IgG antibody levels against avian 
antigens in a population of pigeon breeders has demonstrated a 
spectrum of responsiveness, with approximately half of the 
subjects having no serum antibody despite extensive avian 
exposure. 'The mechanisms of this non-responsiveness, whether it 
is an active tolerance or a progressive desensitisation, would be 
of interest to clarify some of the normal immune functions of the 
lung following repeated antigen exposure, and also because these 
subjects tend not to have alveolitis. 
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5. The presence of serum antibody in a patient confirmed avian 
exposure, but when this antibody was quantified there was an 
association between higher levels of antibody and an increasing 
incidence and severity of symptoms. Serial measurements of 
antibody in indiyiduals was of value in monitoring therapeutic 
progress, and persistently low values thereafter confirmed that 
the patient has avoided further avian contact. 
6. The subjects with serum antibody also had increased serum 
levels of some immunoglobulins, some acute phase proteins, and 
immune complexes, along with lower levels of some complement 
components. These abnormalities suggest an active inflammatory 
response. The levels of some of these non-specific parameters 
were raised in tandem with the specific antibody level, which 
suggests that the inflammatory response was a. consequence of the 
continuous antigen exposure to which these individuals submit 
themselves. Furthermore, these antibody positive subjects should 
be considered as an at-risk population and should be carefully 
monitored for the development of subclinical, insidious disease. 
( 
7. Subclinical physiological changes were observed in sensitized 
individuals following exposure to antigens. Moreover, when 
exposure was extensive enough to provoke mild symptoms, there were 
marked changes in leucocytosis and pyrexia which preceeded the 
onset of symptoms. There were also some fluctuations in 
immunological parameters associated with these changes in some 
indi viduals during the 8 hours following exposure. These 
included the formation of immune complexes and activation of 
complement. There was also an increase in total serum IgG and 
alpha 1 - antitrypsin. The same parameters, returned to normal 
during convalescence in individuals with alveoli tis who avoided 
further avian contact. All these changes, which occurred in 
tandem, suggested that the humoral immune system was involved in 
the active disease process. 
8. Various genetic and environmental factors were examined to see 
which would delineate individuals who were predisposed to 
developing alveolitis, and also to being antibody responders. 
The atopic status, as measured by total serum IgE and IgE 
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antibody to avian antigens, personal and family allergic history 
and skin prick testing with common allergens and avian antigens, 
was not associated with disease. The incidence of rheumatoid 
factor (as one index of autoimmunity) was not raised in 
al veoli tis, and the HLA and P 1 phenotypes appeared to have no 
bearing on disease. A further constitutional factor of age also 
appeared to have no bearing on the ability to mount an antibody 
response nor the development of disease. 
The genetic factors which do predispose to antibody 
responsiveness and to disease susceptibility are still obscure • 
.. 
Some environmental factors on the other hand have a 
profound effect on the antibody response. Cigarette smoking 
appears to inhibit the ability to mount an antibody response to 
the inhaled antigens, and also the disease was less common among 
smokers. The mechanism for this inhibition is not understood, 
but it is thought to be part of a general depression of the immune 
response which is more evident at the pulmonary level. This 
inhibitory effect is reversed in some ex-smokers. The extent of 
avian exposure also affects the antibody response. In general, 
the greater the ecXposure (in terms of hours per day, number of 
birds and years of keeping pigeons) then the greater the incidence 
of antibody responders. However, paradoxically, these antibody 
posi ti ve subjects had progressive lower mean ti tres of antibody 
with increasing exposure. The explanation for this is not clear, 
there may be a desensitization procedure allied to increasing 
exposure, 'or there may be some self-regulation of exposure in the 
symptomatic (high antibody) subjects, which results in decreased 
exposure, for example by wearing a mask or reducing the hours per 
day in avian contact. Some follow-up studies in individuals 
identified in this thesis will clarify these details. 
9. The mechanism for disease proposed and supported by data in 
this thesis involves humoral immunity. However, this position 
was taken up at the outset in order to re-evaluate the position of 
humoral immunity in the disease using mone sensitive methods, and 
stricter clinical selection of subjects than in previous studies. 
The data collected here should form the basis from which further 
studies can continue. For example, it is highly probable that 
cell-media ted immuni ty is also involved in the disease process, 
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and work on this particular arm of the immune response would 
benefit from similar quantitative, antigen-specific analysis. 
The antibody profile of individuals could then be 
compared with th~ir cellular profile at different phases of 
exposure, and during different stages of disease. Of particular 
interest would be the elucidation of cellular events during an 
inhalation provocation test, in association with the other 
measurable physiological and seriological parameters. 
10. In conclusion, it has been demonstrated that the quantitative 
.. 
antibody measurement is of value in the investigation and clinical 
management of patients with extrinsic allergic alveoli tis. One 
further useful clinical adjunct was intradermal skin testing with 
antigen, where an immediate weal and flare reaction was indicative 
of antibody, and strong weal reactions were selective for 
alveoli tis patients. 
The clinical relevance of antigen inhalation provocation 
testing on the· other hand was debatable. However, the 
serological fluctuations associated with a positive acute 
reaction, and thEf therapeutic effects of drugs, along with the 
mechanism of the anaphylatic IgG antibody activity demonstrated on 
skin testing should be of interest in the investigation of the 
disease mechanism and the general antigen-handling and immuno-
responsiveness of the lung. 
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APPENDIX A. 
1. STUDY GROUPS. 
The subjects on whom the work of this thesis was based 
were predominantly active pigeon breeders. They were contacted 
during several large-scale surveys at conventions in Central 
Scotland and Blackpool, by referrals from chest physicians 
throughout the UK and by visi ting various local pigeon racing 
clubs. 
The surveys undertaken in Scotland provided information 
on 277 individuals (1978/1979 survey ) and 102 individuals 
(1979/1980 survey). All the subjects completed a questionnaire 
(Table 38) and were interviewed by chest physicians having some 
experience with alveolitis. A 10ml blood sample was taken, and 
in the latter survey a full range of skin tests was performed 
using common allergens and avian-specific antigens. The 
information obtained formed the basis for Chapter 6 which 
discussed skin testing and al veoli tis. The serological 
investigation of ~hese survey subjects for whom there was also 
data concerning symptoms, avian exposure, smoking history and 
other parameters listed on Table 38, formed the basis for Chapters 
3 and 4 of this thesis. 
Twenty individuals from a local club at Larbert kindly 
agreed to donate monthly blood samples for one year and this 
provided ·the information for Chapter 5, section 4a. The 
challenge subjects on whom the rest of Chapter 5 is based were all 
subjects from Central Scotland who were well known to us and who 
gave informed consent for investigation. The three patients who 
were followed during convalescence (Chapter 5, Section 4) were all 
under the care of Dr. Boyd at Belvidere Hospital, Glasgow. 
Sera were also obtained from 30 subjects belonging to a 
local club at Kirkintilloch, and a further 30 were obtained from 
subjects attending a convention at Blackpool. These sera were 
used to measure resting serum complement levels in pigeon breeders 
and were handl~d accordingly (Chapter 4, Section 6). These 
subjects were also tuberculin (Mantoux) skin tested to complement 
the data in Chapter 6. 
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A further 98 subjects were referrals from chest 
physicians over a 5 year period. 
2. QUESTIONNAIRE. 
This was based on the MRC questionnaire for chronic 
bronchitis, and was expanded to include details of avian exposure, 
avian specific respiratory symptoms, general respiratory symptoms 
and details of occupation, smoking and allergies. The 
questionnaire was completed under medical supervision for 
accuracy (Table 38). 
3. CLINICAL ASPECTS OF EXTRINSIC ALLERGIC ALVEOLITIS. 
The symptoms associated with acute extrinsic allergic 
. alveoli tis described in Chapter 1 and listed in questions 8 and 13 
of the questionnaire (Table 38) were individually non-specific. 
For'this reason it may be difficult for subjects with minimal 
avian contact to recognise symptoms. They may put such an 
episode down to "a touch of flu", or they may imagine that 
progressi ve dyspnoea was due to their age. These reasons are 
thought to expla:tn the insidious nature of chronic alveoli tis , 
especially among subjects exposed to budgerigars, where continuous 
exposure to just one bird is common. Among pigeon fanciers it is 
common to spend a few hours per day in contact with copious 
amounts of antigenic dust during handling large numbers of pigeons 
and daily cleaning out the loft. This heavier periodic exposure 
resul ts in more prominent symptoms in sensitized subjects and 
acute episodes could be recognised. 
The assessment of pigeon breeders disease based on the 
questionnaire and personal. interview required the presence of at 
least one respiratory and one systemic symptom occurring together 
4 - 6 hours after avian exposure on at least three ocasions. 
Subjects were considered to have prominent asthmatic symptoms if 
they had the regular occurrence of at least 3 immediate symptoms 
on contact with birds. Subjects 'who described no symptoms formed 
a clear group, wherea~ a number with vague symptom pattern: 
predominantly hay fever were considered as a separate 
indeterminate group (see Table 39). 
~4~a. 
TABLE 38. QUESTIONNAIRE: 
Pigeon Exposure Data: 
1. Do you keep pigeons at present? 
If NOT when did you stop and why? 
2. How long have you kept pigeons? ____ Years Months 
------
3. Have you kept pigeons continuously or periodically? 
4. How many pigeons do you generally keep? 
5. Have you ever been in regular contact with other birds? 
6. How many hours,~· on average, do you spend in contact with the 
pigeons each week during the season? 
7. Do you ever wear a mask when in contact with pigeons? 
Symptom Data: 
8. When in contact with your pigeons hav~ you EVER noticed: 
a. shortness of breath 
b. wheezing in your chest 
c. a dry cough 
d. sneezing, blocked or running nose 
e. itchy/running eyes 
f. -tightnessrin chest 
9. Have the above symptoms EVER been severe enough to make you come 
away from the pigeons? 
10. How long after coming into contact with pigeons do these 
symptoms occur? 
less .than ten minutes; ten to thirty minutes; more than thirty 
minutes. 
11. Do these symptoms occur: 
Occasionally (once/3mnths); sometimes (once/2wks); usually (at 
least twice/wk). 
12. . How long have you had them? 
141b. 
13. Several hours (4 to 8) AFTER being in contact with pigeons have 
you EVER experienced attacks of, or persistent: 
a. shortness of breath 
b. wheeze 
c. shivering and/or feeling cold 
d. sweating 
e. fever or temperature 
f. dry cough 
g. tiredness or aching muscles 
h. tightness in chest 
14. How long is it before you feel well again? 
15. Have you ever noticed "flu-like" feelings in the evening and at 
night which ve gone by the following morning? 
16. How often do these symptoms occur? 
Occasionally (once/3mnth); sometimes (once/2wk); usually (at 
least twice/wk) 
17. How long ~ve you had them? 
18. Are these symptoms worse, better or the same -
a. at the weekend 
b. after attending a pigeon show 
c. after a holiday away from home 
d. after cleaning out the 10ft 
Respiratory Data: 
19. Do you USUALLY cough first thing in the morning in winter? 
20. Do you USUALLY cough during the day in the winter? 
21. Do you cough like this on most days for as much as three months 
each year? 
22. Do you USUALLY bring up any spit or phlegm from your chest first 
thing in the morning in the winter? 
23. Do you USUALLY bring up any spit or phlegm from your chest during 
the day in the winter? 
24. Do you bring up spit like this on most days for as much as three 
months each year? 
. 25. Do you.ever get short of breath when walking with others of your 
own age, on level ground? 
141c. 
26. During the past three years hve you ever had any chest illnesses 
have kept you from your usual activities for more than a week? 
27. ·Have you ever had -
a. heart trouble 
b. bronchitis 
c. pneumonia/pleurisy 
d. tuberculosis 
e. asthma 
f. other chest illnesses 
28. Have you ever had any illness requiring a period in hospital? 
29. Do you require-regulax medicines for any condition? 
30. Have you ever worked in: 
31. 
32. 
33. 
34. 
a. a coal mine 
b. any other mine 
c. a quarry 
d. a foundry 
e. a pottery 
f. a cotton, flax or hemp mill 
g. with asbestos 
Do you smoke? 
How many cigarettes/cigars do you smoke per day? 
( How long have you smoked? 
If you have ever smoked: 
a. How long did you smoke for? 
b. How many did you smoke per day? 
c. When did you stop? 
Allergies: 
35. Have you ever suffered from: 
a. Hay fever 
b. Asthma 
c. Eczema/Dermatitis 
d. Were you "chesty" as a child? 
36. What do you suspect causes the/these condition/s in your case? 
37. Does any relative have any of the conditions listed above? 
141d. 
S Y M P TOM G R 0 U P 
ALL ALVEOLITIS INDETERMINATE ASTHMA NIL 
n=102 33 32 8 29 
Immediate Symptoms: 
Dyspnoea 27 17(52%) 4( 12) 6(75) 0 
Wheeze 21 13(39) 3 (9) 5(62) 0 
Dry cough 2·7 16(48) 7(22) 4(50) 0 
Rhinitis 26 10(30) 11(34) 5(62) 0 
Conjunctivitis 17 4(12) 9(28) 4(50) 0 
Chest tightness 23 13(39) 4( 12) 6(75) 0 
Late Symptoms: 
Dyspnoea ( 20 16(48) 2 (6) 2(25) 0 
Wheeze 8 6 (18) 1 (3) 1(12) 0 
Shivering/Cold 17 16(48) 0 (0) 1(12) 0 
Sweating 21 19(58) 1 (3) 1(12) 0 
Fever/Temperature 14 14(42) o (0) o (0) 0 
Dry cough 24 18(55) 5(16) 1(12) 0 
Malaise 25 21(64) 2 (6) 1(12) 0 
Chest tightness 17 11(38) 4( 12) 2(25) 0 
'Flu-like' . 36 24(73) 9(28) 3(37) 0 
TABLE 39. The positive response rate to questions concerning 
immediate and late symptoms specifically related to 
avian exposure in 102 pigeon fanciers. The 
symptomatic groupings are described in the text and 
the percentages are in parenthesis. 
These symptoms are most readily demonstrated by a 
controlled bronchial provocation test by inhalation of the 
appropriate antigen. This is often performed to confirm a 
diagnosis of allergic alveolitis, and is sometimes even necessary 
in order to convince some pigeon fanciers that the birds are 
indeed the cause of their disability. 
The results of inhalation challenges in alveoli tis have 
been the subject of several reports (see Appendix C), and the most 
common symptomatic patterns from these reports were general 
malaise and chest tightness (Harries et aI, 1980); malaise, fever 
with widespread ache~ and pains (Hendrick et aI, 1980) which was 
summarised in most subjects by describing a 'flu-like illness' in 
the evening which had resolved by the next day. 
These are in general agreement with symptoms described by 
subjects during positive inhalation challenge tests (see Chapter 
5), and also with the symptom score from survey 'subjects (Table 
39). 
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APPENDIX B. 
SEROLOGICAL MEASUREMENTS 
1. RADIOIMMUNOASSAY OF ANTIBODY. 
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The potential use of a method for accurately measuring 
IgG antibody in extrinsic allergic alveoli tis patients was 
recognised by Nielsen and co-workers (1974), and this group 
developed a quantitative radioimmunoassay, analogous to the RAST 
test, where the soluble antigens relevant to the disease syndrome 
under investigation were bound to a solid phase. The theory and 
'" 
many practical aspects of this assay are discussed at length in a 
recent publication (Parratt, McKenzie, Nielsen & Cobb, 1982). 
Details not covered, however, included the preparation of the 
antigen and quality control of the assay. 
The specific antigen in pigeon breeders disease is the 
serum gamma-globulin (Faux, Hendrick & Anand, 1978). This was 
obtained from fresh pigeon blood, following cardiac puncture of 
ether anaesthetised birds, by ammonium sulphate precipitation of 
the serum globulin (Hebert, 1973) and column chromatography of the 
reconsti tuted gloQulin through Sephadex G200. The second and 
largest of the four protein peak elution profile contained the 
specific antigen (Figure 1). This antigen was then bound to the 
surface of cyanogen bromide activated Sepharaose 4B according to 
the manufacturer's instructions (Pharmacia UK Ltd), thus providing 
a solid phase antigen for the assay. 
Duplicate amounts of this antigen were incubated in 
excess amounts, previously established by chequerboard titration 
with aliquots of patient's serum. After at least 30 minutes the 
Sepharose antigen-bound antibody complex was washed by 3 cycles of 
"resuspension in phosphate buffered saline, O.01M, pH 7.2 (PBS) and 
centrifugation at 2000rpm for 5 min, after each wash the 
supernatant was aspirated. After the 3rd centrifugation step the 
Sepharose antigen-antibody pellet was resuspended in a solution of 
radiolabelled anti-human IgG in excess, previously determined by 
chequerbDard titration. 
The radiolabelled anti-human IgG was prepared from sheep 
anti-human IgG, gamma-chain specific, obtained from the Scottish 
Antibody Production Unit (SAPU, Law Hospital Carluke). The 
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globulin fraction from this antiserum was radiolabelled with 
Iodine-125 by the method of McConachey and Dixon (1966). The 
average efficiency of radiol~belling in eight consecutive 
experiments in this laboratory was 58%. Foll~wing a further 30 
minutes incubation, the washing procedure was repeated, and the 
bound radio-activity was measured on a gamma-counter. 
The quality control of the assay was observed in the 
first instance by estimating the upper limit of normal of sera 
from subjects with no avian exposure, usually 3 or 4 sera from 
control negative subjects were included in each assay. When the 
" 
assay worked optimally these values were always below 4 ug/ml. A 
high titre serum which had been 'previously measured by 
quantitative preCipitation against pigeon gamma-globulin antigen 
was diluted serially with normal human serum to generate a 
standard curve of counts obtained from serial antibody levels, 
previous work having shown a linear relationship between the bound 
radioactivity and antibody content. The counts obtained from the 
unknown sera tested could then be interpolated on to the standard 
curve and therefore quantified. 
The pr~cision of the assay was measured at 'the most 
sensitive part of the standard curve; the 50% point. The 
measuremnt of 100 replicate samples generated a standard deviation 
of 4.8%. 
The between-assay variability and the accuracy of each 
measurement was controlled by incorporating negative, low, medium 
and high standard sera of known value. These samples when 
measured can form a second internal standard curve by which the 
values of replicate samples in different assays could be 
regularised. This was done using a simple mathematical formula:-
True Value = Measured Value - Intersept 
Slope 
Using this, the between assay variation was always less 
then 10%. , 
2. ENZYME LINKED IMMUNOASSAY (ELISA) OF ANTIBODY 
1 t method of Voller, Bidwell & The indirect microp a e 
Bartlett (1976) was employed using polystyrene EIA microtitration 
145 
plates (Flow Laboratories, Irvine) as a carrier surface for 
antigen. Optimal proportions were established by chequerboard 
titration; for the binding of the pigeon gamma-globulin antigen 
on to the plate, this was 60 ug/ml. All the test sera were 
diluted 1 in 50 with. PBS, and the alkaline phosphatase conjugated 
anti-human IgG was used at 1 in 1000 dilution (Miles Laboratories, 
Batch Number S725). 
The assay procedure involved coating the wells of the 
plate with antigen diluted in carbonate buffer 0.1M, pH 9.6, at 
150 ul per well, overnight at 4oC. The plate was washed three 
.. 
times by immersion in wash buffer PBS O.1M, pH 7.2 containing 0.5% 
Tween-20. The test sera were added in duplicate at 100 ul per 
well and incubated for 3 hours at room temperature. The plates 
were washed three times as before and 100 ul of enzyme conjugate 
was added to each well and incubated at room temperature for a 
further three hours. After a further three washes, a substrate 
solution of p-nitrophenyl phosphate (104 phosphatase substrate -
Sigma) at 1 mg/ml in 10% diethanolamine, pH 9.8 was added at 
100 ul per well. After approximately 30 minutes, when sufficient 
colour had developed in positive control sa~ples, the reaction was 
halted by adding 50 ul of 3M sodium hyroxide. The absorbance of 
each well at 405 mm was read using a spectrophotometer (Multiskan, 
Flow Laboratories). 
The results of a comparison between this ELISA method and 
the standard RIA for 102 samples are shown on Figure 36. The 
results ~orrelated highly significantly (r=0.93). 
This assay procedure was used for other antigen 
preparations, e.g. pigeon IgA at 50 ug/ml and feather extract 
(bloom) at 100 ug/ml, and for other antibody classes eg, 
anti-human IgA (batch S873) and anti-human IgM (batch S874) both 
from Miles-Yeda, each used a.t 1 in 200 dilution. 
An amplified ELISA system was used to measure the IgG 
subclass activity against avian antigens.' This method followed 
the standard ELISA procedure except that antisera against the 
subclasses of IgG were used after the incubation with patients' 
serum. Anti-human IgG "subclass 1-4 (M1175) were obtained from 
the Dutch Red Cross, and from Seward Laboratories Ltd. Both 
polyclonal (BA235 BA238) and monoclonal (BAM 8-11) were 
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FIGURE 36. 
ABSORBANCE 40h," (.U.S.A. 
Comparison of individual values of serum IgG 
antibody against avian antig~ns in 101 pigeon 
breeders measured by radio-immunoassay and 
enzyme-linked immunosorbent assay (ELISA). 
The correlation coefficient was r = 0.93. 
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obtained. The polyclonal sera were raised in sheep and, 
therefore, the next incubation step in these cases was with 
alkaline phosphatase labelled anti-sheep IgG (Miles-Yeda, S836). 
The monoclonal sera we~e from mouse ascitic fluid, therefore, the 
next step was an overlay with alkaline phosphatase labelled 
anti-mouse IgG (Miles-Yeda, S148). The washing procedure, and 
application of substrate were as before. 
3. PRECIPITIN TESTS FOR ANTIBODY. 
(i) Double diffusion in agar • 
.. 
Precipitating antibody against pigeon serum (N and N/10 
dilution) in the sera of 102 pigeon breeders was measured using 
Onchterlony double diffusion in agar. The results plotted on 
Figure 37, show an overlap of antibody values between the 
precipitin positive and negative, although in general this 
technique could detect antibody greater than 40 ug/ul which is in 
general agreement with other workers (Parratt, 1975; Gill, 1970). 
(ii) Counter current immuno-electrophoresis. CCIEP. 
To demonstrate precipitating antibody against pigeon 
feather (bloom) ~xtract antigens, which have been shown to be 
negatively charged at pH 8.6, the sera of 97 pigeon breeders were 
tested by CCIEP on an 8 x 8 cm agar slab at 10 v/cm for 2 hours 
against this antigenic extract and the number of precipitin bands 
which resolved was counted. This number was correlated with the 
IgG antibody titre as measured by RIA (Figure 8). 
4. HAEMAGGLUTINATION. 
The pigeon red blood cells are thought to have surface 
bound immuno-globulin light chain which is a major antigenic 
fragment in PBD, and since these cells are nucleated and settle 
quickly they are very con~enient for measuring agglutinating 
antibody directly (mainly IgM class antibody) or following 
reduction by di thiothrei tol treatment (Olson, Wei bIen, 0' Leary, 
Moscowitz & McCulloch, 1976) to measure IgG class antibody. The 
latter agglutinating titres were compared with the specific IgG 
antibody levels as measured by RIA in 100 subjects (Figure 9). 
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FIGURE 37: The serum IgG antibody levels against 
pigeon gamma globulin antigen in 102 
pigeon breeders with and without 
precipitins against pigeon serum. 
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5. STAPHYLOCOCCAL PROTEIN A BINDING ASSAY FOR IMMUNE COMPLEXES 
The cell wall of Staphylococcus aureus contains a protein 
(Pr~tein-A, M. Wt = 42,000 D) which binds non-specifically to the 
Fc portion of human IgG (Forsgren & Sjoquist, 1966), except IgG3, 
and several other mammalian species. Taking advantage of the 
strong affinity of this binding, protein-A bearing staphylococci 
have been used as solid phase immunabsorbents for localisation of 
IgG-antigen complexes (Brunda et aI, 1977) and radiolabelled 
protein A conjugates have been used to measure antibody (Marier, 
.. 
Jansen & Andriole, 1979) and immune complexes (Stevens & Bridts, 
1981; Langone, 1982). The method used in the present study 
utilised the immunabsorbent properties of a protein A rich 
staphylococcal immunabsorbent and radiolabelled protein A to 
detect circulating IgG immune complexes in the serum of subjects 
with extrinsic allergic alveolitis. The method used was that of 
Barkas (1981) without any modifications. 
Staphylococcus aureus, Cowan strain 1, NTCC 8530, 
head-killed and formalin-treated, was obtained from the 
Microbiological Res~arch Establishment, Po~ton Down, and used as a 
1% (v/v) suspension in PBS containing 0.5% sodium azide pH 7.2. 
Protein A was obtained from Sigma and iodinated by the 
method of McConachy & Dixon (1966) to a specific activity of 
between 9 and 13 mCi/mg in different experiments. 50 ug (50 ul) 
of protein A was mixed with 1 mCi (10 ul) of 1-125 and 4 ug (5 ul) 
chloramine- T at room temperature for 1 min. 5 ug (5 ul) of 
sodium metabisulphite was added. All reagents were dissolved in 
PBS. 500 ul of PBS containing 1% BSA was added and the mixture 
fractionated on a 20 x 1cm column of Sephadex G25 equilibrated 
with PBS/BSA. The eluted protein was stored at 4oC. The 
binding efficiency was generally greater than 80%. Test sera 
were prepared by adding 100 ul to an LP3 tube containing 8 ul of 
500mM EDTA pH 7.5, followed by 300 ul PBS, pH 7.2. 2 ml of 6% 
(W/V) polyethylene glycol 6,000, PEG (BDH) in 0.1M boric acid, 
·0.025M sodium tetrabora te, O. 075M sodium chloride pH 8.3, was 
added and the samples incubated at 40 c overnight. The tubes were 
then centrifuged at 1000g for 20 minutes at room temperature. 
The supernata~ts were aspirated and the pellets were washed with 
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1ml of 5% PEG prepared by diluting 5 parts of the 6% solution 
above with 1 part of distilled water. The final pellets were 
re-dissolved in 400 ul PBS at 100 temperature for 15 min •. 
Duplicate 100 ul samples were incubated with 100 ul of 
the 1% S. aureus suspension at 370 C for 1 hour. 500 ul of PBS + 
1% BSA was added to each pellet followed by 50 ul of radiolabelled 
protein A; between 14 and 20 ~ in different experiments, the 
pellets were re-suspended and incubated at 40 C for 30 min. 500 
ul of PBS + 1 % BSA was added and the pellets washed as before 
twice. Precipitated radiolabel was measured on an EMI Nuclear 
Enterprises Gamma Co~nter NE1612. The results were calculated as 
the percentage of the counts bound over the counts added. 
To assess the validity of the assay, IgG was purified 
from normal human serum by salt frationation and column 
chromatography. The IgG was adjusted to 20 mg/ml and heated at 
. 630 C for 30 min to induce aggregation, (Soltis et aI, 1979). The 
high molecular weight aggregates were separated from the monomeric 
IgG by column chromatography using ACA-22. The elution fractions 
were assa~dfor IgG by protein A binding (x---x) and for IgG 
aggrega tes by thy above method (o---o) (Figure 38). This 
demonstrated that monomeric IgG did not interfere with the assay. 
For quality control of the assay, various control 
positive and negative sera were used for calibration (Table 20). 
6. Clq BINDING ASSAY FOR IMMUNE COMPLEXES. 
This assay method depended on the binding of human Clq 
onto the surface of plastic tubes, and the subsequent binding of 
immune complexes via the Fc region which has affinity for the 
solid phase Clq. The method followed was based on that of Hay, 
Nineham & Roitt (1976) using human Clq purified from serum by the 
method of Yonemasu & Stroud (1971). One ml volumes of Clq 
solution 10 mg/l in PBS were incubated in polystyrene tubes (LP3, 
Luckham Ltd., Sussex) for between 1 and 3 days at 40 C. After 
three washes with PBS the tubes were filled with 2ml of 0.01 % 
gelatine solution iQ PBS and incubated at room temperature for 2 
hours. After three more washes with PBS the tubes were ready for 
use or could be stored frozen with the iast wash buffer. 
Test sera were prepared by mixing 50 ul with 100 ul EDTA 
~ 
. 
FIGURE 38. Elution profile of aggregated and monomeric IgG 
through ACA-22. The protein A binding activity 
in each fraction with and without previous PEG 
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(0.2M, pH 7.5) and incubating for 30 min at 37oC, after which the 
sera are kept on ice. A duplicate 50 ul samples were aliquoted 
into the Clq - tubes along with 950 ul PBS + 0.05% V/V Tween 20. 
The tubes were incubated at 37°C for one hour and a further 30 min 
at 4°C. After three washes with cold PBS the tubes were 
incubated with I ug anti-IgG, iodine-125 labelled, in one ml 
PBS-Tween for I hour at 37°C and 30 min at 4oC. The tubes were 
counted empty after three washes with PBS. 
7. RADIAL IMMUNODIFFUSION FOR PROTEIN MEASUREMENT • 
.. 
Serum proteins including alpha 1-an ti trypsin, IgG, IgG 
subclasses 1-4, IgM, IgA, Clq, C4, C3, Factor B, C-reactive 
protein were measured by radialimmunodiffusion (Mancini, Carbonara 
& Heremans, 1965) using commercially available plates (Seward 
Laboratories Ltd) or by incorporating appropriate antisera into 
gel. This latter method was used for measuring C3d, using 
antisera supplied by the Dutch Red Cross, and C3d standards 
supplied by Prof. K. Whaley, Pathology Dept., University of 
Glasgow. Serum Clq was measured similarly, using commercial 
anti-Clq and poole<rt normal human serum as a standard for Clq, 
namely 100%. 
The total IgG subclass levels were measured similarly 
using the antisera described in section 2. Subclass standards 
were supplied by Seward Laboratories (BR99) • The precipitin 
rings were often too faint to be read therefore the gel was washed 
in saline for 48 hours and immersed in a dilution of anti-sheep 
(or anti-mouse if appropriate) antiserum usually at 1 in 10 in PBS 
(both antisera supplied by SAPU, Law Hospital, Carluke) • 
Following 24 hours incubation, the gels were again washed for 48 
hours with saline, dried and stained for protein. 
of the precipitin rings could then be read. 
The diameter 
If necessary, a similar enhancing procedure was applied 
to the measurement of C3d. 
"8. LATEX AGGLUTINATION. 
Human serum rheumatoid factor was measured "by the 
agglutination of latex particles coated with gamma-globulin (Ortho 
R.A. Test). This system is calibrated using WHO rheumatoid 
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arthritis reference sera. 
9. TOTAL AND SPECIFIC IgE MEASUREMENT. 
Total and specific IgE was measured by the Phadeqas PRIST 
and RAST methods respectively (PHARMACIA, U.K. Ltd), according to 
the manufacturers instructions. 
( 
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APPENDIX C 
Inhalation Provocation Tests in Extrinsic Allergic Alveolitis 
The demonstration of a positive reaction to antigen challenge 
by exposure to the dusts normally encountered at the workplace, or at 
home, or by inhalation of a nebulised solution of antigen in a 
controlled environment is of value in establishing a causal role for 
these antigens in disease. 
These studies were predominantly undertaken to clarify 
obscure causes of respiratory and systemic problems and also as an 
experimental model for following the pathology of the disease during 
the acute phase. The main literature reports on inhalation 
provocation testing with reference to alveoli tis are listed below. 
Table 40 Inhalation Provocation Testing: Literature. 
1. Reference: Williams (1963) 
Subjects 
Antigens 
Results 
14 p~tients with farmers lung, 44 controls. . 
1% w/v saline extract of mouldy hay nebulised for 
6 mins. 
One immediate reaction, 9 developed'symptoms of malaise and 
fatigue, feeling hot and shivery, gradually between 3 and 8.5 hours, 
lasting from 4 to 24 hours, 6 developed pyrexia 5 to 6 hours 
post-challenge and in 3 it was 10 to 13 hours. The fever subsided 
gradually over 3 to 4 hours. The pulse and respiratory rates rose 
with the fever. ECG showed a sinus tachycardia. Basal crepitations 
heard in 6 about the same time as the fever and persisted for up to 24 
hours. Rhonchi were not heard. Leucocytosis occurred in 6 with no 
increase in eosinophils. No radiological changes were seen. 
The mean FEV1 decrease at the height of the reaction was 19%, 
(the inhalation of 1% isoprenaline had little effect on this), the 
mean FVC decrease by - 1 9%, the MVV by. -27%, the PEFR by -21 %, the 
static compliance by -46%, the DLco by -31%. The FEV 1 - FVC ratio 
did not change and the mean MV increased by 42%. 
Challenges wi th equivalent amounts of 12 common allergen 
extracts were negative, as were all control challenges. 
2. Reference: Reed et al (1965) 
Subjects 
Antigens 
Results 
3 pigeon breeders, 3 control subjects. 
Dust ~rom pigeon feathers. 
100 mg pigeon droppings extract aerosolised. 
Sterile pigeon serum, 3 mI. 
Fea ther dust provoked a dramatic febrile episode with 
rales and a decreased VC. Two controls showed no effects. 
Pigeon droppings extract provoked a fever of 39.2oC and a decrease 
" 
of 24% in diffusing capacity. Three controls had a pyrexia up to 
38.2oC with no fall in diffusing capacity. Pigeon serum provoked 
a pyrexia of 39.2oC, malaise and cough. The diffusing capacity 
fell by 14%. Exertional dyspnoea persisted for several weeks. 
o Control subjects developed temperatures up to 37.5 C, no symptoms 
and a 4% drop in diffusing capacity. 
3. Reference: Hargreaves et al (1966) 
Subjects 
Antigens 
Results 
10 bird breeders, 7 controls 
Aviap serum at 1 in 100, and 1 in 10 if necessary, 
then droppings extract at 10 mg/ml. 
The most consistent reaction was a rise in temperature at 
about 7 hours, accompanied in 5 subjects by malaise and shivering, 
wi th a leucocytosis at 8 hours, which returned to normal at 24 
hours in 8 cases and 48 hours in 2. Eosinophilia occurred in 4 
subjects after 24 hours, the highest occurring in one asthmatic 
subject. Basal crepititations were heard in the 3 most sensitive 
subjects who developed sharp systemic reactions to relatively low 
doses (1.0 - 2.5 ml of 1 in 100 pigeon serum). 
One patient who had ,had typical attacks of alveoli tis 
until he was desensitised did not react to 1.75 ml of pigeon serum 
at 1 in 10. 
Two subjects had falls in FVC below 85% of pre-test 
values at 8 - 10 hours which was not revers.ed by isoprenaline., 
There was a slight fall in ILCO between 8 and 48 hours in 7 of 9' 
reactors. 
Control subject did not react to similar challenges. 
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~. Reference: Pepys et al (1968) 
Subjects 
Antigens 
Results 
3 bird breeders, 2 allergic aspergillosis 
1% w/v Asp~rgillus fumigatus solution, avian serum 
The early and late reactions associated with inhalation 
of Aspergillus fumigatus and the late reactions associated with 
inhalation of avian serum were inhibited by pre-treatment with 
disodium cromoglyca te, however, subsequent challenges with the 
same allergens provoked milder reactions, considered to be due to 
a loss of sensitivity caused by repeat challenging. 
5. Reference: Hargreave and Pepys (1972) 
Subjects 
Antigens 
Results 
81 subjects 
Nebulised avian' serum initially at concentrations 
which caused a weal of no more than 3 mm on prick 
testing. If skin testing was negative then the 
starting dilution was 1 in 100 for 5 minutes in 
3 diNided doses of 1 then 2 then 2 minutes, with 
10 minutes between, to look for immediate 
reactions. If negative, repeat the next day with 
1 in 10 for 5 minutes, and if necessary for 10 
minutes on the following day. If this was 
negative, try similarly with dropping extract up 
to 10 mg/ml for 20 minutes. 
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Nine immediate reaction, 27 late reactions and ~ dual (early 
and late) reactions. The immediate reaction was associated with a 
history of asthma, immediate skin reactivity (Type 1 reaction). Late 
reactions included pyrexia and polymorphonuclear leucocytosis, with 
feature of a reaction in the peripheral respiratory tissues and 
asthma, often· unassociated with wheezing, not reversed by 
isoproterenol. 
Fever tended to be the first sign and us~ally cleared by 24 
hours, although in 5 it persisted for between 30 and 72 hours. The 
o highest temperature recorded was 39.9 C. Systemic symptoms usually 
preceded or accompanied the fever, these most commonly consisted of 
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chills, shivering, feeling hot or sweating (22 subjects), malaise (16 
subjects) and headache (10 subjects). Leucocytosis occurred in 67% of 
febrile late reactions, was seen between 6 and 14 hours, and tended to 
fall, but was still raised in 35%, by 24 hours. In 16% of the tests 
the WBC count was normal at 6 - 14 hours but raised at 24 hours. All 
returned to normal by 48 hours. The increase was due. to a 
neutrophilia with a mild increase in eosinophils, usually at 24 hours, 
the monocytes and basophils remained consistent, with a decrease in 
lymphocyte number. 
Respiratory signs were mild. Nine symptomatic responders 
had no measurable change in ventilatory capacity. There were no 
changes in TL • 
co 
6. Reference: Moore et al (1974) 
Subjects 
Antigens 
Results 
10 pigeon breeders; 5 with and 5 without alveoli tis 
Nebulised 2ml pigeon serum 
No clinical details. Airflow obstruction, febrile response 
and leucocytosis only in symptomatic subjects. Pre challenge CH-50 
levels were normal .. or slightly raised in symptomatic subjects, but 
tended to be low in asymptomatic breeders. At 4 hours post-challenge 
the CH-50 dropped in 4 asymptomatic subjects, in one subject this was 
noticed at one hour and persisted to 12 hours. In the responders the 
CH-50 did not change at 4 hours. 
7. Reference: Pepys & Hutchcroft (1975) 
Subjects 
Antigens 
Results 
One pigeon breeder 
Pigeon serum 
Pre-treatment with disodium cromoglycate prevent subsequent 
reaction. 
8. Reference: Schatz et al (1976) 
Subjects 
Antigens 
Results 
Family of pigeon breeders, one with and 5 without 
al veoli tis . 
Pigeon serum 
No clinical details. One reacted, 5 did not. The 
responder had an early (one hour) increase in CH-50 of 10% and the 
other 3 did not vary uniformly. By 8 hours all sera had 10% less 
CH-50 than pretest levels and at 24 hours all sera had higher 
CH-50 (between approx. 10 - 20%). 
9. Reference: Warren et al (1977) 
Subjects 
Antigens 
Results 
4 bird breeders 
2ml nebulised avian serum 1 in 10; 2ml feather 
extract at 40 mg/ml. 
No symptoms nor reduction in exercise tolerance for 2 
hours, then they developed dry cough, dyspnoea, fever, malaise, 
headache, and a restrictive ventilatory defect developed at the 
same time. 
There were no changes in lung volumes, VC, FEVI , V max 
and N2 washout curves in the first hour, therefore there was no 
evidence of an immediate pulmonary reaction to inhalation of avian 
antigen in extrinsic allergic alveolitis. 
10. Reference: Slavin (1978) 
Subjects 29 subjects, 2 controls 
Antigens Serum and dander from laboratory animals and 
, domestic pets. 
Results 
Diagnostic significance was established when inhalation 
challenges with animal serum and dander extracts provoked 6 hours 
reaction of fever, dyspnoea and reduction of DLCO. Minimal 
contact with gerbils (transporting 3 in the back of a car) was 
enough to provoke a response. 
11. Reference: Schuyler et al (1978) 
Subjects 1 pigeon breeder 
Antigens 2ml sterile pigeon serum nebulised. 
Results 
Five hours post challenge the patient developed myalgia, 
fever and malaise. Vital capacity dropped from 101% to 91% 
predicted. Leucocyte count rose from 7,000 to 12,000 per mm, 
o c 
oral temperature rose from 36 C to 38.5 C, arterial P02 dropped 
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from 79 to 69mmHg, and single breath diffusing capacity from 125% 
to 86% predicted. All symptoms and signs had resolved by 24 
hours. 
12. Reference: Voisin et al (1979) 
Subjects 6 bird breeders 
Antigens Pigeon serum diluted 1 in 1000, nebulised at 
0.5 ml/min for 0.5, 1, 1.5, and 2 mins. separated 
by 10 mins. Then repeated at 10 fold 
concentration on subsequent days. 
Results 
Symptoms Pyrexia Leucocytosis Pulmonary function 
1 + + +++ not significant 
2 +++ ++ ++ +++ 
3 +++ ++ ++ 
4 + + 
5 +/- nd + 
6 ~ + ++ + 
The complement CH-50 decreased in one subject only, No.2. 
13. Reference: Baur et al (1980) 
Subjects 1 pigeon breeder, 3 farmers 
Antigens Nebulised pigeon serum 0.1 mI. Hay dust 
Results 
(strewing hay, 15-30 1, in a small cabin for 30-60 
mins.) 
Typical reactions occurred between 3 and 7 hours. 
Pyrexia and leucocytosis associated with symptoms of cough, 
fatigue and mild dyspnoea. D~CO, VC and FEV1 decreased, the DLCO 
proved to be the most sensitive method for detecting the pulmonary 
disturbances, whereas VC and FEV1 did not always show significant 
changes. No Significant change in airways resistance was found 
in any of these subjects. 
Before challenge, all four patients had decreased CH-50, 
two also had decreased C3, and C5 was increased in two. After 
challenge there was a significant increase in CH-50 in all four 
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cases (by 28%, 32%, 93% and 117%), in C3 in one, C4 in two and 
Factor Band C5 in one. In most cases these elevations were 
highest 5 to 7 hours or 24 hours after challenge. C3 split 
products could not be detected in the two sera tested. 
14. "Reference: 
Subjects 
Antigens 
Results 
Hendrick et al (1980) 
29 bird breeders, 2 controls 
Avian serum, 1 in 100-1 in 5 in saline for 5 - 30 
mins. and extracts of avian droppings, 3-40 mg/ml 
in saline for 5-30 mins. 
Natural exposure occurred in a budgerigar aviary 
and in a pigeon 10ft for 1, 1-5, or more than 5 
hours. 
Twenty-three posi ti ve reactions, 21 developed malaise, 
fever and headache after 2-9 hours and these symptoms were delayed 
for 12-18 hours in 2 subjects. Respiratory symptoms were less 
striking; few were troubled by undue breathlessness at rest 
although all noted this on exertion. None felt wheezy, several 
developed a dry cough and difficulty taking a deep satisfying 
breath. 
"Facial appearance" proved to be the most informative 
clinical sign and the observers soon learned to recognise the 
onset of positive responses from the loss of normal cheerful and 
active expressions. At this stage the subjects themselves rarely 
admitted to any change in well-being. As the response worsened, 
the unwell appearance was generally readily apparent. 
Auscultatory signs were uncommon. Body temperature exceeding 
o 37.2 C identified 78% of posi ti ve reactors and excluded 95% of 
negatives. Leucocytosis fully attributable to neutrophils was a 
feature of reactors, but there was no significant changes in the 
number of circulating eosinophils. The lymphocytes decreased in 
reactors, but not consistently. 
The ,mean ratio of FEV 1 - FVC was 81% before and at 
maximum fall in FVC. Vita~ capacity was reduced, mean -8%. The 
single, breath diffusing capacity for carbon monoxide was only 
significant (greater than 15% fall) in 2 reactors. There were no 
radiological changes in these subjects. 
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15. Reference: Edwards & Cockcroft (1981) 
Subjects 6 hospital theatre workers, 2 controls 
Antigens Nebulised cpntaminated humidifier water, 
concentrated x 100. 2ml was the equivalent of 8 
hours the exposure. 
Results 
Four reacted, including 2 who had no previous symptoms 
(one with and one without precipitins). The reactions were 
mainly systemic with fever, chills, headache, arthralgia, malaise 
~ 
and a feeling of discomfort on deep inspiration, maximal in 3 
between 10 and 12 hours and 18 hours in the other. All subjects 
felt better the next day but in retrospect said they felt somewhat 
unwell for up to a week after the challenge. 
Vital capacity fell but there was no fall in gas transfer 
factor. No x-ray changes were observed. The WEe count 
increased in all reactors, and also by 180% in one 
precipitin-positive non-reactor. The ESR did not produce any 
significant changes and complement levels showed no significant 
increase or decrease in either group. 
16. Reference: 
Subjects 
Antigens 
Results 
Edwards & Davies (1981) 
16 farmers 
2ml of soluble M. faeni antigens at 1 mg/ml for 10 
mins. 
Three positive reactors had a pyrexial response starting 
at 6 hours, peaking at 15 hours and gradually resolving at 20 
hours. Each described a feeling of malaise, and there was a fall 
in VC and FEV1 maximal at 12 hours. One further subject 
described cough and dyspnoea alone. There were no significant 
increases or decreases in CH-50 levels over the first 6 hour 
period after challenge for ~ither responder~ (2 tested) or 
non-responders (12 tested; 7 with precipitins). 
17. Reference: Lozano et al (1982) 
Subjects 37 bagasse workers; 5 bagassosis patients 
Antigens Daily work exposure. 
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Results 
Before work there were no significant differences in 
pulmonary function between patients and workers. After work 
there were no differences in pulmonary fun~tions in the workers 
since the morning, however, the patients had a significant mean 
reduction in FVC at 8 hours of -28%. There were differences 
between the groups in leucocyte count and serum IgG. There were 
no differences in complement components C3c or C4 nor in CH-100 
Other literature reports which discuss inhalation 
challenge but do not give full details include: 
18. Rodey et al (1979). Inhalation challenge on 51 symptomatic 
and 100 asymptomatic bird breeders. 
19. Muller et al (1976). 6 cases of bird fandiers lung. 
Natural exposure at home resulted in 5 acute reactions. 
20. Sennekamp et al (1975). 8 bird breeders - natural exposure. 
( 
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APPENDIX D 
Animal Models of Extrinsic Allergic Alveolitis 
A recent review has drawn attention to the need for 
animal models for a better understanding of the common diseases of 
the respiratory tract (Reid, 1981). The models that exist for 
extrinsic allergic alveoli tis are firstly, where the disease 
occurs naturally (Slauson & Hahn, 1981), and secondly where a 
similar disease profile can be induced. A summary of these 
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models, and the major literature reports are listed on Table 41. 
There occurs a natural disease in horses and cattle which 
is clinically, aetiologically, immunologically and morphologically 
similar to EAA in man (Table 41: 8, 12 - 18), and the bovine form 
of farmer's lung was first described in cattle from the same 
district in Britain where the first human case was described 
(16,17). These observations on the natural history of the 
disease are of interest, but the experimental use of these animals 
is limited by the comparative rarity of the disease and the 
expense of the ani~als. However, some interesting data 'on the 
seasonal sensitivity of the peripheral blood lymphocytes to 
M. faeni antigen (18), and seasonal differences in antibody to 
M. faeni (17) has been reported, correlating with the seasonal 
pattern of disease, and this is in keeping with observations in 
pigeon breeders disease (McSharry et aI, 1983). Also there may 
be some economic benefit from work which shows that progressive 
desensitisation of cattle is possible with repeated antigen 
injections (15). 
Studies using animal models of EAA started in the late 
sixties, and the main workers include Fink and colleagues in 
Milwaukee studying pigeon breeders disease (1-7), Salvaggio in New 
Orleans (21-29) and Wilkie in Texas (11-15) studying Farmer's 
lung, and Richerson in Iowa City (33-39), and Willoughby in 
Baltimore (44-47) looking at miscellaneous pulmonary 
.hypersensitivities. 
One early 6bserva~ion made during attempts to induce lung 
disease in animals by insufflation of nebulised soluble antigens 
such as ovalbumin, pigeon serum or horseradish peroxidase, was the 
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relative non-responsiveness of the animals (1,4,30,32). However, 
experiments using animals primed with antigens emulsified in 
Fruend's complete adjuvant (FCA) demonstrated that this extra 
stimulation was required Jo render most of them responsive to 
subsequent aerosol challenge with nebulised 'antigen 
(4,5,32-34,41,45), although some animal models were still 
unresponsive despite this vigorous procedure (1,6a). The 
adjuvant effect of carrageenan, alum, concanavalin A, BCG and 
muramyl dipeptide have also been used to prime animals 
(4,1,38,45,46). Administration of some of these agents alone 
without antigen can cause pulmonary inflammation (4,33,48) and 
al though most workers have been careful to control for this, it 
must still obscure the interpretation of lung histology following 
antigen challenge. 
Some workers could induce an immune response by antigen 
inhalation without the preceding adjuvant stimulus (4,5,40,42) but 
this response was unpredictable and usually required longterm 
antigen insufflation. The response also differed with the same 
antigen in different animal species, for example bovine serum 
albumin (BSA) wa& a poor antigen in rats (1) but strongly 
immunogenic in rabbits (23,45), and pigeon serum was a poor 
antigen in guinea pigs (6a) but strongly immunogenic in monkeys 
(2,10). Also within the same species, different proteins could 
have different immunogenicities, for example in rats BSA was a 
poor antigen whereas pigeon droppings extract gave a good response 
(1), also, in guinea pigs, ovalbumin induced a severe pneumonitis 
but pigeon serum failed to produce significant disease (6a). In 
another laboratory, however, pigeon serum was used successfully to 
initiate disease in guinea pigs (6b). 
One model of alveoli tis in rabbits has been carefully 
established by Salvaggio (23). using antigens from Micropolyspora 
faeni, the causative agent in farmer's lung. The disease can be 
reproduced without using prior adjuvant stimulation, but intrinsic 
adjuvant prop~rties of the antigens have been described (23-2~). 
The par~iculate nature of the antigen has been suggested 
to cause a local inflammatory response (23) but soluble antigens 
can also resul t in disease (1, Reed, 1912), and inhala tion 
challenges with soluble antigens can reproduce symptoms. It is 
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possible that the particulate nature of these antigens may help to 
initiate disease, and also these particles may act as a vehicle to 
carry the soluble antigens to the peripheral airways where the 
disease is evident. In this respect, the pigeon bloom may be of 
similar importance in pigeon breeders disease, as discussed in 
Chapter 2. 
Another important factor which needs standardising in 
animal experiments is the dose and route of antigen 
administration. Passive breathing of nebulised antigen in animals 
results in only 0.2% (33) and 0.34% (45) of the delivered dose 
being immediately retained in the lung, corresponding to a total 
dose of a few micrograms of antigen, whereas by direct 
instilla tion, up to 50 milligrams of antigen delivered via the 
trachea has been reported (23). This is clearly a different 
situation, and indeed the extent of responsiveness to antigen, 
irrespective of adjuvant priming, has been'suggested to be related 
to the antigen dose (45). 
Animal models of pigeon breeders disease have been 
produced in rats (1,5) guinea pigs (6a, 6b) rabbits (4,7a,7b) mice 
(9a,9b) and monkeys, (2,3,10). Animal models of farmer's lung 
disease using antigens of Micropolyspora faeni have been produced 
in rats (21) guinea pigs (11,20) and rabbits (19, 22-30). This 
range of models of disease suggests that no one model is entirely 
satisfactory. 
The mechanism for disease is considered to be either 
humoral, immune complex mediated (6a, 6b, 34,44-47) based on 
histology, immuno-fluorescence, passive transfer with serum, 
protection by cobra venom factor (40,43,46 Olenchock et aI, 1976) 
superoxide dismutase (McCormick et aI, 1980) and steroids (42), or 
by cell-mediated hyper-sensitivity based on histology and passive 
transfer of disease with lymph~id cells. However, the consensus 
of opinion is that hyper-sensitivity involving both arms of the 
immune response is necessary for the full disease profile of 
alveoli tis (2,11, Roberts & Moore, 1977). 
The relevance of these animal models to the study of the 
human condition is based on extrapolating what can be interpreted 
from the histology and immunology of controlled manipulation of 
the animal models in ways which would not be possible in humans 
with alveolitis. 
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In addition to this, the human condition has a 
broad clinical and immunological spectrum, the causative antigens 
are diverse and the extent of each individuals' exposure history 
is varied. Inhalation challenge on humans are ge?erally 
unhelpful and can be dangerous in inexperienced hands, and only 
rarely would lung biopsies be indicated. However, some 
similarities between the animal models and the human condition can 
be seen from the available data. Firstly, the predominant state 
in animal and man is non-responsiveness to inhaled antigens (4, 
McSharry et aI, 1984). However, where an immune response becomes 
.. 
established, both specific antibody and sensitised lymphocytes are 
found, and the early acute phase of disease is associated with 
high antibody titres and acute haemorrhagic pneumonitis with 
positive immunofluorescence for antigen, antibody and complement. 
This is similar to acute cases investigated in humans (Barrowcliff 
& Arblaster, 1968; Seal et al 1968; Pepys, 1969; Wenzel et aI, 
1971; Ghose et aI, 1974; Fink, 1974). More chronic antigen 
exposure results in increasing cellular involvement, with a 
characteristic mononuclear cell infiltrate on lung histology 
(Hensley et aI, 196~). For the complete disease profile in 
animals and man both the antibody and cell mediated 
hypersensitivities seem to be involved (Roberts and Moore, 1977). 
This is best illustrated in non-human primates (2). This model 
is the closest to the human condition and some recent studies have 
shown that the regulation of alveoli tis in monkeys is by a lack of 
T-suppressor' cell acti vi ty ( 10) • Similar cellular suppressor 
influences in asymptomatic subjects have been reported, in the 
human condition, which are absent or non-functional in symptomatic 
subjects (Keller et aI, 1982). 
During studies on the active phase of the disease in 
animals it was overlooked until relatively recently that the 
disease activity and the immune response could wane during 
prolonged antigen insufflation (14,37,39,40). The mechanisms 
involved are unresolved, but whether there is an active tolerance 
or desensitisation would be,of considerable theoretical interest 
for insight into the disease"process, and the antigen handling and 
immune responsiveness of the lung. The same phenomenon may also 
exist in humans (McSharry et aI, 1984), and it may also be of 
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economic value for treating alveolitis in cattle (15). 
The unpredictability of the response to inhaled antigens 
in humans reflects indivudal constitutional differences and the 
same would apply to animals. However, experiments to establish 
the disease in diffeent strains of mice has allowed the mapping of 
the genes involved (9a,9b). This responsiveness was multigenic; 
the H-2 linked genes mapped within the I-B subregion, and some non 
H-2 linked genes are also involved, perhaps the same as those 
controlling the pulmonary inflammatory responsiveness to BCG 
(Allen et aI, 1911). So far there have been no fruitful genetic 
analyses of the disease in humans (see Chapter l, 4g), however 
with greater understanding of the spectrum of clinical 
presentation of the disease and the immune responsiveness to 
inhaled antigens, perhaps subpopulations of subjects may be 
defined having acute or chronic disease, or subjects may be 
defined as "high" or "low" antibody responders or indeed 
"non-responders" to inhaled antigens. Only when these groups are 
defined will there be any progress on HLA analysis. 
( 
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TABLE 41. Animal Models of EAA 
Reference Species 
1 • Rat 
2. Monkey 
cells 
both required for 
3. Monkey 
4. 
5. 
6a. 
6b. 
7a. 
7b. 
8. 
9a. 
9b. 
10. 
Rabbit 
Rat 
Guinea Pig 
( 
Guinea Pig 
Rabbit 
Rabbit 
Horse 
Mouse 
Mouse 
Monkey 
Antigen 
PDE 
BSA 
PS 
PS 
PDE 
PDE 
+BCG 
PS 
PS 
OVA 
PS 
PDE 
PDE 
CS 
PS 
PDE 
PS· 
Observation 
BSA poorly immunogenic. 
FCA used. Sensitised 
and antibody 
the full disease profile. 
Humoral response only. 
Normal lung histology. CH50 
drops on challenge. 
Humoral plus cellular 
response. 
Abnormal lung histology. 
No drop of CH50 on 
challenge. 
Early "immune response", 
later "allergic" response 
following 'prolonged 
insufflation. 
PS poor immunogen even with 
CFA 
OVA plus CFA gives IgE 
mediated disease. 
PS in CFA gives a good 
response. Immune-complex 
mediated disease. 
Additional inflammatory 
stimulus required for 
disease. 
Repeated aerosol challenge 
gives CMI response and 
chronic disease. 
Natural disease. 
Disease involves both Band 
T memory cells. 
Multigenic control of lung 
disease susceptibility. 
Disease modulated by 
T-suppressor cells. 
= = 
B. FARMER'S LUNG DISEASE 
11. Guinea Pig Mf 
12,13,14. 
15. 
16,11. 
18. 
19. 
20. 
21. 
22. 
23. 
24,25. 
. 26. 
21. 
28. 
29. 
Cattle 
Cattle 
Cattle 
Cattle 
Rabbit 
Guinea Pig 
Rat. Rabbit 
Rabbit ( 
Rabbit 
Rabbit 
Rabbit 
Rabbit 
Rabbit 
Rabbit 
Rabbit 
Mf 
Mf 
Mf 
Mf 
Mf 
Mf 
Mf 
Mf 
Mf 
+BSA 
Mf 
Mf 
Mf 
Mf 
Mf 
Mf 
CFA used. Sensitised 
cells and serum both 
required for passive 
transfer.of disease. 
Natural disease. 
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Desensitisation by antigen 
injection. 
Natural disease. 
Cell mediated immune 
reaction in peripheral 
blood lymphocytes of 
cattle. 
Type I reaction. 
Minimal effects of 
steroids. 
Antigen i.v. gave no DTH 
skin or peripheral node 
lymphocyte reactivity. 
Antibody positive. 
MMIF production by 
sensitised respiratory 
tract lymphocytes. 
M.faeni adjuvant boosts the 
anti-BSA response. 
Local adjuvant effect of 
spores • 
Passive transfer of 
sensitivity with lymphoid 
cells. 
Review of animal models. 
Steroids abrogate disease. 
M. faeni spores activate 
alveolar macrophages. 
Prolonged antigen 
insufflation results in 
waning of disease and 
antibody levels. 
C. EXPERIMENTAL ALVEOLITIS 
31. Monkey Af 
32. Guinea Pig 
33. Rabbit 
34. Guinea Pig 
35. Guinea Pig 
Rabbit 
36. Rabbit 
( 
37. Rabbit 
38. Rabbit 
39. Rabbit 
40. Rabbit 
41. Rabbit 
42. Rabbit 
OVA 
CFA 
OVA 
OVA 
PPD 
Haptens 
OVA 
PPD 
Haptens 
Ferritin 
OVA 
OVA 
OVA 
OVA 
HSA 
HRP 
HRP' 
Passive transfer of 
sensitivity with human 
serum. 
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CFA used. Both humoral and 
cellular hyp~rsensitivity 
involved in disease. 
Non-specific granuloma 
formation. 
Only 0.2% aerosolised dose 
retained in lung. 
Induction of type I, III 
and IV 
hypersensitivity in the 
lung. 
Conditions favouring CMI 
give 
EAA; conditions favouring 
anti-
body give haemorrhagic 
pneumonitis. 
Antigen in CFA. Reaction 
histologically similar to 
alveolitis. 
Types I,III or IV reactions 
depending on protocol. 
Adjuvant effect of muramyl 
dipeptide in initiating 
disease. 
Repeated intravenous or 
aerosol challenge caused 
antigen-specific 
desensitisation. 
Disease pattern following 
in-halation challenge did 
not cor-relate with 
presence of precipitins. 
CFA used. Pulmonary 
lesions correlate with CMI. 
No adjuvant used. Reaction 
suppressed by steroids. 
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43. Guinea pig OVA Suppression with CoVF and 
passive transfer with 
serum. 
44. Rabbits -- BSA Mitogenic stimulation, Con 
A required to initiate 
disease. 
45. Rabbits BSA Extra stimulus required for 
disease. Increased 
exposure resulted in 
decreased lung response 
despite maintenance of 
antibody. 
46. Rabbit BSA Stimulation with Con A -
suppression with CoVF. 
47. Rabbit BSA Lung disease inhibited by 
cholera toxin. 
( 
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Abbreviations for Table 41 
PDE = Pigeon droppings extract HSA = Human serum albumin 
BSA = Bovine serum albumin HRP = Horseradish 
peroxidase 
PS = Pigeon serum CMI = Cell mediated 
immunity 
FCA = Freunds complete adjuvant s.c.= subcutaneous 
administrn. 
BCG = Bacille Calmette Gu~rin i.v.= intravenous 
administrn. 
OVA = Ovalbumin MMIF= Macrophage migration 
inhibition factor 
CS = Chicken serum .,. DTH = Delayed type hyper-
Mf = Micropolyspora faeni senstivity 
Af = Aspergillus fumigatus CoVF= Cobra venom factor 
PPD = Purified protein derivative ConA= Concanavalin A. 
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